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Human Rifl, the ortholog of the yeast Rapl interacting factor 1, a telomere 
length regulator was identified. Immunofluorescence did not reveal an association of 
human Rifl with telomeres. Preliminary co-immunoprecipitation with known telomeric 
proteins and chromatin immunoprecipitation failed to show an interaction of human Rifl 
with telomeric protein complexes or with telomeric DNA. Unexpectedly, Rifl responded 
to ionizing radiation (IR), UV light, and clastogens, forming foci that co-localized with 
other DNA damage response factors such as 53BP1, ATM, BRCA1, Chkl, Nbsl, and 
Rad 17. Furthermore, Rifl localized to uncapped telomeres, as do other DNA damage 
response factors. Among DNA damage response proteins, Rifl showed a unique 
dependence on the ATM kinase. Whereas inhibition of ATR signaling did not suppress 
the Rifl response, ATM deficient cells treated with IR or UV lacked Rifl foci even after 
prolonged incubation or high radiation dose. Therefore, IR-induced Rifl foci constitute 
an assay for ATM status. The Rifl response also depended on the presence of 53BP1 but 
was not affected by reduced function of BRCA1, Chk2, Nbsl, and Mrell. RNAi-
mediated Rifl inhibition resulted in increased radiosensitivity, indicating that Rifl 
contributes to ATM-mediated protection against exposure to ionizing radiation. 
In order to more fully understand telomere length regulation in mammalian cells 
and the evolutionary history of telomere-binding complexes, a search for novel hRapl -
binding proteins and studies of the Rapl telomere complex at human telomeres were 
performed. Both genetic and biochemical methods were used in order to better 
understand the role of the Rapl complex, consisting of hRapl, TRF2, and the Mrell 
complex, in human telomere biology. A yeast two-hybrid screen was carried out using 
hRapl as a bait and two genes were identified. The first gene, called candidate 144 
(C144), encodes a novel zinc-finger containing protein. Immunofluorescence and co-
immunoprecipitation failed to reveal an association of C144 with telomeres. Deletion of 
the open-reading frame YDL175c in S. cerevisiae, the ortholog of C144, did not result in 
detectable changes in telomere length. The second gene, called FLASH, was previously 
identified to play a role as an adaptor in ligand-mediated apoptosis. In 
immunofluorescence experiments, FLASH did not co-localize with known telomeric 
proteins. 
I n t r o d u c t i o n 
Part 1: The D N A damage response 
The viability of both cells and organisms depends on the transmission of genetic 
information in an accurate manner. In order to facilitate this process, cells must maintain 
genomic stability and prevent an excess of potentially harmful heritable mutations. 
Eukaryotes have evolved a variety of checkpoints in order to verify that a proper 
sequence of events occurs at each stage of the cell cycle prior to the next. Such events 
include replication of genomic DNA once and only once, proper chromsome attachment 
to the mitotic spindle, and the presence of necessary growth conditions in the 
environment. The classic definition of a checkpoint is a pathway where progress through 
the cell cycle can be stopped until conditions are suitable for the cell to proceed to the 
next stage (Hartwell and Weinert 1989). 
Genomic DNA can be damaged by both endogenous and exogenous stimuli. 
Failure to properly repair this damage is catastrophic and can lead to genomic instability 
and cell death. A number of specialized checkpoint mechanisms, collectively referred to 
as the DNA damage response, have evolved to recognize DNA damage. The ability of 
mammalian cells to survive chromosomal damage depends on the coordinated activity of 
DNA response pathways that halt cell cycle progression and facilitate DNA repair prior 
to DNA replication or mitosis. The DNA damage response extends beyond the classical 
definition of the checkpoint pathway because the DNA damage response links cell cycle 
arrest mechanisms with diverse processes including the recruitment of protein complexes 
to sites of DNA damage, DNA repair, apoptosis and transcription (Zhou and Elledge 
2000). 
The D N A damage response is a complex and overlapping set of molecular 
pathways that detects damage and triggers cellular responses. The ability of cells to 
detect double-stranded breaks (DSBs) is exquisitely sensitive and rapid. Studies in which 
a single break is generated with the HO endonuclease in yeast indicate that one DSB is 
sufficient to generate a DNA damage response and cell death (Weiffenbach and Haber 
1981). The detection of DNA damage then initiates the effector arms of the DNA 
damage response. 
The execution phase of the DNA damage response involves the establishment 
and maintenance of cell cycle arrest, repair processes, and the decision to re-enter the cell 
cycle or undergo apoptosis. Following the recognition of DNA damage, eukaryotic cells 
will halt their cell cycle progression until the DNA damage is repaired. Cells are capable 
of undergoing arrest in S and M phases as well as at the Gl/S and G2/M transitions of the 
cell cycle through a number of molecular pathways (Figure 1-1). Cells also initiate repair 
processes to correct the specific DNA lesion detected (see below). If the DNA damage is 
repaired, then cells can re-enter the cell cycle and continue to grow. In certain cases, 
such as overwhelming quantities of DNA damage or inability to properly execute repair, 
the damaged cell will undergo apoptosis. The exact signals involved in cell-cycle re-
entry and apoptosis are not currently known. 
Nature Reviews | Cancer 
Figure 1-1. Mechanisms of cell cycle arrest in response to double-stranded breaks. 
M a n y of the k n o w n factors involved in the D N A damage response are shown along with 
their ability to activate (arrows) or inhibit (t-shaped arrow) one another. Figure taken 
directly from Shiloh 2003. 
The causes and types of D N A damage and repair 
DNA can be damaged through a number of mechanisms that each leave signature 
alterations in DNA structure. DNA damage can arise from either endogenous or 
exogenous means. The three primary ways in which DNA damage occurs are the 
exposure of cells to exogenous radiation (including ultraviolet (UV) and ionizing 
radiation (IR)) or chemicals (including compounds found in cigarette smoke and cancer 
chemotherapy agents), the products of normal cellular metabolism (including reactive 
oxygen species and products of lipid peroxidation), and spontaneous chemical changes in 
DNA bases (including hydrolysis of nucleotide bases that result in abasic sites and 
spontaneous deamination) (reviewed in (Hoeijmakers 2001)). In addition to this list, 
normal replication can lead to stalled replication forks which can be processed into 
single-stranded and double-stranded DNA breaks. The inability of cells to properly 
repair damaged DNA leads to gross chromosome rearrangements (GCRs), a proposed 
source of genomic instability (Kolodner et al. 2002). Genes involved in the processes of 
maintaining S-phase checkpoints, recombinational repair and telomere maintenance act to 
suppress GCR in S. cerevisiae and these genes likely perform similar functions in 
mammalian cells (Myung et al. 2001; Kolodner et al. 2002). 
Different DNA damage response pathways are capable of detecting and repairing 
the various types of DNA damage that occur. These pathways include the mismatch 
repair, base-excision repair, transcription-coupled repair, and the repair pathways for 
single- and double- stranded breaks. Cells can also replicate directly though certain types 
of DNA damage in an error-prone process termed damage tolerance (Friedberg 2003). 
The Y-family D N A polymerases are capable of replicating damaged D N A (Goodman 
2002). Double-stranded DNA breaks (DSBs) are particularly harmful to the cell because 
it is unable to properly progress through mitosis. When DSBs occur as a result of DNA 
damage, a rapid DNA damage response begins within minutes in order to facilitate repair 
and prevent either replication or mitosis, which would be fatal to the damaged cell 
(Khanna and Jackson 2001; van Gent et al. 2001; Jackson 2002). 
In mammalian cells, DSBs are repaired with high fidelity by homologous 
recombination (HR) or they are processed through the error-prone non-homologous end-
joining (NHEJ) pathway. It is unclear exactly how mammalian cells decide whether to 
repair DSBs via HR or NHEJ. Since HR is more accurate, it is assumed that this is the 
preferred mechanism of DSB repair. However, DSBs that occur in repetitive sequences 
should be repaired by NHEJ since HR may lead to inappropriate recombination with an 
incorrect locus (Lieber et al. 2003). In S. cerevisiae, DSBs are repaired primarily through 
HR (Haber 1995) and loss of NHEJ components do not lead to radiosensitivity in diploid 
strains. In vertebrate cells, HR seems to occur preferentially after replication when a 
sister is present, whereas NHEJ takes place in Gl (Takata et al. 1998). DSBs also occur 
under physiologic conditions including meiotic recombination, V(D)J recombination in 
the formation of the T cell receptor and immunoglobulin genes, and isotype class 
switching. Factors involved in NHEJ, including Ku70/Ku86, Artemis, DNA-PK,.,,, 
XRCC4 and DNA ligase IV, and in HR, including the Mrell complex, Rad51, Rad52, 
Rad54, Rad55, Rad57, BRCA1, and BRCA2, play a role in the processing of DNA 
breaks. 
A T M and A T R : master regulators of the D N A damage response 
Ataxia-telangiectasia mutated (ATM) and ATM- and rad3- related (ATR) play a 
central role in the response of mammalian cells to IR, UV and replication stress. ATM 
was identified in 1995 as the gene mutated in the disease ataxia-telangiectasia (A-T) 
(Savitsky et al. 1995). A-T is an autosomal recessive, pleiotropic genetic disorder 
characterized by cerebellar degeneration at an early age leading to progressive motor 
dysfunction, immunodeficiency, genomic instability, gonadal and thymic atrophy and 
cancer predisposition (reviewed in (Shiloh 1995; Lavin and Shiloh 1997; Crawford 1998; 
Becker-Catania and Gatti 2001)). The initial observation that A-T patients were 
particularly sensitive to the radiotherapy used to treat their lymphoreticular tumors 
suggested that A-T was a disorder involving an improper response to DNA damage 
(Gotoff et al. 1967; Morgan et al. 1968). At the cellular level, cells from A-T patients are 
hypersensitive to IR and other agents that cause DSBs (Agarwal et al. 1977). In response 
to IR, these cells have diminished ability to undergo Gl and G2 arrest and reduce their 
level of DNA synthesis (Painter and Young 1980; Kastan et al. 1992; Paules et al. 1995). 
The ATM cDNA was cloned by two groups and could complement many of the cellular 
defects of A-T cells (Zhang et al. 1997; Ziv et al. 1997). Heterozygous carriers of ATM 
mutations have an elevated risk of developing breast cancer (Swift et al. 1991; Athma et 
al. 1996; Inskip et al. 1999; Olsen et al. 2001). The effect of diminished ATM function 
on this finding was recently substantiated in a murine model that also is cancer-prone 
(Spring et al. 2002). 
A T M and A T R contain a C-terminal domain similar to the protein PI3 kinase 
domain. Whereas PI3 kinase phosphorylates lipids, many other members of the PIKK 
family, including ATM, ATR, DNA-PK, ATX/SMG-1, mTOR/FRAP, and TRRAP, have 
protein targets. DNA-PK plays an accessory role in the NHEJ pathway. TOR proteins 
play a role in monitoring nutrient levels and TRRAP, which does not have a functional 
kinase domain, plays a role in histone acetylation (Grant et al. 1998; McMahon et al. 
1998; Schmelzle and Hall 2000). Members of this family also contain a FAT domain 
adjacent to the kinase domain and the exact role of this domain is unclear. PIKK family 
members are large proteins with molecular weights ranging from 270 - 450 kilodaltons 
and the kinase domain and the FAT domain together make up only a small portion of the 
total protein. Members of the PIKK family have been shown to contain numerous HEAT 
repeat sequence motifs, which suggests an relationship between PIKKs that extends 
beyond the kinase domain (Perry and Kleckner 2003). 
ATM and ATR play a central role in the DNA damage response by 
phosphorylating target proteins that act as mediators and effectors of the DNA damage 
response. ATM has a number of direct targets, including the Nbsl component of the 
Mrell complex, a proposed DNA damage sensor that is also involved in recombinational 
repair ((Gatei et al. 2000b; Lim et al. 2000; Zhao et al. 2000), reviewed in (Petrini and 
Stracker 2003)). Additional ATM targets include Chkl and Chk2, Mdm2, p53 and 
53BP1, BRCA1, Rad9, Rad 17, Smcl, and H2AX (reviewed in (Kastan and Lim 2000; 
Shiloh 2003)). ATM and ATR, serine/threonine kinases that are often referred to as 
(S/T)-Q kinases because the glutamine residue is almost invariably found after either a 
serine or threonine residue in phosphorylation sites. A broader consensus sequence was 
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identified for A T M by changing the known target sequences and monitoring the effect in 
in vitro ATM kinase assays (Kim et al. 1999). A similar approach yielded an optimal 
target sequence of LSQE for ATM when a library of peptides was tested (O'Neill et al. 
2000). 
ATM and ATR phosphorylate overlapping targets. An example of the 
overlapping specificity of ATM and ATR is the phosphorylation of p53 on serine 15. 
Both ATM and ATR phosphorylate this site both in vitro and in vivo (Banin et al. 1998; 
Canman et al. 1998; Lakin et al. 1999; Tibbetts et al. 1999). The phosphorylation of 
BRCA1 on residues 1423 and 1524 is another example of a single target that can be 
modified by both ATM and ATR (Scully et al. 1997b; Cortez et al. 1999). Even though 
ATM and ATR have overlapping target specificities, the kinetics and extent to which 
they participate in the phosphorylation of a given target in response to different DNA 
damage stimuli often differs. For example, ATM phosphorylates p53 on serine 15 almost 
immediately after exposure of cells to IR, whereas ATR phosphorylation of p53 serine 15 
occurs only at late stage following IR. Additionally, ATR phosphorylates p53 on serine 
15 in a time-independent manner when cells are exposed to UV (Tibbetts et al. 1999). 
One basic difference between ATM and ATR signaling is that ATM is more 
strongly activated by IR, whereas ATR is more strongly activated by UV and drugs that 
cause replication stress such as hydroxyurea (HU). This division is not strict. Targets of 
ATM are still phosphorylated in A-T cells in response to IR, albeit with slower kinetics 
and to a lesser extent. Furthermore, ectopic expression of ATR can complement the 
radioresistant DNA synthesis phenotype in A-T cells (Cliby et al. 1998). 
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The detection of double-stranded breaks 
The actual detection of DSBs and other DNA lesions is the first step in the 
initiation of the DNA damage response. A longstanding question in the DNA damage 
field involves the mechanism(s) by which DSBs are detected. It is clear from 
immunofluorescence (IF) studies that DNA damage proteins associate with presumptive 
sites of DNA damage within minutes (and possibly shorter) after exposure of cells to IR. 
A variety of mechanisms have been proposed to explain the rapid and sensitive detection 
of DNA damage. It is currently unclear if a single proposed mechanism dominates or if 
multiple mechanisms act either simultaneously or in concert. Studies in bacteria and 
yeast indicate that lesions such as mismatched bases or abasic sites can be recognized by 
specific proteins. Thus, the most obvious mechanism of DSB detection involves one or 
more proteins that are able to detect DSBs. Two early candidates as the sensors of DSBs 
were poly(ADP-ribose) polymerase (PARP) and DNA-protein kinase (DNA-PK) because 
they could recognize abberant DNA structures in vitro. However, genetic evidence has 
failed to substantiate these claims and cells deficient in these proteins can still form 
ionizing radiation induced foci (IRIF) (Wang et al. 1995; Jimenez et al. 1999). Ionizing 
radiation induced foci represent the accumulation of DNA damage response factors on 
DNA lesion and these can be visualized with IF microscopy. Thus, these molecules are 
either not functioning as sensors or there is considerable redundancy in their function. 
ATM and/or ATR have been proposed as direct sensors of DNA damage since 
ATM and ATR play a critical role in the cellular response to IR. The question of whether 
ATM and ATR can directly recognize DSBs and other abberant DNA structures in vitro 
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and in vivo is controversial. Following the generation of DSBs by IR or clastogens, 
inactive ATM kinase dimers are converted into active monomers through 
autophosphorylation on serine 1981 (Bakkenist and Kastan 2003). This phosphorylation 
event takes place at IR doses as low as 0.1 Gy and occurs almost immediately after DNA 
damage. The suggested stimulus for this mechanism of ATM activation is a gross change 
in chromatin based on the effects of chloroquine and altering salt conditions (Bakkenist 
and Kastan 2003). Although the exact mechanism of ATM activation has not been 
conclusively established, it is clear that the phosphorylation of ATM at serine 1981 is an 
early and critical event in the cellular response to IR. ATR requires a signaling partner, 
ATR-interacting protein (ATRIP), in order to respond to DNA damage (Cortez et al. 
2001). ATRIP is phosphorylated by ATR and is required for the stability of ATR and 
ATR signaling following DNA damage. 
Recent studies have provided significant insight into possible mechanisms by 
which ATM and ATR could be sensors of DNA damage. A heterotrimeric complex of 
Rad9, Rad 1, and Hus 1, often termed the 9-1-1 complex, may act as a sensor. ATM 
phosphorylates Rad9 on Serine 272 and Husl is also an ATM target (Chen et al. 2001; 
Foray et al. 2003). These proteins are thought to form a structure related to proliferating 
cell nuclear antigen (PCNA) (Thelen et al. 1999). Another DNA damage response, 
Radl7, is phosphorylated at multiple sites by ATM after IR exposure and is proposed to 
have structural homology with replication factor C (RFC) (Green et al. 2000). During 
DNA replication, the clamp loader, RFC, loads the heterotrimeric PCNA ring onto the 
product of primase and PCNA subsequently facilitates polymerase recruitment and 
replication. By analogy, Radl7 may act to recruit and load the 9-1-1 complex onto DSBs 
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and other D N A lesions (Bermudez et al. 2003). It is unclear whether Rad 17 
phosphorylation by ATM is required for this recruitment event. Alternatively, the 9-1-1 
complex may act as a surveillance complex to constantly monitor the genome for DSBs 
based on its presumptive ability to slide along the DNA. 
Finally, another important complex in the DNA damage response, the Mrell 
complex, which consists of Mrell, Nbsl and Rad50, acts as a sensor of DNA damage. 
The criteria for a DNA sensor are as follows: the sensor should physically associate with 
DNA after damage; the sensor should be associated with DNA damage in a manner 
independent of activating modifications such as ATM phosphorylation; mutations that 
affect the ability of the sensor to bind damaged DNA should correlate with failure to 
activate DNA damage cell cycle checkpoints; and it should be possible to identify 
mutations that result in a constituitively active damage signal or a sharply up-regulated 
signal. Thus far, the Mrel 1 complex fits all of these criteria (Petrini and Stracker 2003). 
RPA may also act as a sensor of DNA damage. Recent evidence suggests that RPA 
interacts with ATRIP and recruits the ATR-ATRIP complex to ssDNA after DNA 
damage (Zou and Elledge 2003). The binding of RPA to damaged DNA in yeast had 
previously been demonstrated (Carr 2003). 
DNA damage induced cell cycle arrest 
The ATM-dependent DNA damage response pathway can affect progression 
through the cell cycle before, during, and after DNA replication. ATR also plays a role 
in the ability of cells to halt cell cycle progression following DNA damage. 
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Cells with D N A damage undergo an arrest at the Gl/S transition that presumably 
prevents the cell from replicating damaged DNA until the damage is properly repaired. 
The central player in Gl/S arrest of cells after DNA damage is p53, a target of ATM 
(Canman et al. 1994; Siliciano et al. 1997; Banin et al. 1998; Canman et al. 1998; Khanna 
et al. 1998). p53 functions as a transcriptional activator of the cyclin-dependent kinase 
inhibitor (OKI), p21 (el-Deiry et al. 1993; Canman et al. 1994; Dulic et al. 1994; Deng et 
al. 1995). p21 directly inhibits the kinase activities of both cylinA-cdk2 and cyclinE-
cdk2 complexes which facilitate the Gl-S transition. ATM phosphorylates p53 on a 
number of residues and it was assumed that this modification is the molecular event that 
leads to p53 accumulation and, hence, p21 transcriptional activation. Initial attention 
went to p53 serine 15 modification because this residue is in the region of p53 that binds 
its inhibitor MDM2. The release of MDM2 from p53 as a result of serine 15 
phosphorylation would lead to p53 accumulation. The actual situation, however, is more 
complicated. First, serine 15 modification does not affect the p53-MDM2 interaction 
(Dumaz and Meek 1999). Second, ATM also phosphorylates MDM2 on residue serine 
395 and there is evidence to suggest that this event results in the disruption of the p53-
MDM2 complex (Maya et al. 2001). Finally, another ATM target, Chk2, is itself a kinase 
and phosphorylates p53 on serine 20 (Chehab et al. 2000; Hirao et al. 2000; Shieh et al. 
2000). Serine 20 phosphorylation interferes with the p53-MDM2 interaction. In 
addition to the various mechanisms by which p53 accumulates after DNA damage, Gl 
arrest to DNA damage is more complicated than p53 transcriptional activation of p21. 
More specifically, Gl arrest following DNA damage is at least a two-step process with an 
initial p53-independent process mediated by cyclin Dl proteolysis followed by a slower 
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arrest maintenance mediated by p53-dependent p21 transcription (Agami and Bernards 
2000). 
Cells also activate an intra S-phase checkpoint following DNA damage 
presumably in order to resolve stalled replication forks. A number of redundant 
molecular mechanisms underlie the intra S-phase checkpoint. The phenomenon of 
radioresistant DNA synthesis (RDS), which is the inappropriate replication of DNA 
following DNA damage, was first observed in A-T cells (Painter and Young 1980). 
ATM phosphorylates Chk2, which has a role in Gl/S arrest but also plays a role in the 
intra S-phase checkpoint. ATM and Chk2 are responsible for the phosphorylation of 
Cdc25A, resulting in its degradation (Falck et al. 2001). The destruction of Cdc25A 
prevents the dephosphorylation of Cdk2 which leads to intra S-phase arrest. Cdk2 is 
necessary for DNA replication because it loads Cdc45, which recruits the MCM complex 
to cellular origins of replication (Walter and Newport 2000). The intra S-phase 
checkpoint is due in part to phosphorylation of Nbsl, Smcl, FANCD2, and BRCA1 by 
ATM (reviewed in (Shiloh 2003)). The phosphorylation of Nbsl and Chk2 by ATM act 
as separate and parallel pathways in the intra S-phase checkpoint (Falck et al. 2002). 
Finally, cells with DNA damage undergo an arrest at the G2/M transition, 
presumably to prevent the cells from undergoing mitosis and segregating defective or 
broken chromosomes. Similar to the other checkpoint responses to DNA damage, the 
G2/M arrest following damage results from an overlapping series of mechanisms. Both 
ATM and ATR play a role in the G2 arrest pathway through their phosphorylation of 
Chkl and Chk2, respectively. Chkl and Chk2 subsequently phosphorylate Cdc25C, 
which leads to the dephosphorylation of Cdkl (reviewed in (Shiloh 2003)). It has been 
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proposed that phosphorylated Cdc25C binds 14-3-3 proteins which render Cdc25C 
inactive and unable to activate the mitotic cyclin B/Cdc2 kinase (Abraham 2001). 
The DNA damage response signal transduction network 
The DNA damage response is often described as a signal transduction network 
with one or more DNA damage signals detected by sensors which signal to effectors 
through a series of mediators and transducers. Signal amplification is a common property 
of transduction pathways. The phosphorylation cascade that results from ATM and ATR 
activation described above acts to modify and mobilize multiple cellular proteins in 
response to even a single DSB. Redundancy and cross-talk are two additional hallmarks 
of signal transduction which apply to the DNA damage response. The redundancy and 
cross-talk of ATM and ATR have been described above. Redundancy and cross-talk 
complicate the study of the DNA damage response just as they complicate the study of 
other signaling networks. 
An appreciation of the complexities of the DNA damage response provides a 
more realistic picture of what occurs in the cell following DNA damage. First, there is 
not always a sharp distinction between DNA damage sensor, transducer and effector. As 
discussed above, many of the proposed sensors also serve as transducers and effectors in 
response to DNA damage. Also, many proteins play a number of distinct roles in the 
DNA damage response. Several DNA damage response factors such as 53BP1, BRCA1, 
and the Mrell complex have multiple toles in the DNA damage response. Additionally, 
traditional notions of upstream and downstream signaling relationships are not always 
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instructive and may be difficult to dissect in the rapid D N A damage response. As 
discussed below, the Mrell complex appears to function both upstream and downstream 
of ATM. Finally, the effector functions of the DNA damage response occur 
simultaneously and involve common players. It is likely that the cell monitors the 
consequences of both cell-cycle arrest and repair in order to determine whether damage 
can be resolved or apoptosis should be initiated. 
The following sections will feature a description of a number of key players in 
the mammalian DNA damage response. Their roles in various aspects of the DNA 
damage response, such as checkpoint arrest, phosphorylation, and repair will be 
discussed. 
53BP1 
53BP1 was originally identified as a protein that interacts through a yeast two-
hybrid screen with p53 and was subsequently shown to be a co-activator of p53-
dependent transcription (Iwabuchi et al. 1994; Iwabuchi et al. 1998). 53BP1 contains 
BRCA1 carboxy terminal (BRCT) domains that are often found in DNA damage 
response factors and, as a result, the hypothesis arose that 53BP1 functions in the DNA 
damage response. Indeed, both human and Xenopus 53BP1 formed IRIF rapidly which 
co-localized with other known DNA damage response proteins (Schultz et al. 2000; 
Anderson et al. 2001; Rappold et al. 2001). Although the exact details differed slightly in 
the original publications, it appears that 53BP1 responds more strongly to IR than to UV 
or replication stress; that 53BP1 is phosphorylated in vitro and in vivo by ATM; and that, 
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although 53BP1 is capable of forming IRIF in A-T cells, the kinetics and extent of IRIF 
formation depend on ATM (Schultz et al. 2000; Anderson et al. 2001). Numerous studies 
have attempted to elucidate the specific function of 53BP1 in the DNA damage response. 
53BP1 is found at the kinetochore during mitosis and it is suggested that this may play a 
role in the mitotic checkpoint (Jullien et al. 2002). An siRNA approach that lowered 
levels of 53BP1 revealed that 53BP1 plays a role in p53 accumulation, the G2/M 
checkpoint, and the intra-S-phase checkpoint in response to IR (Wang et al. 2002). 
53BP1 forms foci in cancer cell lines expressing mutant p53, which suggests that the 
DNA damage respsonse may be constuitively activated in human tumors lacking p53 
(DiTullio et al. 2002). The exact role of 53BP1 in DNA damage response signal 
transduction is still under investigation. 
BRCA1 
Breast cancer 1 (BRCA1) plays an assortment of roles in the DNA damage 
response. Germline mutations of BRCA1 lead to a hereditary breast and ovarian cancer 
syndrome (Miki et al. 1994). BRCA1 is a large molecular weight protein that contains an 
N-terminal RING domain and two C-terminal BRCT domains (Wu et al. 1996; Bork et 
al. 1997; Callebaut and Mornon 1997). A large number of proteins with BRCT domains 
play a role in the DNA damage response and several factors, including TopBPl, MDC1 
and 53BP1, have been identified as DNA damage response proteins because of the 
presence of one or more BRCT domains (Makiniemi et al. 2001; Yamane et al. 2002; 
Goldberg et al. 2003; Lou et al. 2003a; Lou et al. 2003b; Stewart et al. 2003; Xu and 
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Stern 2003). B R C A 1 has many characterized cellular functions and it is difficult to 
identify which functions are critical for the DNA damage response. Early studies reveal 
that BRCA1 can function as a transcription factor with association to RNA pol II via 
RNA helicase A and that it can function in a complex with histone deacetylase activity 
(Scully et al. 1997a; Anderson et al. 1998; Yarden and Brody 1999). BRCA1 has a large 
number of proposed interacting partners, including BARD1 and CtlP. BRCA1 was 
shown to interact with the Mrell complex and biochemical purification revealed a large 
molecular complex termed the BRCA1 genome surveillance complex (BASC) which 
contains a variety of DNA damage components (Zhong et al. 1999; Wang et al. 2000). 
A large body of experimental evidence suggests that BRCA1 plays a role in the 
cellular response to DNA damage. BRCA1 forms nuclear foci during S phase and when 
exposed to DNA damaging stimuli such as UV, IR or mitomycin C (Scully et al. 1997b). 
A cell line termed HCC1937, deficient in BRCA1, was shown to be hypersensitive to IR 
(Scully et al. 1999). BRCA1 is a target of ATM and co-immunoprecipitates with ATM 
(Cortez et al. 1999). BRCA1 is directly phosphorylated by ATM on a number of 
residues, including serine residues 1387, 1423, 1457 and 1524 as shown by phospho-
specific antibodies (Gatei et al. 2000a; Gatei et al. 2001). The ATM-dependent BRCA1 
phosphorylation on serine 1387 is necessary for the ATM-mediated intra-S-phase 
checkpoint (Xu et al. 2002b). ATR can also phosphorylate BRCA1 (Tibbetts et al. 2000). 
BRCA1 is required for a subset of ATM- and ATR- dependent responses to DNA 
damage (Foray et al. 2003). Chk2 phosphorylates BRCA1 at serine 988 and this event is 
important for rescue of cell survival after damage in HCC1937 cells (Lee et al. 2000). 
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The exact mechanism by which B R C A 1 deficiency leads to tissue-specific 
tumorigenesis is currently unknown. One possibility is the concept of redundancy in 
which tissues other than the breast and ovary are able to properly execute BRCAl's 
functions in its absence. Conversely, it has been suggested that only breast and ovary 
provide a suitable environment for cells that have lost BRCA1 to survive. This idea is 
termed the BRCA1 suppressor hypothesis (Elledge and Amon 2002). The finding that 
BRCA1 co-localizes with the inactive X chromosome in females provides another 
possible mechanism underlying tissue-specific tumorigenesis upon loss of BRCA1 
(Ganesan et al. 2002). The authors propose that perturbations of the behavior of the 
inactive X resulting from BRCA1 loss may contriute to tumorigenesis in the breast and 
ovary. 
The Mrell complex 
The Mre 11 complex is a large molecular-weight complex consisting of Mre 11, 
Nbsl (originally termed p95), and Rad50 that plays a role in the DNA damage response 
as well as a diverse array of other biological activities. Mrell complex components are 
evolutionarily related to the SbcCD proteins found in bacteriophage T4, bacteria, yeast, 
Drosophila, and vertebrates (Sharpies and Leach 1995). The Mrell complex has a 
structure resembling SMC proteins and have a 3' -> 5' nuclease activity in vitro 
(Sharpies and Leach 1995; Connelly et al. 1999). The Mrell complex in yeast, 
consisting of Mrell, the Nbsl ortholog Xrs2, and Rad50 has been extensively 
characterized. It is known to play a critical role in the following three biological 
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processes: the creation of meiotic DSBs through the removal of Spoil, homologous 
recombination, and the DNA damage response (reviewed in (Haber 1998; Petrini and 
Stracker 2003)). The identification of a human ortholog of Mrel 1 began the study of the 
human Mrell complex and human orthologs of Rad50 and Nbsl were subsequently 
identified (Petrini et al. 1995; Dolganov et al. 1996; Carney et al. 1998). The Mrell 
complex is essential in chicken and mouse cells, but it is unclear which function is 
responsible for this property. 
The known biochemical functions and interaction partners of the Mrel 1 complex 
may contribute to its biological function(s). Nbsl has a 3' to 5' exonuclease activity in 
vitro (Trujillo et al. 1998). It has been suggested that this nuclease activity may work on 
DSBs and facilitate repair (Paull and Gellert 1998), although the exact mechanism is 
unknown. The Mrell complex has a helicase activity as well which is potentiated by 
Nbsl (Paull and Gellert 1999). A proposed zinc hook structure for Rad50 suggests that 
it might bridge multiple DNA molecules together and this may enable the Mrell 
complex to properly carry out its roles in DSB repair and recombination (Hopfner et al. 
2002). The Mrel 1 complex has been shown to co-immunoprecipitate with mediator of 
DNA damage checkpoint 1 (MDC1), an important DNA damage response factor (Stewart 
et al. 2003). Mrel 1 complex has also been found at human telomeres as part of the TRF2 
complex (Zhu et al. 2000). 
The components of the Mrel 1 complex play an important role in the reponse to 
DNA damage. Mrel 1 complex components were among the first proteins shown to form 
IRIF in response to DSBs (Maser et al. 1997). A special overlay technique using a 
layered grid placed over cells exposed to soft x-rays provides evidence that these IRIF 
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correspond to sites of DSBs (Nelms et al. 1998). Mrell complex components were 
originally predicted targets of ATM phosphorylation (Kim et al. 1999). It was then 
subsequently shown that Mrell and Nbsl are targets of ATM. Nbsl is necessary for 
Mrel 1 phosphorylation after damage (Dong et al. 1999). ATM phosphorylates Nbsl and 
loss of this site leads to a defect in the intra-S-phase checkpoint (Gatei et al. 2000b; Lim 
et al. 2000; Zhao et al. 2000). The Mrell complex also plays a role in the G2/M 
checkpoint following IR (Xu et al. 2002a). Nbsl is required for Chkl phosphorylation 
after IR (Gatei et al. 2003). Interestingly, ATM does not seem to be required to the 
localization of Mrel 1 to sites of DSBs (Mirzoeva and Petrini 2001). The Mrel 1 complex 
can still localize to dysfunctional telomeres in cells treated with caffeine, which inhibits 
both ATM and ATR (Takai et al. 2003), further indicating a role in the sensing of DNA 
damage. This requirement of the Mrell complex for Atm function has been 
demonstrated by others (Carson et al. 2003; Uziel et al. 2003). 
Deficiencies in the components of the Mrell complex lead to human 
chromosome instability syndromes. Nbsl is mutated in patients with Nijmegen breakage 
syndrome (NBS) (Varon et al. 1998). This rare, autosomal recessive genetic disease 
results in microencephaly, growth defects, immunodeficiency, and an increased risk of 
cancer. NBS has been classified as a disorder related to A-T based on the properties of 
cells from NBS patients and it is interesting that both Nbsl and ATM play a role in the 
DNA damage response. The discovery that Mrel 1 is mutated in patients with an ataxia-
telangiectasia-like disorder (ATLD) suggests an even closer link between the Mrell 
complex and ATM (Stewart et al. 1999). ATLD is a disorder in which patients have a 
clinical syndrome resembling A-T, but have wild type ATM. Although Rad50 has not 
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currently been associated with a chromosome instability disorder, the growth defects and 
cancer predisposition of knockin mice expressing the Rad50S allele of Rad50 suggest 
that mutations in Rad50 could lead to human disease (Bender et al. 2002). 
Y-H2AX 
H2AX has been proposed to play an important role in the mammalian DNA 
damage response. Each nucleosome contains eight proteins with two proteins each from 
the families H2A, H2B, H3, and H4. H2AX is one of the H2A subfamilies (H2A1-H2A2 
and H2AZ are the others) and H2AX represents 2 - 25% of cellular H2A in mammalian 
cells and virtually all of the H2A in yeast. The difference between H2AX and the other 
family members is a motif that contains residue serine 139, which is phosphorylated by 
ATM in response to IR (Rogakou et al. 1998; Burma et al. 2001). This response occurs 
within one minute of damage and it maximal after ten minutes post-IR. Calculations 
indicate that approximately 2 x 103 kilobases of DNA contain phosphorylated H2AX per 
DSB and points to models where large chromatin domains are formed at sites of DSBs 
(Rogakou et al. 1998; Rogakou et al. 1999). 
The ATM pathway and DSB repair 
A-T cells have a diminished ability to survive ionizing radiation (IR) and other 
genotoxic treatments that create double-strand breaks ((Taylor et al. 1975); reviewed in 
(Shiloh 2003)). This phenotype could be due to either checkpoint deficiency or 
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inadequate D N A repair or both. A-T patients are proficient in NHEJ as evidenced by 
their normal V(D)J recombination (Hsieh et al. 1993). However, A-T patients show 
aberrant interlocus recombination events in the T-cell receptor locus (Aurias et al. 1980; 
Lipkowitz et al. 1990), potentially leading to translocations that promote 
lymphomagenesis. A defect in the regulation of DNA repair pathways is also suggested 
by the fact that A-T cells show an error-prone hyperrecombination phenotype, have 
increased rates of chromosome mis-rejoining after damage, and have a high rate of 
spontaneous telomere fusions ((Luo et al. 1996), reviewed in (Kojis et al. 1991)). 
Furthermore, A-T cells have increased rates of intrachromosomal recombination (Meyn 
1993) and several ATM targets have been implicated in homologous recombination (HR) 
(e.g. BRCA1, FANCD2, and the Mrell complex (reviewed in (Petrini 2000; Jasin 2002; 
Moynahan 2002; D'Andrea and Grompe 2003)). However, in other settings, ATM 
deficient cells show impaired HR (Takao et al. 1999; Morrison et al. 2000) or have 
normal rates of sister chromatid exchanges (SCEs) (Galloway and Evans 1975; Galloway 
1977), which are thought to be generated by HR (Sonoda et al. 1999). Thus, the exact 
role of ATM signaling in the regulation of NHEJ and HR is still poorly defined. 
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Part II: Rifl and telomere biology 
Telomeres: Discovery and Basic Structure 
Telomeres are functional elements at the physical ends of eukaryotic 
chromosomes. Early observations hinted that telomeres play an important role in 
chromosomal stability and maintenance. In the late 1930's, H.J. Muller observed that 
terminal deletions and inversions were not recovered in the offspring of X-ray irradiated 
Drosophila males (Muller 1938). At about the same time, McClintock examined broken 
chromosomes in maize. She noticed the resulting formation of dicentric chromosomes 
and the subsequent loss breakage of these fused chromatids during cell division 
(McClintock 1941). McClintock suggested that telomeres act to prevent fusion and 
breakage events in intact, linear chromosomes. Taken together, these experiments laid 
the foundation for the protective role of telomeres in eukaryotic cells. It is now clear that 
telomeres serve to protect the ends of linear chromosomes from being recognized as 
DNA damage. 
Telomeres consist of tandem, repetitive, G+C-rich sequences. The G-rich strand 
runs 5' - 3' towards the end of the chromosome. The actual telomeric repeat sequence 
varies between species and these repeats can be either homogeneous or heterogeneous. 
Telomere length ranges from 30 bp in Euplotes and Oxytricha to 250 - 400 bp in 
Saccharomyces cerevisiae to 2 - 30 kb in humans. Murine chromosomes contain even 
longer telomeres, but have the same TTAGGG double-stranded telomeric repeat as 
human chromosomes. Typically, telomeres also have a 3' overhang of the G-rich 
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telomeric strand, which is approximately 150 nucleotides at human chromosome ends. 
Telomeric repeats are occasionally found at interstitial sites in eukaryotic genomes where 
they may represent the remnants of ancestral chromosomal fusion events. 
An early dilemma in the telomere field arose from the characterization of the 
strategy of DNA replication. The so-called "end-replication problem" results from the 
inadequacy of the replication machinery to complete lagging strand synthesis due to a 
requirement for an RNA primer (Watson 1972; Olovnikov 1973). This inability of the 
replication machinery to copy the ends of linear chromosomes results in a loss of 
sequence at the telomere in the absense of mechanisms to synthesize additional telomeric 
repeats (Levis 1989; Lundblad and Szostak 1989; Johnson et al. 2001). The loss of 
telomeric repeats ultimately leads to a critically short telomere that is unable to protect 
the end from DNA damage and other signaling pathways, which results in senescence or 
apoptosis (as discussed below). 
One solution to this problem came with the discovery of telomerase. Blackburn 
and Greider identified a telomere synthesizing activity, now known as telomerase 
(Greider and Blackburn 1985). Telomerase is a ribonudeoprotein that uses its essential 
RNA component, called the telomerase RNA component (TERC, TR or TER), as a 
template for the synthesis of tandem repeats on the G-rich strand (Greider and Blackburn 
1989; Shippen-Lentz and Blackburn 1990; Singer and Gottschling 1994; Feng et al. 
1995). The protein component of core telomerase, called telomerase reverse transcriptase 
(TERT), uses the TERC template to synthesize additional telomeric repeats (Lingner et 
al. 1997; Meyerson et al. 1997; Nakamura et al. 1997). Telomerase provides a solution to 
the end-replication problem by adding additional telomeric sequences. 
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Although most unicellular organisms have constitutive telomerase activity, 
telomerase is tightly regulated in human cells. Human somatic cells have suppressed 
telomerase activity, whereas ovaries, testis, and various proliferating cell populations 
such as stem cells have telomerase activity (Kim et al. 1994; Meyerson et al. 1997; 
Nakamura et al. 1997). The protein component, TERT, rather than the RNA component, 
TERC, is the limiting component responsible for the suppression of telomerase in 
somatic cells (Feng et al. 1995). The transcriptional suppression of the protein 
component of telomerase occurs through a number of individual pathways, including 
Menin, the Mad/Myc pathway and the TGFp target Sipl (Lin and Elledge 2003). This 
ensures that the loss of any one pathway will not result in spurious telomerase activity. 
The exact regulation of telomerase in terms of the timing of telomere repeat addition is 
still being investigated. It is thought that telomere addition takes place during S phase. 
The observation that Est2p, the telomerase protein component in S. cerevisiae, is found in 
telomeric chromatin during S phase is consistent with S phase telomere repeat addition 
(Taggart et al. 2002). However, telomerase is competent to extend telomere-like 
substrates in mitosis (Diede and Gottschling 1999; Taggart et al. 2002). Est2p is also at 
telomeres in Gl (Taggart et al. 2002). 
Exogenous expression of hTERT in primary human fibroblasts is sufficient to 
reconstitute telomerase activity and counter-act telomere erosion. The resulting telomere 
maintenance immortalizes most human cells types (Bodnar et al. 1998; Vaziri and 
Benchimol 1998; Ramirez et al. 2001). Like primary cells, tumor cells require a telomere 
maintenance system for long-term proliferation and in the majority of cases this is 
provided by upregulation of hTERT (reviewed in (Cong et al. 2002)). Other tumor cells 
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maintain their telomeres through telomerase-independent pathways. This mechanism is 
known as alternative lengthening of telomeres (ALT), although it is unclear whether there 
are one or more such pathways (discussed below). Telomerase activity per se does not 
induce transformation (Morales et al. 1999) and although telomerase is necessary for 
immortalization, hTERT is not an oncogene (Hahn et al. 1999; Hahn et al. 2002). 
Additionally, oncogenic transformation per se does not require telomerase activity and 
cells with very long telomeres can be fully transformed into a tumorigenic phenotype in 
vitro without a telomerase maintenance system (Seger et al. 2002). Similarly, certain 
childhood tumors that originate in young cells with long telomeres can be cancerous and 
metastatic even though they lack telomerase (Hiyama et al. 1995). However, the 
extensive proliferation of cells during the prolonged multi-step tumorigenesis pathways 
that leads to most adult human cancers is predicted to exhaust the telomere reserve, 
necessitating telomerase activation (Hiyama et al. 1995). Thus, telomere maintenance, 
particularly through telomerase activity, plays a critical role in facilitating tumorigenesis. 
Telomerase and telomerase-binding factors 
The telomerase RNA and reverse transciptase component of telomerase that 
together form the core telomerase enzyme required for catalysis in vitro are not the only 
components of the telomerase holoenzyme. In addition to core TLC1 and Est2p in S. 
cerevisiae, Estlp and Est3p are also part of the telomerase holoenzyme and both estl and 
est3 strains display the progressive telomere shortening phenotype, known as ever shorter 
telomeres (est) (Lundblad and Szostak 1989; Lendvay et al. 1996; Hughes et al. 2000). 
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Additionally, TLC1 is also associated with S m proteins in S. cerevisiae (Seto et al. 1999). 
The human telomerase holoenzyme also contains components other than the core RNA 
and reverse transcriptase. Two orthologs of EST1, EST1A and EST IB, have been 
identified and shown to be found in the telomerase holoenzyme (Reichenbach et al. 2003; 
Snow et al. 2003). Orthologs of Est3p in humans have not been identified and there is no 
data that Sm proteins bind TERC in humans. 
Another component of the human telomerase holoenzyme is the protein dyskerin 
(Mitchell et al. 1999b). TERC contains an H/ACA motif which dyskerin is able to bind 
(Mitchell et al. 1999a). The X-linked form of dyskeratosis congenital, DKC, which 
includes abnormal skin pigmentation, nail dystrophy and mucosal leukoplakia, is due to a 
mutation in dyskerin while the autosomal dominant form is due to mutations in the 
hTERC gene (Mitchell et al. 1999b). 
Telomerase-independent telomere maintenance pathways 
Telomere length can be maintained through mechanisms that do not depend on 
telomerase. One type of telomerase-independent telomere maintenance pathway involves 
recombination. The majority of estl 5. cerevisiae cells die in culture, but a minor 
population of cells manages to survive (Lundblad and Blackburn 1993). The ability of 
estl survivors to appear was critically dependent on RAD52 function, which implied a 
recombination-based mechanism to the S. cerevisiae survivor pathway (Lundblad and 
Blackburn 1993). It was subsequently shown that two types of survivors formed, termed 
type I and type II survivors, and that these survivors were dependent on RAD51 and 
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RAD52, respectively (Teng and Zakian 1999). Type I survivors are characterized by 
extensive amplification and dispersal of sub-telomeric Y' elements to most telomeres and 
type II survivors are characterized by a long telomeric tract (Teng and Zakian 1999). In 
competition experiments, telomerase-positive wild type cells outgrow telomerase-
deficient survivors (Morris and Lundblad 1997). 
Although the majority of immortalized and cancer cells in humans use up-
regulation of telomerase for telomere maintenance (Shay 1997), a subset of immortalized 
cells lack detectable telomerase activity (Bryan et al. 1995; Bryan et al. 1997a; Bryan et 
al. 1997b; Bryan and Reddel 1997). These cells seem to maintain their telomeres through 
one or more recombination-mediated mechanisms similar to the survivor pathway in 5. 
cerevisiae. ALT cells have long, heterogeneous telomeres and contain ALT-associated 
PML bodies (APBs) (Henson et al. 2002). APBs contain RAD51, RAD52, telomeric 
DNA and known telomere binding proteins (Yeager et al. 1999). The role of APBs in the 
ALT remains unclear. 
Additional telomerase-independent mechanisms of telomere maintenance are 
present in certain circumstances. In the absence of telomerase, S. pombe is able to 
survive with three circularized chromosomes (Naito et al. 1998). This pathway is 
presumably not available to either S. cerevisiae or mammalian cells because of their 
higher number of chromosomes. Another mechanism of telomerase-independent 
telomere maintenance is the transposon-mediated telomere maintenance that occurs 
normally in Drosophila (Danilevskaya et al. 1994; Cenci et al. 1997; Danilevskaya et al. 
1998). 
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The discovery of cis-acting telomere-binding factors 
Studies of telomerase confirmed the idea that eukaryotic cells have proteins that 
bind specifically to telomeric DNA. Yu et al. mutated the RNA component of 
Tetrahymena telomerase in vivo and noticed a deprotected telomere phenotype due to the 
change in the sequence of the telomeric DNA, consistent with the requirement for a 
sequence specific telomere binding protein (Yu et al. 1990). A similar phenomenon was 
observed in the budding yeast Kluyveromyces lactis (McEachern and Blackburn 1995). 
A number of groups identified sequence-specific telomeric DNA binding proteins, 
including the a/fj telomere binding proteins in Oxytricha, Rapl in the budding yeasts S. 
cerevisiae and K. lactis, Tazl in S. pombe (Berman et al. 1986; Price and Cech 1987; 
Larson et al. 1994; Cooper et al. 1997). The de Lange lab first discovered TRFI 
(TTAGGG repeat binding factor 1) and TRF2, the telomeric DNA binding proteins in 
vertebrates (Chong et al. 1995; Broccoli et al. 1997b). 
The discovery of TRFI and TRF2 led to insights into how telomere length is 
maintained within given limits in telomerase positive cells (telomere length regulation) as 
well as how human chromosome ends are protected. TRF2 plays a critical role in the 
prevention of telomeric ends from being recognized by cells as double-stranded breaks. 
Expression of a dominant negative allele of TRF2 in cells leads to the loss of telomeric 3' 
overhangs, chromosome fusion, cell cycle arrest, p53/ATM-dependent apoptosis, or a 
senescence-like state (van Steensel et al. 1998; Karlseder et al. 1999). Thus, the TRFs 
seem to be essential for this important function of telomeres. The over-expresssion of 
TRFI and TRF2 using the tetracycline-inducible system resulted in gradual telomeric 
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shortening (van Steensel and de Lange 1997; Smogorzewska et al. 2000). Expression of 
a dominant negative TRFI allele results in telomere elongation. This allele does not 
affect the activity of telomerase in cell extracts, which suggests that TRFI regulates 
telomere length in cis. A number of other factors have been identified as proteins that 
associated with telomeres (Figure 1-2). The protein protector of telomeres 1 (POT1) was 
identified in human cells and initially shown to protect telomeric ends (Baumann and 
Cech 2001). POT1, which binds to single-stranded telomeric DNA, plays a role in 
telomere length regulation by acting as a telomerase-dependent positive regulator of 
telomere length (Loayza and De Lange 2003). Since POT1 binding can be affected by 
the TRFI complex, POT1 may act as a transducer of TRFI signalling to control telomere 
length (Loayza and De Lange 2003). 
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Figure 1-2. Factors that bind to mammalian telomeres. 
The following factors have been described as being found at telomeres in mammalian 
cells. This figure does not show POT1, which can bind to both the TRFI complex and to 
the 3' G-rich overhang. Figure courtesy of Titia de Lange (de Lange 2003). 
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T-loops 
Mammalian telomeres form structures termed t-loops that result from strand 
invasion of the 3' overhang into the telomeric duplex DNA (Griffith et al. 1999). A 
similar structure exists in the ciliate Oxytricha, in the typanosome T. brucei, and in the 
plant A, thaliana (Murti and Prescott 1999; Munoz-Jordan et al. 2001). Incubation of a 
telomeric model containing 3 kb of non-telomeric DNA followed by 0.5 kb of telomeric 
DNA with baculovirus-derived human TRF2 increases the rate of formation of t-loops 
(Griffith et al. 1999). T-loops are observed in isolated psoralen-crosslinked telomeric 
DNA (Griffith et al. 1999). A preliminary model predicts that TRFI and TRF2 aid in the 
formation of t-loops in vivo. TRFI, because of its spatial and orientational flexibility in 
binding telomeric DNA, brings together regions of the duplex DNA array and TRF2 
facilitates the invasion of the G-rich 3' overhang (Bianchi et al. 1999; Griffith et al. 
1999). 
The telomeric complex in Saccharomyces cerevisiae: Rapl and its binding factors 
Raplp is the predominant telomeric binding protein in S. cerevisiae. Berman et 
al. first identified the presence of a yeast protein that could bind telomeric repeats 
(Berman et al. 1986). This factor turns out to be Rapl (Repressor and Activator Protein 
1) (Longtine et al. 1989). Different labs independently identified factors identical to 
Rapl known as TBA, GRF1 or TUF1 that bound a number of DNA sequences and play a 
role in silencing at the mating-type loci, transcriptional activation of ribosomal protein 
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genes, and transcriptional regulation of other genes (Shore and Nasmyth 1987; Vignais et 
al. 1987; Buchman et al. 1988; Chambers et al. 1989). Rapl is an essential gene in yeast 
that encodes an abundant 120 kD nuclear protein that is similar to the mammalian 
transcription/replication factor NF1 and the yeast ARS-binding protein ABF1 (Shore and 
Nasmyth 1987; Buchman et al. 1988; Santoro et al. 1988; Diffley and Stillman 1989)). 
The consensus binding site for Rapl is 5'-AAYCCRYNCAYY-3' which occurs 
approximately every 18 bp within yeast telomeric DNA allowing approximately twenty 
copies of Rapl to associate with each chromosome (Gilson et al. 1993). 
Rapl plays a significant role in yeast telomeric function. Rapl is found in 
telomeric chromatin and is located at telomeres by indirect immunofluorescence (Conrad 
et al. 1990; Klein et al. 1992). Telomere shortening occurs when yeast cells with 
temperature-sensitive Rapl mutations are grown at semipermissive temperature (Lustig 
et al. 1990). These mutations are recessive with respect to the wild type allele. 
Overexpression of full-length Rapl results in a slight, dose-dependent telomere 
elongation, increased length heterogeneity, and increased rates of recombination and 
chromosome loss (Conrad et al. 1990). The expression of C-terminal truncation Rapl 
mutants leads to telomere elongation, highly unstable telomeres susceptible to rapid 
deletion, and chromosome nondisjunction rates that are 15- to 30- fold higher than wild 
type levels (Kyrion et al. 1992). 
Rapl functions to recruit other proteins to the yeast telomere. Two-hybrid 
studies using the C-terminus of Rapl were used to identify two sets of proteins, the SIRs 
(Sir3p and Sir4p) and the RIFs (Riflp and Rif2p) (Hardy et al. 1992; Moretti et al. 1994; 
Cockell et al. 1995; Liu and Lustig 1996; Wotton and Shore 1997). SIR (Silent 
36 
Information Regulator) proteins are required for silencing at H M mating-type loci and 
telomeres. Sir3p and Sir4p colocalize with Rapl at telomeres by indirect 
immunofluorescence and FISH using telomeric repeat probes (Gotta et al. 1996). Sir3p 
no longer colocalizes with Raplp in sir4~ cells and Sir4p no longer colocalizes in sir3~ 
cells (Gotta and Gasser 1996). Sir3 and Sir4 are not required for telomere length 
regulation or telomere protection. 
The Rifs (Rapl-Interacting Factors), Rifl and Rif2, play a direct role in telomere 
length regulation. Overexpression of either Rifl or Rif2 leads to telomere shortening and 
overexpression of Rifl and Rif2 reverses the elongation seen with overexpression of the 
C-terminus of Rapl (Wotton and Shore 1997). Thus, telomere length changes resulting 
from overexpression of wild type or mutant Rapl alleles may result from titrating Rifl 
and Rif2 away from the telomere. A more extensive introduction to Rifl is given in the 
introduction sections of chapters 1 and 2. A major portion of this thesis focuses on the 
identification and characterization of the human ortholog of yeast Rifl. 
Deletion analysis using gel shifts of telomeric oligonucleotides indicated that the 
minimal DNA-binding domain (DBD) of Rapl lies between amino acids 361 and 596 
(Henry et al. 1990). The crystal structure of the Rapl DBD with an 18 nucleotide 
telomeric DNA fragment shows that Rapl binds DNA with two myb-like HTH motifs 
(Konig et al. 1996). The vertebrate telomeric-binding proteins TRFI and TRF2 and the 
S. pombe protein Tazl also use myb domains to bind DNA (Bianchi et al. 1997; Broccoli 
et al. 1997a; Cooper et al. 1997). There are important differences in the way Rapl and 
TRFs bind their consensus sequences. Rapl binds to DNA with two myb-like motifs in a 
single polypeptide, whereas TRFI and TRF2, each having only a single C-terminal Myb 
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domain, homodimerize in order to bind D N A with two Myb domains (Bianchi et al. 
1997; Broccoli et al. 1997b). The existence of two nearly adjacent Myb domains within 
each Rapl molecule confines the protein to recognize two tandem sites in yeast telomeric 
DNA. In contrast, the TRFI homodimer is able to bind two 5'-YTAGGGTTR-3' half-
sites with spatial and orientational flexibility (Bianchi et al. 1999). This flexibility may 
serve a tethering function in establishing higher order DNA structures. 
The TRFI complex: TRFI, Tankyrase, Tin2, and PinXl 
In human cells, the TRFI complex acts as a negative feedback control system in 
the regulation of telomere length. Telomerase-positive cells often have stably maintained 
telomere length. This telomere length "set-point" varies between cells lines and even 
between subclones of a given cell line. In order to initially study telomere length, 
individual clones were analyzed by using an inducible gene expression system to regulate 
the amount of TRFI alleles in cells (van Steensel and de Lange 1997; Smogorzewska et 
al. 2000). The idea behind this negative feedback control system is that TRFI binds 
along the length of duplex telomeric DNA and exerts a negative regulatory influence on 
telomerase. If the telomere shortens, less TRFI will bind to the telomere and telomerase 
can more easily act to lengthen the telomere. Conversely, telomere lengthening results in 
increased TRFI binding and diminished ability for telomerase to lengthen longer 
telomeres. The observations that the TRFI IF signal increases with telomere length 
(Smogorzewska et al. 2000) and that a comparable percentage of telomeric chromatin is 
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immunoprecipitated with TRFI in ChIP experiments regardless of telomere length 
(Loayza and De Lange 2003) are consistent with this model. 
The binding of TRFI to telomeres can be inhibited by two related enzymes, 
tankyrase 1 and 2 (Smith et al. 1998; Smith and de Lange 2000; Kaminker et al. 2001; 
Cook et al. 2002; Sbodio et al. 2002; Seimiya and Smith 2002). The takyrases are 
poly(ADP-ribose) polymerases (PARPs), that were originally identified as TRF1-
interacting proteins. Tankyrases can ADP-ribosylate TRFI in vitro and in vivo and this 
modification diminishes the ability of TRFI to bind to telomeric DNA in vitro (Smith et 
al. 1998). Ectopic expression of tankyrase 1 in the nucleus results in the removal of 
TRFI from telomeres in vivo (Smith and de Lange 2000; Cook et al. 2002; Loayza and 
De Lange 2003). Consistent with these findings, overexpression of tankyrase 1 leads to 
telomere elongation, the phenotype seen upon TRFI inhibition. TRFI also binds to Tin2 
and PinXl. Tin2 is able to form a ternary complex with TRFI and tankyrase (Ye, J. and 
de Lange, T., in press). PinXl has been proposed to inhibit telomerase directly in order 
to participate in telomere length regulation (Zhou and Lu 2001). The proposed role of 
PinXl differs dramatically from the cis-acting mechanisms proposed for TRFI, tankyrase 
and Tin2. 
The end of the telomere: CDC13 and Potl 
The Cdcl3 protein in S. cerevisiae plays a critical role in the regulation of 
telomere length maintenance and telomere protection through its actions at the most distal 
part of the telomere; namely, the telomere terminus. Although CDC 13 was initially 
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identified as a gene essential for cell division cycle (Garvik et al. 1995), it was 
subsequently identified as one of several genes whose mutation leads to an ever shorter 
telomere (est) phenotype, similar to the loss of telomerase (Lendvay et al. 1996). Cdcl3 
is able to bind to the G-rich single-stranded overhang and acts by recruiting telomerase 
through an interaction with Estl (Garvik et al. 1995; Nugent et al. 1996). Indeed, there is 
an allele specific suppression of the cdcl3-2es' mutant (which is a loss-of-function mutant 
resulting in an est phenotype) by an estl-60 mutant (which also displays an est 
phenotype), consistent with a physical interaction between Cdcl3 and Estl (Pennock et 
al. 2001). The proposed model underlying this genetic data is that a role of Cdcl3 at the 
telomere is to recruit telomerase. In fact, a fusion between the DNA-binding domain of 
Cdcl3 and Est2, the protein component of core telomerase, rescues the inability of 
cdcl3-2esl and estl-A strains to maintain their telomeres (Evans and Lundblad 1999; 
Pennock etal. 2001). 
In addition to the ability of Cdcl3 to recruit telomerase to the telomere in 5. 
cerevisiae, Cdcl3 also recruits additional factors that limit telomere elongation. In 
particular, Cdcl3 recruits the protein Stnl and mutations in either CDC 13 that fail to bind 
Stnl or STN1 mutations result in telomere elongation (Chandra et al. 2001; Grandin et al. 
2001). One such CDC13 mutant, cdcl3-5, results in increased telomere length and 
excessive G-strand overhangs in late S phase that become duplex with delayed kinetics 
(Chandra et al. 2001). This suggests a defect in the co-ordination of lagging strand 
synthesis with telomere elongation. The observation that Stnl suppresses both the 
telomere elongation and G-stand overhang phenotype points to Stnl as the cause of these 
phenotypes. 
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P0T1, a factor distantly related to Cdcl3, binds to the telomere terminus in S. 
pombe and human cells. This gene was first discovered in the fission yeast S. pombe and 
was shown to bind to the G-rich strand of telomeric DNA in vitro (Baumann and Cech 
2001). Potl binds to telomeric DNA through an OB fold that resembles that of the 
telomere binding protein Oxytricha a and Cdcl3 (Baumann and Cech 2001; Mitton-Fry 
et al. 2002). The binding of Potl to the S. pombe telomeric DNA occurs in a cooperative 
fashion (Lei et al. 2002). Deletion of the potl-i- gene results in chromosome instability, 
as demonstrated by a mis-segregation phenotype, as well as the loss of telomeric DNA 
and subsequent circularization of chromosomes (Baumann and Cech 2001). Hence the 
name Potl, protector of telomeres 1, was given because Potl plays a critical role in 
protecting telomeres. 
A human ortholog of Potl was identified and characterized. Human Potl co-
localizes with known telomere proteins in immunofluorescence experiments (Baumann et 
al. 2002). Additionally, human POT1 is also able to bind to telomeric DNA in vitro 
(Baumann et al. 2002) and is present at telomeres in vivo based on ChIP (Loayza and De 
Lange 2003). The amount of POT1 on telomeres was reduced when the quantity of 
single-stranded telomeric DNA was reduced (Loayza and De Lange 2003; Loayza et al. 
2004). Furthermore, a deletion of the POT1 DNA-binding domain results in rapid 
telomere elongation (Loayza and De Lange 2003). Since POT1 interacts with the TRFI 
complex, it has been proposed that TRFI sends information about telomere length to 
POT1 at the telomere terminus, which regulates either the recruitment or access of 
telomerase to the telomere terminus (Loayza and De Lange 2003). 
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hRapl and spRapl as orthologs of scRapl 
A search for TRF2-interacting proteins using a yeast two-hybrid approach has 
uncovered a factor, termed hRap, that has significant sequence identity to Rapl in S. 
cerevisiae (Li et al. 2000). hRapl encodes a 47-kD, 399-amino acid protein that contains 
an N-terminal BRCT domain, a Myb-type domain, and an acidic C-terminus (Figure 1-3). 
These domains in hRapl have approximately 25% sequence identity and 50% sequence 
homology to their respective domains in scRapl (Figure 1-3). Thus, hRapl seems to be 
an ortholog of scRapl. 
Further analysis reveals that hRapl plays a role at human telomeres. Northern 
analysis reveals a 2.5 kb band that is widely expressed in human tissues. Indirect 
immunofluorescence using an anti-hRapl antibody in HeLa cells, HT1080 cells, and 
IMR90 cells shows punctuate nuclear staining. hRapl colocalizes with TRF2 and TRFI 
in cells and immunofluorescence of metaphase chromosomes shows a signal only at 
chromosome ends. Using a tetracycline-inducible system in telomerase-positive HTC75 
cells (derived from HT1080 cells), inducible overexpression of full-length FLAG-tagged 
hRapl results in the gradual elongation of telomere length (Li et al. 2000). Surprisingly, 
hRapl does not appear to bind directly to telomeric DNA, though it can supershift TRF2-
telomeric DNA complexes (Li et al. 2000). 
A more thorough discussion of the domain structure and the importance of hRapl 
is found in the introductions to chapters 1 and 3 of this thesis. Since one of the projects 
in this thesis is the identification of novel Rapl-interacting factors, this topic is discussed 
in depth along with the data in chapter 3. 
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The T R F 2 complex: TRF2, hRapl, and the Mrell complex 
The protein complex associated with TRF2 plays a critical role in telomere length 
regulation and end protection. Studies of the proteins found in TRF2 immunoprecipitate 
pellets resulted in the identification of the Mrel 1 complex, consisting of Mrel 1, Rad50, 
and Nbsl (Zhu et al. 2000). As discussed earlier in this introduction, the Mrel 1 complex 
plays a role in a variety of biological functions including recombination and DNA 
damage repair. Components of the Mrell complex co-localized with known telomere 
proteins (Zhu et al. 2000). Additional studies of TRF2-interacting factors resulted in the 
identification of ERCC1 and XPF in the TRF2 complex (Zhu, X, et al., submitted). 
Human Rapl and the evolution of the telomere complex 
The identification of hRap 1 raises important questions regarding the evolution of 
telomeric complexes. A contradiction seems to exist between the structure and function 
of Rapl in vertebrates and budding yeast. S. cerevisiae utilizes Rapl to bind directly to 
telomeric DNA while, in humans, Rapl does not bind telomeric DNA and associates with 
the telomere via its interaction with TRF2. S. cerevisiae lacks a TRF-like component at 
their telomeres. What factors were contained in the "ancestral" telomeric complex? 
Further examination of known telomeric protein similarities suggests a possible 
resolution to this problem. The major binding factor in the fission yeast, S. pombe, is the 
protein Tazl. Although no ortholog of Rapl is currently known in S. pombe, Tazl can be 
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Figure 1-3. Domain stucture and sequence alignments of human Rapl. 
The domain stucture of hRapl is given in A. The protein structure is given in C. D, E 
and F depict alignments of the B R C T domain, M y b domain, and R C T domains, 
respectively. G illustrates the conservation of the various domains between human Rapl 
and yeast Rapl. Figure courtesy of Titia de Lange (Li et al. 2000). 
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classified as a member of the TRF family of proteins (Li et al. 2000). The Myb domain 
of Tazl more closely resembles the Myb domains of the TRFs than the Myb domains of 
Rapl. Tazl also contains a central TRFH (TRF homology) domain (Li et al. 2000). The 
TRFH domain acts as a dimerization domain in TRFI and TRF2 (Bianchi et al. 1997; 
Broccoli et al. 1997b; Fairall et al. 2001) A model emerges in which the "ancestral" 
telomeric complex contains both a TRF-like component and a Rapl-like component. 
Budding yeast, including C. albicans, K. lactis and 5. cerevisiae, seemed to have lost the 
TRF component. In support of this, the budding yeast has a more divergent telomeric 
repeat than the TTAGGG found in vertebrates (most lower organisms have telomeric 
repeats that very closely resemble TTAGGG). Possibly a mutation in the telomerase 
RNA template resulted in a change in the telomeric template and the ability of Rapl to 
bind to this new telomeric repeat enabled the budding yeast to remain viable (Li et al. 
2000). Further discussion of how the discovery and characterization of Rapl and Rifl in 
S. pombe add to this picture of evolution and the roles of these proteins in telomere 
biology is reserved for the introductions of later chapters. 
DNA damage response factors and telomeres 
A number of DNA damage response factors are involved in telomere length 
maintenance. Telomere maintenance and length control in S. pombe are influenced by 
the DNA damage response factors Radl7, Rad53, Mec3 and Ddcl (Dahlen et al. 1998; 
Longhese et al. 2000; Nakamura et al. 2002). Additionally, in both S. cerevisiae and S. 
pombe, the deletion of the NHEJ factor Ku leads to very short, but stable, telomeres 
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(Porter et al. 1996; Boulton and Jackson 1998; Gravel et al. 1998; Nugent et al. 1998; 
Polotnianka et al. 1998; Baumann and Cech 2000). This phenotype is unrelated to the 
loss of NHEJ in cells, as the loss of DNA ligase IV, another factor involved in NHEJ, 
does not affect telomere length (Boulton and Jackson 1998; Baumann and Cech 2000). 
Factors involved in the DNA damage response, including ATM, play a role in 
telomere length maintenance in mammalian cells. Peripheral blood lymphocytes from A-
T patients show significant telomere shortening compared to age-matched donors 
(Metcalfe et al. 1996). Also, cells from ATM deficient mice and A-T patients have 
extrachromosomal telomeric DNA (Hande et al. 2001). The mechanism of ATM 
regulation of telomere length maintenance and telomere stability is unknown. 
The mechanism is also unclear for the role of Ku70/80, DNA-PK,.,;, and PARP-1 
in telomere length maintenance. While DNA-PKCS null mice have normal telomere 
length (Goytisolo et al. 2001; Espejel et al. 2002), mice with the DNA-PK^ SCID 
mutation have been reported to have longer telomeres (Hande et al. 1999; Goytisolo et al. 
2001). Perhaps the SCID mutation, while deficient in NHEJ, may be a gain of function 
mutation for the role of DNA-PK^ in telomere length control. It is more difficult to 
explain discrepancies in reports on Ku80. Even though two groups measured telomere 
lengths in the same Ku86 null mouse strain, one report indicates shorter telomeres 
(d'Adda di Fagagna et al. 2001), while another found no change (Samper et al. 2000). 
Finally, mice lacking PARP-1 have shorter telomeres but this phenotype is only seen in 
the absence of p53 (dAdda di Fagagna et al. 1999; Samper et al. 2001). 
46 
Consequences of telomere dysfunction and link to the D N A damage response 
Telomeres prevent the ends of linear chromosomes from being recognized as 
damaged DNA. Dysfunctional telomeres, which fail to protect chromosome ends, are 
indeed recognized by the DNA damage response. The consequences of telomere 
dysfunction are disastrous and potentially lethal for cells. Model systems for telomere 
dysfunction can be generated by passaging primary cells, which lack telomerase, in 
culture. Primary fibroblasts undergo telomere attrition and will enter into a type of 
growth arrest known as senescence after a given number of passages in culture (Hayflick 
1998). Senescence occurs when one or more telomeres have shortened to a certain 
critical length and are unable to properly protect chromosome ends. The ectopic 
expression of a dominant negative TRF2 allele lacking both the basic and Myb domains 
(TRF2ABAM) also results in dysfunctional telomeres (van Steensel et al. 1998). The 
following discussion will briefly describe the consequences of telomere dysfunction, 
including apoptosis and senescence, and the recognition of dysfunctional telomeres by 
the DNA damage response. 
Dysfunctional telomeres resulting from the ectopic expression of TRF2ABAM result 
in apoptosis and senescence, depending on cellular context. Telomere-telomere fusions 
and anaphase bridges occur as a result of TRF2ABAM over-expression (van Steensel et al. 
1998). Additionally, cells can also enter senescence (van Steensel et al. 1998; 
Smogorzewska and de Lange 2002). Telomeric DNA is still detectable by Southern blot 
and IF, which is consistent with the idea that TRF2ABAM results in telomere dysfunction 
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because of structural changes in the telomere rather than loss of telomeric D N A . The 
telomere end-to-end fusions and anaphase bridges are consistent with dysfunctional 
telomeres being recognized as DNA damage and subsequently being fused together by 
the NHEJ repair pathway. The formation of telomere end-to-end fusions upon TRF2ABAM 
over-expression is dependent upon ligase IV, a critical component of the NHEJ pathway 
(Smogorzewska et al. 2002). Additionally, certain cells over-expressing TRF2ABAM can 
undergo apoptosis in a manner dependent on ATM and p53 (Karlseder et al. 1999). The 
formation of telomere dysfunction-induced foci (TIFs), wherein DNA damage response 
factors accumulate at dysfunctional telomeres, provides further evidence that deprotected 
telomeres induced by TRF2ABAM are interpreted by the cell as DNA damage (Takai et al. 
2003). 
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Summary and Relevance 
This thesis deals primarily with the identification and characterization of human 
Rifl, an ortholog of the telomere length regulator Rifl in S. cerevisiae and 5. pombe. 
Chapter 1 describes the identification of human Rifl using a bioinformatics approach 
where sequences from S. cerevisiae Rifl were used to query the human database. The 
generation of antibodies led to the initial characterization of human Rifl. Chapter 1 
describes efforts to implicate Rifl in human telomere biology. These efforts failed to 
discern a definitive role for human Rifl in telomere biology. Immunofluorescence, co-
immunoprecipitation and ChIP techniques were all used to determine if Rifl localizes to 
telomeres, interacts with known telomeric proteins, or associates with telomeric 
chromatin. Chapter 2 reports on the most significant and surprising discovery in this 
thesis which is that Rifl plays a role in the DNA damage response in human cells. The 
data demonstrate that Rifl forms foci in response to DNA damage. Rifl responded to 
ionizing radiation (IR), UV light, and clastogens, forming foci that co-localized with 
other DNA damage response factors such as 53BP1, ATM, BRCA1, Chkl, Nbsl, and 
Rad 17. Furthermore, Rifl localized to uncapped telomeres, as do other DNA damage 
response factors. Among DNA damage response proteins, Rifl showed a unique 
dependence on the ATM kinase. Whereas inhibition of ATR signaling did not inhibit the 
Rifl response, ATM deficient cells treated with IR or UV lacked Rifl foci even after 
prolonged incubation or high radiation dose. Therefore, IR-induced Rifl foci constitute 
an assay for ATM status. The Rifl response also depended on the presence of 53BP1 but 
was not affected by reduced function of BRCA1, Chk2, Nbsl, and Mrell. RNAi-
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mediated Rifl inhibition resulted in increased radiosensitivity, indicating that Rifl 
function contributes to the ATM-mediated protection against exposure to ionizing 
radiation. 
This thesis also focuses on the human TRF2 complex, which includes Rapl and 
the Mrel 1 complex. Chapter 3 describes a yeast two-hybrid screen conducted using 
Rapl as a bait to identify novel Rapl-interacting factors in mammalian cells. Two genes, 
a novel gene called cDNA 144 and a previously identified gene called FLASH, were 
identified in this screen. Neither cDNA 144 nor FLASH were shown to have a role in 
human telomere biology. 
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C h a p t e r 1 - Identification o f h u m a n R i f l 
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Introduction 
The importance of yeast Rifl in telomere biology provided the impetus that led 
to the identifications of a Rifl ortholog in human cells. Rifl was first discovered through 
a yeast two-hybrid screen as a protein that binds to Rapl (Hardy et al. 1992). 
Specifically, the C-terminal portion of Rif extending from amino acids 1614 to 1916 
interacts wth the C-terminus of Rap 1 extending from amino acids 667 to 827 (Hardy et 
al. 1992). The fact that there is allele-specific suppression of rapls mutants, which have 
altered telomere length and do not bind Rifl, by the RIF1 allele rif 1-1 confirms the 
biological significance of this interaction (Hardy et al. 1992). 
Rifl plays a role in telomere length regulation, transcriptional silencing at the 
yeast mating-type locus, and transcriptional silencing of telomere proximal genes, known 
as the telomere position effect (TPE) (Hardy et al. 1992; Kyrion et al. 1993). Yeast one-
hybrid analysis suggests that S. cerevisiae (scRifl) associates with telomeric DNA in 
vivo (Bourns et al. 1998). Deletion of RIF1 leads to mild telomere elongation that is 
telomerase-dependent and RAD52-independent (Kyrion et al. 1993; Teng et al. 2000). 
Rif2, which is not related to Rifl, also binds to the C-terminus of Rap 1 in S. cerevisiae 
(Wotton and Shore 1997). Like deletion of RIF1, deletion of RIF2 leads to telomere 
elongation and rifl rif2 strains have telomeres longer than either rifl or rif2 strains alone 
(Wotton and Shore 1997; Mishra and Shore 1999). 
While most S. cerevisiae cells that lack telomerase will die after 50-100 
generations, survivors arise spontaneously and fall into two types (Lundblad and 
Blackburn 1993). Type I survivors have a tandem repeat of the Y' element and very 
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short tracts of telomeric repeat D N A , and type II survivors have very long and 
heterogeneous tracts of telomeric repeat DNA. In culture, type I survivors frequently 
convert to type II survivors and type II survivor telomeres return to wild-type length with 
the re-introduction of telomerase (Teng and Zakian 1999). The distribution of type I and 
type II survivors after loss of telomerase is affected by Rifl, as rifl tlcl cells result in 
18% type II survivors whereas tlcl cells result in 6.5% type II survivors (Teng et al. 
2000). The mechanism underlying the effect of Rifl on the survivor pathway in 5. 
cerevisiae is currently unknown. 
The discovery of S. pombe Rifl (spRifl) and analysis of its roles in telomere 
biology reveal that scRifl and spRifl behave similarly in terms of telomere length 
regulation. Deletion of spRifl also results in telomere elongation (Kanoh and Ishikawa 
2001). As mentioned in the introduction, spRifl is recruited to telomeres through its 
interaction with Tazl, whereas scRifl is recruited to telomeres through its interaction 
with Rapl (Hardy et al. 1992; Kanoh and Ishikawa 2001). 
Rifl, Rif2, Sir3 and Sir4 all compete for binding to the carboxy-terminus of Rapl 
(Buck and Shore 1995; Mishra and Shore 1999). Furthermore, there is also competition 
between Ku and Rifl in terms of telomeric silencing (Mishra and Shore 1999). This 
competition may be the reason underlying a decrease of telomeric silencing seen in cells 
lacking scRifl (Kyrion et al. 1993). S. pombe Rifl (spRifl) also plays a role in telomere 
length regulation and TPE (Kanoh and Ishikawa 2001). S. pombe rifl" strains have 
decreased spore viability and aberrant chromosome segregation which implies an 
additional role for rifl in meiosis (Kanoh and Ishikawa 2001). 
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Based on these findings, the identification of human Rifl was anticipated to 
provide insight into human telomere function. The role of human Rifl (hRifl) could also 
address issues related to the evolution of telomere protein complexes. In S. cerevisiae, 
Rapl is the predominant double-stranded telomeric binding protein. Rifl is then 
recruited to S. cerevisiae telomeres through its interactions with Rapl. In 5. pombe, Tazl 
is the major protein that binds directly to telomeres. Rapl is recruited to telomeres 
through its interaction with Tazl (Chikashige and Hiraoka 2001; Kanoh and Ishikawa 
2001). 5. pombe Rifl is also recruited to telomeres by Tazl, but this recruitment is Rapl 
independent (Kanoh and Ishikawa 2001). Thus, the interactions of the telomere proteins 
differ in these two yeast species (Figure 1-1). The discovery of human Rapl and the 
finding that Tazl in S. pombe is similar to human TRFI and TRF2 raises the question of 
what role human Rifl may play in the human telomere complex (Li et al. 2000). Does 
the human telomere complex resemble the complex in 5. cerevisiae where Rifl is 
recruited to telomeres through Rapl or the complex in S. pombe where Rifl is brought to 
telomeres through the TRF-like Tazl ? 
This chapter focuses on the identification and initial characterization of a human 
ortholog of yeast Rifl. hRifl was found using a bioinformatics approach where the 
human genome and expressed sequence tags (ESTs) were queried with scRifl and 
spRifl. Antibodies were generated against human Rifl in order to study this protein. 
Since Rifl plays a role in telomere biology in both S. cerevisiae and S. pombe, a series of 
experiments were conducted to address whether or not Rifl plays a role in human 
telomere biology. An indirect immunofluorescence (IF) approach was taken to address 
whether Rifl co-localizes with previously known human telomere proteins such as TRFI, 
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TRF2, hRapl and Tin2. Additionally, attempts were made to co-immunoprecipitate Rifl 










Figure 1-1. Evolution of the telomere complex. 
The relationship among telomeric protein complexes in vertebrates, fission yeast, and 
budding yeast. TRF2 and Tazl are structurally related. In budding yeast, Rapl binds 
telomeric D N A whereas human and fission yeast Rapl bind to telomeres via TRF2 and 
Tazl, respectively. Budding yeast Rifl binds to Rapl, whereas fission yeast Rifl binds 
to Tazl. The role of Rifl at human telomeres is currently unclear. Figure courtesy of 
Agata Smogorzewska and Titia de Lange. 
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Results 
A search for the human ortholog of yeast Rifl was undertaken due to its 
importance in telomere biology. Initially, the S. cerevisiae Rifl protein sequence (Hardy 
et al. 1992) was used to query the human database in a BLAST search. Using this 
approach, a human ortholog of S. cerevisiae RIF1 was not detected. Then, S. cerevisiae 
RIF1 sequence was used to query the S. pombe database using a BLAST search and an S. 
pombe ortholog was identified (P value = 1 x IO"7). This gene was identical to S. pombe 
Rifl gene later published as the functional ortholog of S. cerevisiae Rifl (Kanoh and 
Ishikawa 2001). S. pombe Rifl was then used to identify a human Rifl ortholog using a 
BLAST search (P =9 x IO"5, Unigene hypothetical protein FLJ10599). The DNA 
sequence of human Rifl was assembled from the following overlapping clones in 
Genbank: Homo sapiens cDNA FLJ12870 fis, clone NT2RP2003727 (Genbank 
accession number AK022932); Homo sapiens cDNA FLJ10599 fis, clone 
NT2RP2004959 (Genbank accession number AK001461); IMAGE clone 2187070 3' end 
(Genbank accession number AI537278); and cDNA DKFZp434D193 (Genbank 
accession number AL080129). The full DNA sequence of human Rifl is given in 
Genbank accession number AY585745. 
The predicted open reading frame of combined ESTs is 2472 amino acids 
encoding a protein with a pi of 5.46 and a predicted MW of 274 kilodaltons (Figure 1-2). 
The sequence similarity of hRifl to scRifl and spRifl was low (15% and 18% sequence 
identity, respectively) but extended throughout the reading frame. The initial alignment 
of S. cerevisiae, S. pombe and human Rifl using a CLUSTAL 
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Figure 1-2. Alignment of human Rifl with mouse Rifl and fugu Rifl. 
The human Rifl amino acid sequence is depicted and aligned with mouse Rifl and fugu 
Rifl. Conserved amino acids are depicted in red and blue and a consensus sequence is 
given below. The protein product of human Rifl is predicted to be 2472 amino acids. 
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911 320 930 340 950 960 370 380 390 1000 1010 1020 1030 1040 Figure 1-3. Alignment of conserved regions I and II of Rifl in human and 5. 
cerevisiae. 
The CLUSTAL algorithm was used to align Rifl in 5. cerevisiae and human. A 
schematic of human Rifl above depicts the three conserved regions of Rifl with 
sequence conservation of 20-25%. The alignment shown depicts the first two conserved 
regions of Rifl. 
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Figure 1-4. Alignment of conserved region III of Rifl in h u m a n and 5. cerevisiae. 
The C L U S T A L algorithm was used to align the C-terminal portions of Rifl in 5. 
cerevisiae and human. The alignment depicts conserved region III. 
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algorithm suggests more sequence similarity between the N-terminal regions and less 
similarity between the C-terminal regions. Further analysis reveals three conserved 
regions when human, mouse and fugu Rifl are aligned (Figure 1-2). These conserved 
regions, designated CRI-III, have 20-25% conserved amino acids (Figures 1-3 and 1-4). 
Secondary structure analysis revealed a series of conserved predicted helices between S. 
cerevisiae, S. pombe and human Rifl proteins. The mammalian Rifl proteins are 
composed almost entirely of Armadillo repeats. ARM repeat folds, which are composed 
of three helices, often occur in long arrays and form an extended curved protein 
interaction surface (Huber et al. 1997; Conti et al. 1998). The open reading frame 
predicts a high density of helical segments in its N-terminal 800 amino acids, a putative 
bipartite NLS sequence at position 2188 and a serine-rich region from position 1149-
1204 (Figure 1-4 and 1-5A). 
In order to understand the role of Rifl in human cells and determine whether or 
not Rifl is associated with telomeres, antibodies were generated against hRifl. Two 
types of antigens, KLH-conjugated peptides and GST-fusion proteins, were used to 
produce antibodies (Figure 1-5A). The PROTEAN program in the Lasergene navigator 
software package was used to predict the optimal peptides for antibody generation based 
on the criteria of hydrophobicity and antigenicity (Figure 1-5B). Using the output, a total 
of four peptides individually containing amino acids 773-798 
(YNIKYQPKVKSPQRPSDWSKKKNEPC), amino acids 1552-1587 (NH2 -
NSESDSSEAKEEGSRKKRSGKWKNKC - COOH), amino acids 2077-2102 (NH2 -
EEGIIDANKTETNTEYSKSEEKLDNC - COOH) or amino acids 2448-2473 (NH2 -
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Figure 1-5. Antibodies generated against h u m a n Rifl. 
A . A schematic of h u m a n Rifl is shown. Conserved regions I-III (black), the serine-rich 
region (purple), and N L S (aqua) are shown. T h e positions of the antigens used in 
antibody generation are s h o w n (green). 
B. T h e biochemical properties of the amino acids in hRifl. T h e P R O T E A N program in 
the Lasergene software package w a s used to generate the plots from the hRifl protein 
primary sequence. A combination of the antigenic index and the surface probability plot 
w a s used to select the peptides that would be used as i m m u n o g e n s to generate antibodies 
against hRifl. 
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(Biosynthesis) and conjugated to keyhole limpet haemocyanin (KLH). Each KLH-
conjugated peptide was used to immunize two rabbits (Covance) and the resulting sera 
were affinity-purified. A carboxy-terminal cysteine was added to each peptide to allow 
for conjugation to KLH. Table 1-1 below describes the various antibodies raised against 












































































Table 1-1. Characteristics of antibodies against human Rifl. 
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The antibodies designated 1025 and 1060 recognized a single large (>250 kDa) 
polypeptide in Western blots of HeLa cells, whereas preimmune serum did not recognize 
this polypeptide (Figure 1-6A). The 1060 peptide antigen was also injected into mice to 
generate a polyclonal mouse serum designated as mouse 1060. GST-fusion proteins were 
also used to generate anti-Rifl antibodies. Proteins with an N-terminal GST fused to 
portions of hRifl were made in order to generate antibodies. Four GST-fusion proteins 
were constructed. The first two, from amino acids 177-797 and 177-907, designated 
GST-hRif 1177.797 and GST-hRif 1,77.907, respectively, did not yield protein products 
detectable by Coomassie staining. It is unclear if this was due to protein solubility, 
stability, or some other factor. A GST-Rifl fusion containing amino acids 907-1327, 
designated GST-hRif 1907.1327, was used as an antigen to generate the rabbit polyclonal sera 
1066 and 1067 (Figure 1-5A). This GST-fusion protein was expressed in BL21 strain E. 
coli and purified using glutathione-conjugated sepharose beads (Figure 1-6B). Another 
GST-hRif 1 fusion containing Rifl amino acids 1974-2472, designated GST-hRif 11974.2472, 
was produced (Figure 1-6B), but sufficient quantities for antibody production were 
difficult to obtain. GST-hRifl90-7.1327 was used to immunize two rabbits and the resulting 
crude sera, designated 1066 and 1067, reacted with the same large molecular weight 
polypeptide as the previously described 1025 and 1060 (Figure 1-6A). Cells treated with 
siRNAs corresponding to Rifl diminished the abundance of this protein (see Chapter 2), 
confirming that this polypeptide is encoded by the Rifl gene and establishing the 
specificity of the sera used in this study. 
Human Rifl mRNA is greater than nine kilobases and is present in a wide variety 
of tissues (Figure 1-7A). The Rifl protein was detectable in different human cell lines 
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and strains (e.g. IMR90, GM847, VA-13, HeLa, U20S) suggesting ubiquitous expression 
(Figure 1-7B, see also below and Chapter 2). Thus, Rifl is found in all primary 
fibroblasts, including IMR90 and BJ cells, and tumor cells, including HeLa and HT1080 
cells. It is interesting to note that Saos-2 cells have diminished levels of hRifl whereas 
other ALT lines such as GM847, U20S, and VA-13 cells have normal hRifl levels 
(Figure 1-7B). It is unclear how and why this decrease in Rifl protein is observed with 
these cell lines and it has not been determined if these cell lines have Rifl mutations at 
the DNA level or if they fail to express Rifl mRNA. The inability of the Rifl antibodies 
to detect Rifl in the murine NIH3T3 cells merely indicates that these antibodies do not 
cross-react with mouse Rifl. Mouse Rifl does exist and studies to elucidate the role of 
mouse Rifl in vivo are currently being performed (S. Buonomo, unpublished results, 
(Adams and McLaren 2004)). As mentioned in the introduction, ALT resembles the 
survivor pathways in yeast that lack telomerase. S. cerevisiae Rifl affects the 
distribution between type I and type II survivors (Teng et al. 2000). The mechanism 
underlying this is unclear, but a similar mechanism may be occurring in human ALT cells 
where Rifl can inhibit the initiation or maintenance of ALT. This proposed mechanism 
is still highly speculative. A subset of ALT cells, such as Saos-2, may actually require 
the loss of Rifl in order to survive. The antibodies 1025 and 1067 fail to detect Rifl in 
NIH 3T3 cells, indicating that they do not cross-react with mouse Rifl (Figure 1-7B). 
HeLa cells in Gl, S, or G2/M phase obtained by centrifugal elutriation contained similar 
amounts of Rifl protein (Figure 1-7C). FACS analysis of the individual elutriation 
fractions which were pooled to generate the Gl, Gl/S, S and G2/M fractions is shown in 
figure 1-7C. 
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Figure 1-6. Antibodies to human Rifl. 
A. Detection of human Rifl protein. Immunoblots of HeLa whole cell extract probed 
with the indicated antibodies or a pre-immune serum (1060 PI). 
B. G S T fusion proteins. GST-fusion proteins containing GST fused to either hRifl 
amino acids 907-1327 or hRifl amino acids 1979-2296 were produced in BL21 strain E. 
coli. 
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Figure 1-7. Human Rifl is expressed ubiquitously. 
A. Rifl R N A levels in human tissues. A Rifl-specific sequence was used to probe a 
multiple tissue northern blot (Clontech). R N A sources are indicated. 
B. Immunoblotting of Rifl in multiple cell lines. Whole cell lysates were made from 
HeLal.2.11, VA-13, GM847, Saos-2 and NIH-3T3 cells. Immunoblots were performed 
using Rif antibodies 1025 and 1067. The tubulin immunoblot serves as a loading control. 
C. Rifl expression throughout the cell cycle. HeLa cells were subjected to elutriation. 
FACS analysis was performed on the resulting fractons. Whole cell lysates were then 
prepared from the pooled fractions as indicated. Immunoblotting was performed using 
antibodies recognizing Rifl (1060) and tubulin. Elutriation and FACS analysis were 
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Indirect immunofluorescence (IF) with Rifl antibodies revealed a nuclear 
staining pattern with most of the signal distributed in a fine granular pattern throughout 
the nucleus of interphase cells (Figure 1-8A). We also observed one or a few nuclear 
sites of more intense Rifl staining with the Rifl antibodies 1025, 1060, 1066, and 1067 
(Figure 1-8A and Chapter 2). Cell cycle experiments using HeLa cells released from 
double thymidine block were conducted in order to determine if these Rifl dots varied 
during the cell cycle. Almost no cells displayed the intense dot pattern after release from 
double thymidine block (Figure 1-9A and B). Between 50 and 70 percent of cells display 
one or more intense Rifl foci after the 10 hr point (Figure 1-9A and B). This indicated 
that these Rifl dots formed as cells exited mitosis and disappeared in S-phase. Rifl dots 
did not co-localize with antibodies to coilin (a marker for Cajal bodies) and their nature 
remains to be determined (Figure 1-10). Rifl was also found at the mid-body of the cell 
and in the Golgi complex. The mid-body is a structure that forms at the point of cell 
division as cells undergo cytokinesis and its exact role is unclear. The localization of 
Rifl to the mid-body is seen with antibodies 1025 and 1060 (Figure 1-1 IA). Using anti-
Rifl antibody 1025, Rifl co-localizes with the Golgi complex protein GM130 (Figure 1-
1 IB). The localization of Rifl to the Golgi is only observed with antibody 1025, so it is 
likely that this is actually an artifact or that 1025 cross-reacts with another protein that is 
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Rifl (m1060) TRF1 (371) 
Rifl (m1060) TRF2 (647) merge 
* * * i § 
Figure 1-8. Rifl does not accumulate at telomeres. 
Rifl is a nuclear protein. Immunofluorescence (IF) of paraformaldehyde-fixed 
HeLal.2.11 cells with mouse serum raised against Rifl antigen 1060 (green) and 
antibodies against TRFI (371) and TRF2 (647) (both red) along with DAPI staining 
(blue). 
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Figure 1-9. Cell-cycle distribution of Rifl dots. 
A. HeLal.2.11 cells were synchronized using a double-thymidine block. Cells were then 
released into media and fixed at the time points indicated. IF was performed on fixed 
cells. Cells were stained with Rifl antibody (1060) and DAPI and the percentage of cells 
with at least one Rifl-intense focus was determined by counting 200 cells. Each color 
represents an independent count from the same experiment. 
B. A micrograph of double thymidine arrested HeLal.2.11 cells treated as in A at 0 and 





Dot pattern in HeLal.2.11 cells 
after release from double-thymidine block 
Time (hours pnsl-relrascl 
B 
73 
Figure 1-10. Rifl dots do not co-localize with Cajal bodies. 
IF performed on HeLal.2.11 cells using antibodies against Rifl (green) and coilin (red) 
along with DAPI (blue). 
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B 
Figure 1-11. Localization of Rifl to the mid-body and Golgi complex. 
A. Rifl at the mid-body during telophase. IF was performed on paraformaldehyde-fixed 
HeLal.2.11 cells. Cells were stained with Rifl 1060 (green) and DAPI. 
B. Rifl in the Golgi complex. IF was performed on paraformaldehyde-fixed BJ/hTERT 
cells. Cells were stained with Rif 1 1025 (green), GM130 (red) and DAPI. This 
localization is only observed by using Rifl 1025 antibody. 
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at the Golgi complex (Figure 1-1 IB). The possible role of Rifl at both the mid-body and 
Golgi apparatus is currently unknown. The single dot pattern was not suppressed in cells 
treated with Rifl siRNA. Whether the Golgi pattern disappears after Rifl siRNA 
treatment was not determined. 
Dual IF with markers for telomeric sites, including TRFI, TRF2, and Rapl, 
failed to reveal accumulation of Rifl on chromosome ends (Figure 1-5 and Chapter 2). 
This failure of Rifl to co-localize with telomeres occurs in HeLa, IMR90, and BJ cells. 
Negative results were also obtained using different methods for cell fixation 
(paraformaldehyde and methanol) or extraction of soluble nucleoplasm^ proteins with 
Triton X-100. Co-immunoprecipitation (co-IP) experiments were performed in order to 
determine if hRifl interacts with known telomere proteins. Co-IP failed to find an 
association of Rifl with TRFI, TRF2, and Rapl in HeLal.2.11 cells. Antibodies against 
Rifl are able to successfully immunoprecipitate Rifl from HeLal.2.11 whole cell 
extracts (Figure 1-12B). TRFI, TRF2 and Rapl are not detected in Rifl 
immunoprecipitates (Figure 1-12A, E, and F). Conversely, Rifl is not detectable in 
TRFI and TRF2 immunoprecipitates (Figre 1-12B). There is a small amount of Rifl in 
the Rapl immunoprecipitate shown, but this is not reproducible in other experiments 
(Figure 1-12B). The telomere complexes behaved as expected. As a positive control, 
TRF2 and Rapl interact in this co-IP experiment (Figure 1-12A and E). Neither Rapl 
nor TRF2 interact with TRFI in this experiment (Figure 1-12A,E, and F). 
Co-IP was also used to determine whether or not Rifl interacts with components 
of the Mrell complex. Using co-IP of endogenous complexes, Nbsl is detected in 
Mrell immunoprecipitate as expected (Figure 1-12C and D). In this experiment, the 
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Mrell immunoprecipitate contains detectable levels of Rifl (Figure 1-12B). Rifl 
immunoprecipitates contain no more Mre 11 than the beads alone control and only a small 
amount of additional Nbsl (Figure 1-12C and D). It is unclear if these results indicate a 
true biochemical interaction between Rifl and the Mre 11 complex. It is likely that either 
the Mrell antibody used cross-reacts with additional proteins or that only a small 
percentage of the Mre 11 complex is engaged in a complex with Rifl. 
Chromatin immunoprecipitations (ChIP) with Rifl antiserum did not bring down 
telomeric DNA (data not shown; experiment performed by Jill Donigian with technical 
assistance from Diego Loayza). In this experiment, TRFI, TRF2, and Tin2 
immunoprecipitates contained telomeric chromatin. These findings do not exclude a 
possible association of a minor fraction of Rifl with telomeric sites or association of Rifl 
with telomeres in specialized cells or in response to specific stimuli. 
Interestingly, Rifl associated with unusual telomeric loci present in certain ALT 
cell lines. As discussed in the introduction, these structures are referred to as ALT 
associated PML Bodies, or APBs. IF analysis showed that Rifl associated with APBs in 
the ALT cell line GM847 (Figure 1-13). Rifl co-localizes with APBs in only about 20% 
of cells and only a fraction of APBs contain Rifl within many cells. This may indicate 
that APBs resemble DNA damage foci or that the telomeric DNA in the APBs represent a 
rare state of the telomeric complex in which Rifl contributes to telomere function. 
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Figure 1-12. Co-immunoprecipitation of human Rifl and known telomeric proteins. 
Buffer C extracts were prepared from HeLai.2.11 cells and antibodies against Rifl 
(1060), Rapl (765), TRFI (371) and TRF2 (647), Mrell (874) and Nbsl (16/9, gift of 
John Petrini) were used to immunoprecipitate endogenous complexes. Pellets were 
washed and Laemelli buffer was added. The indicated IP pellets were immunoblotted 
with antibodies against Rapl, Rifl, Mrel 1, Nbsl, TRF2 and TRFI (A-F, respectively). 
1 % of the input whole cell extract and a sample pellet with no IP antibody (beads alone) 
were also immunoblotted. The lower bands in the immunoprecipitate lanes in Rapl and 
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Figure 1-13. Rifl is found at APBs in ALT cells. 




This chapter discusses the identification and initial characterization of human 
Rifl, an ortholog of Rifl in yeast. Orthologs are genes that have primary sequence 
similarity between two organisms, whereas homologs have primary sequence similarity 
and the same function. We classify human Rifl as an ortholog rather than a homolog 
because Rifl plays a role in telomere biology in yeast and a role in the DNA damage 
response in human cells. Further work may establish that yeast and human Rifl are 
homologs. Antibodies were raised against this large molecular weight protein in order to 
address whether or not human Rifl is found at human telomeres. IF studies, co-
immunoprecipitation experiments, and ChIP failed to detect an accumulation of Rifl at 
telomeres, an interaction with telomeric proteins, or an association with telomeric 
chromatin, respectively. The failure to detect Rifl at human telomeres under the 
conditions tested does not conclusively rule out a possible role for Rifl at human 
telomeres. Rifl can be found at APBs, although this is no guarantee that hRifl localizes 
to human telomeres because APBs may contain other factors not normally found at 
telomeres such as Rad52 (Yeager et al. 1999). 
There are both possible technical reasons and biological reasons that these 
experiments may represent a false negative result for Rifl at telomeres. Technical 
limitations involve the ability of antibodies to recognize a potentially small amount of 
telomeric Rifl and possibly weak or transient interactions between Rifl and telomeric 
protein complexes. A number of biological factors may contribute to an inability to 
localize Rifl to the telomere in human cells. First, Rifl may not be constuitively at 
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telomeres and may require a signal or some other condition to localize to telomeres. 
There is a precedent for the inability to detect Rifl at telomeres even when it is clearly 
telomeric. The primary IF data in 5. pombe reveals that spRifl only co-localizes with 
Tazl in strains lacking spRapl; wild type strains display a diffuse nucleoplasmic staining 
for tagged spRifl (Kanoh and Ishikawa 2001). However, spRifl accumulates at 
telomeric chromatin (Kanoh and Ishikawa 2001). Thus, further work is needed to 
address the issue of whether Rifl is at telomeres. A complete data set would include an 
analysis of telomere length when levels of human Rifl are perturbed and studying cells 
expressing altered alleles of human Rifl. The human situation may also resemble the 
situation in S. pombe where a component of the telomeric complex, such as Rapl, must 
be deleted or altered before Rifl is detected at telomeres. 
Rifl was also found at a variety of other sites in the cell and the exact role of 
Rifl at these sites remains unclear. The cell-cycle nuclear dot pattern is a complete 
mystery. The localization of Rifl at the Golgi apparatus is likely to be an artifact as it is 
only detected with the 1025 antibody and no others. The finding of Rifl at the mid-body 
is more robust, seen with multiple antibodies, and may well represent a physiologic role 
for Rifl in the execution of mitosis. It is possible that mice lacking Rifl will demonstrate 
phenotypes related to these other cellular localizations for Rifl. 
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C h a p t e r 2 - T h e role o f h u m a n R i f l 
in t h e D N A d a m a g e r e s p o n s e 
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Introduction 
Evidence in yeast telomere biology suggests that Rifl is in a common pathway 
with TEL1 and MEC1, orthologs of mammalian ATM and ATR. Rifl, Tell and Mecl 
play important roles in telomere length regulation in both S. cerevisiae and 5. pombe. As 
mentioned previously, yeast strains deficient in Rifl have elongated telomeres (Hardy et 
al. 1992). Rifl is in the telomerase epistasis group in terms of telomere length regulation 
with the other two groups being the Ku/Mrell/Xrs2/Rad50 group and the Cdcl3 group 
(Nugent et al. 1998). Mutations in S. cerevisiae TEL1, the ATM ortholog, result in 
telomere shortening (Greenwell et al. 1995). Deletion of S. cerevisiae MEC1 and its 
ortholog S. pombe Rad3 leads to telomere shortening as well (Dahlen et al. 1998; Naito et 
al. 1998; Ritchie et al. 1999). Tell and Mrel 1, Xrs2, and Rad50 are in the same telomere 
length epistasis group (Ritchie and Petes 2000). Like ATM and ATR, Tell and Mecl 
possess kinase activity and mutations in Tell and Mecl that abolish kinase activity result 
in phenotypes identical to TEL1 and MEC1 deletion (Mallory and Petes 2000). 
The combination of loss of TEL1 and MEC1 in S. cerevisiae or tell+ and rad3+ in 
5. pombe results in disastrous consequences for yeast cells (Naito et al. 1998; Ritchie and 
Petes 2000). tell-A mecl-A cells undergo telomere loss and senescence. Deletion of 
both tell and rad3 in 5. pombe leads to the loss of all telomeric DNA and tell" rad3 cells 
survive by circularizing their chromosomes (Naito et al. 1998). S. cerevisiae tell mecl 
cells can not circularize their chromosomes and undergo a senescence phenotype similar 
to the loss of telomerase (Ritchie et al. 1999). Thus, S. pombe cells survive only because 
they are able to circularize their chromosomes after the loss of telomeric DNA. Strains 
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lacking TEL1 and M E C 1 senesce later than tell mecl tlcl strains and strains deleted for 
tell and mecl still have telomerase activity in vitro, suggesting that Tell and Mecl do 
not act by changing telomerase activity (Chan et al. 2001). 
Studies of telomeres with X subtelomeric repeats and Y' subtelomeric repeats 
initially demonstrated that the telomere length regulation of Rifl is affected by Tell 
(Craven and Petes 1999). Rifl deletion is able to bypass the senescence phenotype of 
tell mecl cells because tell mecl cells undergo senescence, yet tell mecl rifl yeast are 
able to survive (Chan et al. 2001). Thus, the deletion of Rifl enables tell mecl cells to 
bypass senescence, which suggests that Rifl may function in the same pathway as Tell 
and Mecl. Additionally, rifl rif2 cells have long, heterogeneous telomeres, whereas tell 
mecl smll rifl rif2 (the SML1 deletion is necessary to maintain viable cells in a MEC1 
delete strain) do not have heterogeneous telomeres (Chan et al. 2001). The epistatic 
relationship and underlying mechanism between TEL1 and RIF1 is unclear. Because of 
this link in yeast, we examined the possible relationship between Rifl and ATM and 
ATR in human cells. 
This chapter documents the unexpected discovery that human Rifl is involved in 
the DNA damage response. The characteristics of Rifl ionizing radiation induced foci 
(IRIF), such as the rapid kinetics of formation and dose response are discussed. Rifl 
IRIF co-localize with a number of other previously identified DNA damage response 
proteins, specifically ATM, BRCA1, Chkl, y-H2AX, 53BP1 and the Mrell complex. 
Furthermore, Rifl localized to uncapped telomeres, as do other DNA damage response 
factors. Whereas inhibition of ATR signaling did not inhibit the Rifl response, ATM 
deficient cells treated with IR or UV lacked Rifl foci even after prolonged incubation or 
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high radiation dose. The Rifl response also depended on the presence of 53BP1 but was 
not affected by reduced function of BRCA1, Chk2, Nbsl, and Mrell. RNAi-mediated 
Rifl inhibition resulted in increased radiosensitivity, indicating that Rifl function 
contributes to the ATM-mediated protection against exposure to ionizing radiation. 
Results 
In cells treated with IR, the Rifl IF signal became redistributed into discrete foci 
that were detectable with all Rifl antibodies (Figure 2-1). This response was rapid, 
occurring within 5 min, and persisted for many hours (Fig. 2-1C). All cells of an 
asynchronous population showed the same or a similar response indicating that Rifl can 
relocalize in Gl, S, and G2 cells. Rifl foci were observed after an IR dose as low as 0.5 
Gy and the number of foci increased with higher doses, reaching a plateau between 10 
and 20 Gy (Fig. 2-1 A). Rifl ionizing-radiation-induced foci (IRIF) exhibit similar 
behavior, such as a distribution in number of IRIF per cell, a dose-response relationship 
in average number of foci, and changes in foci number and size over time, to previously 
described DNA damage response factors such as Mrell and 53BP1 (Schultz et al. 2000; 
Mirzoeva and Petrini 2001). IRIF were observed in BJ cells using the four antibodies 
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Figure 2-1. H u m a n Rifl forms foci in cells exposed to ionizing radiation. 
A. Rifl foci after IR treatment. Rifl IF (Ab 1060) of IMR90 primary fibroblasts (pi7), 
exposed to the indicated levels of IR and fixed after 30 min. 
B. Co-localization of Rifl with 53BP1. IF of DVIR90 (pl5) cells, exposed to 5 Gy IR and 
fixed 2 hr post-IR. Cells were then stained with Rifl (green) and 53BP1 (red) antibodies 
for IF. 
C. Time course of the Rifl response. IF as in A. but after 5 Gy IR and with fixation at 
the indicated time points. 
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IR-induced foci were observed in a wide range of cell lines examined, including IMR90, 
BJ, HeLa, and U20S cells (Figure 2-1, 2-2, 2-10B and 2-12B). The IR-induced Rifl foci 
showed a complete co-localization with the DNA damage response factor 53BP1 
(Anderson et al. 2001; DiTullio et al. 2002; Wang et al. 2002) (Fig. 2-IB and see below), 
consistent with the idea that Rifl re-localizes to sites of DNA damage. Rifl does not 
form these foci or co-localize with 53BP1 in cells not exposed to radiation (Figure 2-2, 2-
3, 2-4 and 2-7A). IR-induced foci did not co-localize with the known telomeric proteins 
TRFI, TRF2, and Rapl (Figure 2-3). 
Rifl also formed foci after treatment of cells with MMS or etoposide and the 
Rifl foci in these cells co-localized with 53BP1 foci (Figure 2-4A). UV treatment 
resulted in the formation of Rifl foci which co-localized with 53BP1 foci (Figure 2-4B). 
UV treatment induced a Rifl response in a subset of the cells (~20-30%) whereas IR-
induced Rifl foci occurred in all interphase cells (Figure 2-1 and 2-4C). Furthermore, the 
UV-induced Rifl foci were slow to develop compared with IR-induced Rifl foci. The 
UV-induced foci first appear 1 hr after UV exposure (Figure 2-4B). This time frame is 
markedly different from the rapid response after IR. A possible explanation for the 
occurrence of foci in only a subset of cells treated with UV as well as the delay in Rifl 
response to UV is that the primary UV-induced lesions are converted into double-
stranded breaks (DSBs) during S phase and that Rifl actually responds to these DSBs. 
In addition to 53BP1, the Rifl foci contained several other DNA damage 
response factors, including y-H2AX, Chkl phosphorylated on S317, ATM 
phosphorylated on SI981, Rad 17 phosphorylated on S645, Mrel 1, and BRCA1 (Figure 
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Figure 2-2. Multiple Rifl antibodies recognize Rifl IRIF. 
BJ primary fibroblasts were fixed 2 hr after exposure to 5 Gy IR. Cells were stained with 
Rifl (antibody 1025 in A., antibody 1060 in B., antibody 1066 in C , and antibody 1067 
in D.). In A. and B., cells were also stained with 53BP1 antibodies (red). In C. and D., 
cells were also treated with DAPI (blue). 
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Figure 2-3. Rifl IRIF do not co-localize with human telomeres. 
A. HeLal.2.11 cells were either untreated or exposed to 5 Gy IR and fixed 30 minutes 
post-IR. Cells were then stained with Rifl (green), TRFI (red) and DAPI (blue). 
B. HeLal.2.11 cells were either untreated or exposed to 5 Gy IR and fixed 30 minutes 
post-IR. Cells were then stained with Rifl (green), TRF2 (red) and DAPI (blue). 
C. HeLal.2.11 cells were either untreated or exposed to 5 Gy IR and fixed 30 minutes 
post-IR. Cells were then stained with Rifl (green), Rapl (red) and DAPI (blue). 
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Figure 2-4. Rifl forms foci following exposure to clastogenic drugs and U V 
treatment. 
A. Rifl foci in response to M M S , etoposide and hydroxyurea treatment. IMR90 (PI5) 
cells were treated for 1 hr with 0.01% M M S , 50 mg/ml etoposide, or no drug prior to 
fixation. For H U treatment, IMR90 (p26) cells were incubated for 18 hr with 2 m M 
hydroxyurea prior to fixation. Rifl and 53BP1 were detected as in Figure IB. 
B. Response of Rifl to U V irradiation. IMR90 (P14) cells were exposed to U V light (25 
J/m2), fixed at the indicated time points, and processed for Rifl and 53BP1 IF as in A. 
C. A subset of cells responds to U V irradiation. IMR90 (P14) cells were exposed to U V 
light (25 J/m2), fixed 1 hr post-UV. and stained with Rifl antibody (green), 53BP1 
antibody (red) and DAPI (blue). 
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2-5). As a control, Rifl IR-induced foci do not co-localize with the telomere proteins 
TRFI, TRF2, and Rapl (Figure 2-3A-C). It has previously been shown that y-H2AX, 
ATM phosphorylated on SI981, 53BP1, Rad 17 phosphorylated on S645 and the Mrell 
complex do not co-localize with telomeric proteins (Zhu et al. 2000; Takai et al. 2003). 
Rifl behaves similarly to previously described factors that respond to the formation of 
double strand DNA breaks. 
Work in the de Lange lab has previously shown that dysfunctional telomeres are 
recognized as sites of DNA damage (Takai et al. 2003). Cells have the ability to 
distinguish functional telomeres from DNA breaks and this distinction is made based on 
the presence of a specific telomeric protein complex (de Lange 2002). The main 
protective protein at telomeres is TRF2. Inhibition of TRF2 with a dominant negative 
allele or siRNA results in telomere uncapping. Such uncapped telomeres induce a cell 
cycle arrest and are processed by DNA damage repair pathways, including the NHEJ 
pathway which generates chromosome end fusions. Furthermore, uncapped telomeres 
activate the ATM-dependent DNA damage response (Takai et al. 2003). As a 
consequence, telomeres become associated with DNA damage response factors, such as 
Nbsl, 53BP1, ATM, Radl7, and y-H2AX (Takai et al. 2003). The foci formed at 
uncapped telomeres resemble DNA damage response foci and are referred to as Telomere 
Dysfunction Induced Foci (TIFs). To test whether Rifl is a component of the TIFs 
formed at uncapped, dysfunctional telomeres, IF was done in BJ/hTERT cells that were 
infected with an adenovirus expressing the dominant negative allele of TRF2 (Ad-
TRF2ABAM; (Karlseder et al. 1999)). Co-staining with an antibody to TRFI was used to 
determine whether Rifl binds to the telomeric sites. 
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Figure 2-5. Rifl IRIF co-localize with other known D N A damage response proteins. 
IMR90 cells were treated with 5 Gy IR and fixed with paraformaldehyde 1 hr later. Cells 
were then co-stained for Rifl (rabbit 1060, green) and BRCA1 (red) or Rifl (mouse 
1060, green) and ATM-S1981-P, Chkl-S317-P, g-H2AX, Radl7-S645-P and Nbsl (red) 
as indicated. The merged images include DAPI stain (blue). For co-staining of Rifl and 
Nbsl, cells were treated with cytoskeleton extraction buffer and fixed as in (Mirzoeva 
and Petrini 2001). 
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Comparison of cells infected with a control adenovirus and cells in which TRF2 was 
inhibited using Ad-TRF2ABAM showed that Rifl formed foci on uncapped telomeres 
(Figure 2-6; experiment performed by Hiroyuki Takai). Thus, also in this regard, Rifl 
behaves as other DNA damage response factors, many of which have no known role in 
normal telomere function. 
The induction of Rifl foci was severely reduced when cells were treated with 
inhibitors of the PI3 kinase-related family of kinases (PIKKs), which includes ATM and 
ATR. The central role of the ATM and ATR in the DNA damage response makes the 
dependence of Rifl IRIF on ATM and ATR signaling an important question. The drugs 
caffeine and wortmannin were used in order to initially address whether Rifl is 
dependent on PIKK family members in terms of foci formation. Treatment with caffeine 
and wortmannin almost completely abolished the Rifl response to IR (Figure 2-7A and 
2-7B). The effect of caffeine on Rifl was more pronounced than its effect on 53BP1 
(Figure 2-7A), suggesting that Rifl is exquisitely sensitive to signaling by one or more 
PIKKs. 
In order to test the dependence of Rifl on the ATM kinase, we examined the 
response of Rifl to IR and UV in cells derived from A-T patients. Two unrelated A-T 
fibroblast strains, AG02496 and AG04405, lacked the ATM kinase as verified by 
immunoblotting (Takai et al. 2003). These A-T cells failed to show Rifl foci when 
examined 2 hr after 5 Gy (Figure 2-8A). Rifl foci were also not observed after treatment 
with 20 Gy and at later time-points (up to 8 hr) (Figure 2-8A). By contrast, the A-T cells 
formed 53BP1 foci after IR (Figure 2-8A), albeit at diminished levels as previously noted 
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(Rappold et al. 2001). The A-T cells contained normal amounts of Rifl proteins as 
detected by immunoblotting (Figure 2-8B). Although the figure depicts elevated Rifl in 
cells exposed to 20 Gy, this is not reproducible. 
Human Rifl contains 11 ST and 13 QT sites that could potentially be a direct 
target of the ATM kinase, but direct evidence for the phosphorylation of Rifl by ATM is 
not available at this stage. A number of DNA damage response proteins, including the 
large molecular weight proteins BRCA1, MDC1 and 53BP1, shift upward in 
immunoblots after being phosphorylated by ATM or ATR (Cortez et al. 1999; Goldberg 
et al. 2003; Lou et al. 2003a; Stewart et al. 2003). Rifl does not have a detectable shift in 
immunoblots 4 hours after cells are exposed to 20 Gy IR (Figure 2-9). The blot shown 
contains varying amounts of Rifl in the lanes, making interpretation difficult. In other 
experiments, the amount of Rifl is equal between untreated and irradiated cells and no 
shift is detected. It is important to note that a lack of Rifl shift in immunoblot following 
radiation exposure is not conclusive evidence that Rifl is not phosphorylated by ATM. 
In vitro phosphorylation assays are underway to determine if Rifl is directly 
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Figure 2-6. Rifl localizes to dysfunctional telomeres. 
hTERT-BJ cells were infected with the indicated adenoviruses (control: b-galactosidase 
virus) fixed 48-52 hr post-infection and processed for Rifl (mouse anti-1060, green) and 
TRFI (Ab 371; red) IF as described in (Takai et al. 2003). D N A was stained (DAPI, 
blue) in the merged images. White arrows highlight a subset of the Rifl foci at telomeres. 
The enlarged images are derived from the same experiment. This experiment was 
conducted by Hiroyuki Takai. 
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Figure 2-7. The PIKK inhibitors caffeine and wortmannin inhibit Rifl IRIF 
formation. 
A. Effect of caffeine on Rifl foci. IMR90 (P14) cells were treated with 20 m M caffeine 
2 hr prior to 1 Gy IR and fixed 30 min post-IR. IF for Rifl and 53BP1 as in Figure IB. 
B. Effect of wortmannin on Rifl foci. IMR90 (P29) cells were treated with 100 m M 
wortmannin 1 hr prior to 5 Gy IR, fixed 30 min post-IR, and processed for IF as in A. 
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Figure 2-8. Absence of Rifl foci in A-T cells. 
A. A-T fibroblasts (AG02496 and AG04405) which lack the A T M kinase were exposed 
to either 5 Gy IR or 25 J/m2 UV. Cells were fixed 2 hr or 8 hr after IR and 6 hr after U V 
and processed for IF as in Figure IB. 
B. A-T fibroblasts (AG04405) were exposed to IR as indicated and whole cell lysates 
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Since Rifl forms foci after treatment with UV, which is thought to activate the 
ATR kinase, we tested whether Rifl depends on both ATR and ATM, as is the case for 
numerous other DNA damage response factors. ATR signaling can be inhibited using 
siRNAs against ATRIP, an essential partner for ATR (Cortez et al. 2001). As previously 
shown, two different ATRIP siRNAs resulted in strong reduction of the ATRIP protein 
(Figure 2-10A). These siRNAs did not affect Rifl protein levels (Figure 2-10A). 
Despite the reduction in ATRIP protein levels, UV treatment continued to induce Rifl 
foci in these cells (Figure 2-10B). Therefore, we tested whether the Rifl foci formed 
after UV treatment were dependent of ATM signaling. No Rifl foci were formed upon 
UV treatment of A-T cells (Figure 2-8A), even though the cells formed 53BP1 foci. 
Thus, Rifl appears to depend exclusively on ATM rather than ATR for its response to 
DNA damage, even when the damage is a consequence of UV treatment. 
Several components of the ATM signaling pathway were tested for their role in 
Rifl regulation. Although Chk2 is a downstream target of ATM (Matsuoka et al. 1998), 
its activity was not required for Rifl regulation; Chk2-deficient HCT15 cells still 
displayed Rifl foci after IR (Figure 2-11 A). Furthermore, we tested the role of the 
Mrel 1 complex, which has been shown to contribute to the ATM pathway both upstream 
and downstream of ATM ((Carney et al. 1998; Lim et al. 2000); reviewed in (Petrini and 
Stracker 2003)). LB1 cells derived from a Nijmegen breakage syndrome patient with a 
hypomorphic mutation in the Nbsl component of the Mrell complex, specifically a 
657del5 mutations in NBS1, did not display an obvious defect in Rifl focus formation 
(Zdzienicka 1999) (Figure 2-1 IB). Similarly, two Mrell mutant cell lines (ATLD3 and 
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Figure 2-9. Rifl immunoblot following ionizing radiation. 
U 2 0 S cells were pretreated with 100 m m wortmannin as indicated 1 hr prior to IR 
exposure of 0, 10, or 20 Gy IR as indicated. Whole cell lysates were prepared at 
indicated times following IR and cells were immunoblotted using an anti-hRif 1 antibody. 
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Figure 2-10. ATRIP siRNA treatment does not inhibit UV-induced Rifl foci. 
A. Immunoblotting analysis of the effect of ATRIP siRNAs. HeLai .2.11 cells were 
transfected twice with the indicated siRNAs and analyzed by immunoblotting 72 hr after 
the first transfection for expression of the indicated proteins. Rifl was detected with 
mouse serum 1060. 
B. UV-induced Rifl foci in cells treated with ATRIP siRNA. HeLa 1.2.11 cells were 
exposed to 25 J/m2 U V 72 hr after siRNA transfection. Cells were fixed after 6 hr and 
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Figure 2-11. Deficiency of Chk2, Nbsl, Mrell or Nbsl does not affect Rifl IRIF. 
A. Effect of Chk2 deficiency on response of Rifl to IR. Chk2 deficient HCT15 cells. For 
panels A-D, cells were treated with 5 Gy and processed for Rifl and 53BP1 IF after 1 hr 
as in Figure IB. 
B. Effect of Nbsl deficiency on response of Rifl to IR. SV40-transformed NBS1-LB1 
cells. 
C. Effect of Mrel 1 deficiency on response of Rifl to IR. Mrel 1 mutated ATLD4 cells. 
D. Effect of BRCA1 deficiency on response of Rifl to IR. BRCA1 deficient HCC1937 
cells. 
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Figure 2-12. Rifl IR-induced foci are dependent on 53BP1. 
A. Immunoblotting analysis of the effect of 53BP1 siRNAs. HeLa cells were transfected 
twice with the indicated siRNAs and analyzed by immunoblotting 72 hr after the first 
transfection for expression of the indicated proteins. Rifl was detected with mouse 1060. 
B. Rifl foci formation upon IR in cells treated with 53BP1 siRNA. Cells were exposed 
to 5 Gy IR 72 hr after mock transfection or transfection with either control (GFP) or 
53BP1 siRNA olgionucleotides. Cells were fixed 1 hr after exposure and processed for 
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cell lines are primary fibroblasts derived from siblings that carry an A to G missense 
mutation at nt 350 that results in an N -^ S amino acid change (Stewart et al. 1999). 
Finally, HCC1937 cells deficient for the ATM target BRCA1 retained the ability to form 
Rifl foci (Tomlinson et al. 1998) (Figure 2-1 ID). HCC1937 cells produce a truncated 
disease-producing mutant allele (5382insertC) and no wild type protein (Chen et al. 1998; 
Tomlinson et al. 1998). 
In contrast, inhibition of 53BP1 completely abolished the Rifl DNA damage 
response. Reduction in 53BP1 expression was achieved with two different siRNAs as 
demonstrated by Western analysis ((Wang et al. 2002); Figure 2-12A). Rifl protein 
expression was not affected by these siRNAs (Figure 2-12A). As expected, the induction 
of 53BP1 foci by IR was strongly reduced in cells treated with the 53BP1 siRNAs 
(Figure 2-12B). Cells without 53BP1 foci also lacked Rifl foci indicating a Rifl depends 
on 53BP1 for its localization to damage foci. Normal Rifl foci occurred in the few cells 
that had escaped the effects of the 53BP1 siRNAs, providing an internal control in the 
experiments (Figure 2-12B). The repression of Rifl foci with two independent 53BP1 
siRNAs argues against off-target siRNA effects, namely the suppression of mRNA and 
protein levels of other genes by a given siRNA sequence. Off target effects are 
minimized by obtaining similar results with multiple siRNAs and by checking that 
siRNA target sequences are unique within the genome. Furthermore, the Rifl response 
was not affected by several other siRNAs (GFP, BRCA1, ATRIP, and luciferase; Figures 
2-10A and 2-12A), demonstrating the specificity of the 53BP1 siRNA effect. Thus, Rifl 
appears to be regulated by two components of the ATM pathway, 53BP1 and ATM itself. 
Since 53BP1 forms foci in A- T cells but Rifl does not (Figure 2-8A), it appears that Rifl 
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requires an A T M regulated event in addition to 53BP1 foci formation. This implies that 
at least two independent molecular events, one ATM-dependent and the other 53BP1-
dependent are required for the recruitment of Rifl to sites of DNA damage. It is 
currently unclear whether or not ATM acts to directly phosphorylate Rifl. As mentioned 
previously, Rifl does not shift in immunoblots after radiation (Figure 2-9). As 
mentioned previously, in vitro kinase assays to address whether ATM directly 
phosphorylates Rifl are being performed. 
RNAi was used to study the consequences of diminished Rifl functions. We 
created 8 independent sets of siRNA oligonucleotides to Rifl (Chapter 1). The siRNA 
nucleotides were designed through inspection of the Rifl sequence (using the guidelines 
set forth in (Elbashir et al. 2001)). Additionally, a goal was to design siRNA 
oligonucleotides that were distributed throughout the predicted Rifl open reading frame. 
Six of these eight siRNAs strongly reduced Rifl protein levels and the other two siRNAs 
led to a 50% decrease in Rifl protein levels (Figure 2-13A). The siRNAs also interfered 
with the formation of Rifl foci after ionizing radiation (Figure 2-13B). siRNA transient 
transfection affects approximately 90% of cells. The untranfected cells shown in the 
bottom right panel of Figure 2-13B) still display foci formation after radiation and act as 
an internal positive control. As mentioned above, control siRNAs do not have this effect, 
demonstrating the specificity of the Rifl siRNAs. Temporary knock-down of Rifl 
expression with siRNA did not affect cell viability or long term growth. This is 
demonstrated by the ability of Rifl siRNA treated cells to form similar numbers of 
colonies as control cells in a colony formation assay without radiation (Figure 2-16B). 
Furthermore, in keeping with the lack of obvious association of Rifl with telomeres, Rifl 
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siRNA treatment did not have an acute effect on telomere function. For instance, the 
telomeric DNA remained intact and telomere fusions, which are indicative of telomere 
uncapping, were not induced (Figure 2-14). In fact, metaphase spreads in Rifl siRNA 
treated cells did not appear to be abnormal or different from control treated metaphase 
spreads (Figure 2-14). 
As Rifl is a component of the ATM pathway, we examined the effect of Rifl 
siRNAs on several aspects of ATM signaling. The activating auto-phosphorylation of 
ATM at serine 1981 was not affected by Rifl siRNA treatment and the phosphorylation 
of Nbsl, Chkl, BRCA1, and p53 on ATM target sites occurred normally in irradiated 
cells with reduced Rifl (Figure 2-15A). This demonstrates that Rifl siRNA treatment 
does not affect the ability of ATM to phosphorylate these targets. Furthermore, Rifl 
inhibition did not affect IR-induced focus formation by 53BP1 (Figure 2-13C), showing 
that Rifl is downstream of 53BP1 in terms of focus formation. 
Exposure of cells to IR leads to the accumulation of p53, transcriptional 
activation of p21, and subsequently the induction of a Gl/S cell cycle arrest. U20S cells 
treated with Rifl siRNAs had a comparable level of p21 induction to Mock, GFP and 
53BP1 treated cells (Figure 2-15B). 
Although ATM signaling was not strongly affected, treatment of HeLa cells with 
two different Rifl siRNAs resulted in decreased clonogenic survival after ionizing 
radiation (Figure 2-16A). Control cultures were either mock treated or treated with an 
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Figure 2-13. Rifl siRNA. 
A. Immunoblotting analysis of Rifl siRNAs. HeLa cells were transfected twice with the 
indicated siRNAs and analyzed by immunoblotting 72 hr after the first transfection for 
expression of the indicated proteins. Rifl was detected with Ab 1060. 
B. Rifl siRNA abrogates Rifl ionizing radiation-induced foci. Rifl siRNA treatment as 
in (A). Cells were fixed 1 hr after IR. IF for Rifl (green) was performed using antibody 
1060. 
C. IR-induced 53BP1 foci in cells treated with Rifl siRNA. U20S cells were exposed to 
5 Gy IR 72 hr after mock transfection or transfection with Rifl siRNA #2. Cells were 
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Figure 2-14. Metaphase spreads of cells treated with Rifl siRNA. 
HeLal.2.11 cells were transfected twice with the indicated siRNAs and metaphase 
spreads were prepared 72 hr after the first transfection. Metaphase spreads were stained 
with DAPI (blue). 
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Figure 2-15. ATM-dependent phosphorylation of targets and p53 IR response in 
cells treated with Rifl siRNAs. 
A. U20S cells were transfected twice with the indicated siRNAs and treated with either 
0 Gy or 10 Gy IR 72 hr after the first transfection. Whole cells lysates were then prepared 
1 hr after IR exposure. Immunoblotting of these lysates was performed using mouse 
1060 antisera and antibodies recognizing ATM-S1981-P, BRCA1-S1524-P, Chkl-S317-
P, p53-Serl5-P and Nbsl-S343-P. Anti-tubulin blotting was used as a loading control. 
B. U20S cells were transfected twice with the indicated siRNAs and treated with either 
0 Gy or 10 Gy IR 72 hr after the first transfection. Whole cells lysates were then prepared 
at 0, 1, 2, or 4 hr after IR exposure as indicated. Immunoblotting of these lysates was 
performed using mouse 1060 antisera and antibodies recognizing p53 and p21. Anti-
tubulin blotting was used as a loading control. 
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Figure 2-16. Cells deficient in Rifl are radiosensitive. 
A. Effect on Rifl siRNA on clonogenic survival after IR. Cells treated with siRNA as 
indicated were brought to the same concentration and irradiated with the indicated dose 
of IR 72 hr after transfection and plated in triplicate at multiple concentrations. 
Commassie stained colonies were counted after 14 days using dilutions resulting in 
similar colony numbers for the various treatments. Error bars indicate standard deviation 
within triplicate plating for each experiment. Dashed lines indicate the least squared 
linear regression through either mock and Scrambled I (black) or two independent Rifl 
siRNAs (#2 and #4) (red) data points. 
B. Clonogenic survival assay. Cells treated, plated and stained as in A. Photograph of 
coomassie stained sample plates (IO4 cells plated per 6 cm2 dish) from mock and Rifl set 
#2 siRNA treated cells. 
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irrelevant control siRNA. Reduction in Rifl reproducibly resulted in a 5 0 % increase in 
the radiosensitivity (Figure 2-16A). After radiation with 6 Gy, Rifl knockdown cells 
showed a 4.3-fold less clonogenic survival (P < 0.0001, students t test). This effect is 
comparable to the radiosensitivity due to knockdown of BRCA1 with siRNA (Ganesan et 
al. 2002) (data not shown), but modest compared to the radiosensitivity of A-T cells 
which typically show 10-fold lower survival rates. The RNAi experiments may 
underestimate the importance of Rifl for survival after DNA damage as siRNA effects 
are incomplete and short-lived. 
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Discussion 
Rifl is a bona fide member of the DNA damage response in human cells. Rifl 
forms IRIF and co-localizes with other DNA damage components. Rifl critically 
depends on both ATM and 53BP1 for its localization to sites of damage after IR. The 
radiosensitivity of cells deficient in Rifl confirms that Rifl plays a biologically 
significant role in the cellular response to IR. These results were quite surprising given 
the role of Rifl in yeast telomere biology. The observation that rif 1-A yeast strains 
display significantly elevated rates of chromosome loss suggests that Rifl may play a 
role in the maintenance of genomic stability and DNA damage response in yeast (Wotton 
and Shore 1997). However, rifl-A yeast do not have a GCR phenotype (Myung et al. 
2001). As mentioned, RIF1 deletion also allows tell mecl strains to bypass senescence, 
which suggests that ATM and Rifl are in a common pathway in telomere maintenance. 
It appears that this pathway extends to the DNA damage response in mammalian cells. 
The elucidation of more details about the role of Rifl in the DNA damage 
response could provide light as to the exact function of Rifl in the DNA damage 
response. One of the basic issues that remains is the determination of whether or not Rifl 
is phosphorylated directly by ATM (and/or other kinases) in response to IR and the 
location(s) of these phosphorylation sites. This would allow one to test the consequences 
of re-introducing Rifl with mutated phosphorylation sites back into cells. Another 
important piece of work that would aid in the understanding of Rifl is the cloning of the 
full-length Rifl cDNA to determine which domains are responsible for recruitment to 
sites of damage and hypersensitivity phenotype. Finally, the limitations of the transient 
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nature of the siRNA transfections used to study Rifl could be overcome through either 
the use of retroviruses that express shRNA hairpin oligonucleotides which allow for a 
longer-term knockdown of Rifl. Questions such as a possible role of Rifl in telomere 
length regulation and the issue of whether or not Rifl deficiency results in genomic 
instability could be addressed this way. 
A critical issue involves the molecular mechanism underlying the radiosensitivity 
of Rifl. The possible mechanisms of hypersensitivity involve roles in ATM signaling, 
one or more cell-cycle checkpoints, apoptosis and repair. The ability of ATM to 
phosphorylate many of its targets remains intact in cells treated with Rifl siRNAs. This 
suggests that ATM signaling remains intact in Rif 1-deficient cells, although there may 
still be an as-of-yet unidentified target of ATM. It is still possible that Rifl could play a 
role in either the Gl/S or intra-S-phase checkpoint. Radioresistance DNA synthesis 
(RDS) assays should be performed on cells deficient in Rifl to assay the intra-S-phase 
checkpoint. Rifl does not seem to affect IR-induced apoptosis as assayed by TUNEL. 
Finally, a role for Rifl in DNA repair may explain the radiosensitivity of Rif 1-deficient 
cells. 
122 
C h a p t e r 3 -
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Introduction 
The identification and characterization hRapl-interacting factors could 
potentially answer a number of important questions in the field of telomere biology. 
First, it could provide insight into the differences between mammalian and yeast 
telomeric complexes in terms of both evolutionary considerations and mechanisms of 
telomere length regulation. As mentioned in the introduction, Rapl binds directly to 
telomeric DNA directly in S. cerevisiae, while it is recruited to telomeres through its 
interaction with TRF2 in human cells and the TRF-like Tazlp in S. pombe. The 
identification of additional protein components at telomeres could help shed light on the 
evolution of the Rapl complex and explain the differences between these complexes in S. 
cerevisiae, S. pombe and mammalian cells. The elucidation of Rapl-interacting factors 
would also extend current knowledge regarding telomere length regulation in telomerase-
positive mammalian cells. Presumably, other factors besides telomerase, TRFI, and 
TRF2 function to regulate telomere length either via influencing the properties of t-loops 
or via some other mechanism. 
An understanding of the domain structure of hRapl is necessary in order to select 
baits for yeast two-hybrid screens. The most obvious candidate for a protein interaction 
domain is the C-terminal domain of Rapl, termed the RCT (Li et al. 2000). In S. 
cerevisiae, this domain recruits Sir3, Sir4, Rifl and Rif2 (Hardy et al. 1992; Moretti et al. 
1994; Cockell et al. 1995; Liu and Lustig 1996; Wotton and Shore 1997). Additionally, 
Rapl in S. cerevisiae contains an N-terminal BRCA1 C-terminal (BRCT) domain, which 
is a domain known to be involved in protein-protein interactions (Bork et al. 1997; 
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Callebaut and Mornon 1997). Both the R C T and B R C T domains are conserved in human 
Rapl (Li et al. 2000). S. cerevisiae Rapl contains two Myb-type helix-turn-helix motifs, 
which recognize two tandem GGTGT sites spaced 8 bp apart (Konig et al. 1996). This 
domain has been crystallized bound to DNA and folds like two copies of the Myb proto-
oncogene DNA binding domain (Konig et al. 1996). Human Rapl contains a single Myb 
domain and is unable to directly bind to telomeric DNA (Li et al. 2000). TRFI and TRF2 
each contain a single Myb domain, but both TRFI and TRF2 homodimerize in order to 
be able to bind to telomeric DNA (Bianchi et al. 1997; Broccoli et al. 1997a; Bianchi et 
al. 1999). Rapl has a transcriptional activation domain in S. cerevisiae, but this is not 
conserved in human Rapl (Li et al. 2000). Finally, hRapl contains a coiled-coil region 
which may be involved in protein-protein interactions. Thus, both the N-terminal BRCT 
domain and the C-terminal RCT are reasonable candidates for regions of hRapl that 
might interact with proteins. As described in this chapter, a bait consisting of the hRapl 
C-terminus was used to perform a yeast two-hybrid screen. Recent data based on both 
the localization of various Rapl alleles to telomeres and the telomere length phenotypes 
of these alleles suggests that both the BRCT domain and the Myb domain of hRapl 
recruit an as-of-yet unidentified factor that inhibits telomere elongation (Li and De Lange 
2003). 
This chapter describes the execution of a series of yeast two-hybrid screens in 
order to screen for proteins that interact with hRapl. The positive clones in a screen 
using the C-terminus of hRapl as a bait correspond to two genes, a novel zinc finger 
protein referred to as C144, and a previously identified factor called FLASH which is 
known to play a role in apoptosis. The full-length C144 was cloned and experiments 
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were conducted to determine whether or not C144 has a role in human telomere biology. 
Co-immunoprecipitation and studies fail to show that C144 interacts with known 
telomere proteins or that C144 localizes to telomeres. A yeast ortholog of C144 was 
identified and yeast strains lacking this C144 ortholog do not experience changes in 
telomere length over the course of 100 generations. 
Results and discussion 
A standard yeast two-hybrid screen was used in order to search for factors that 
interact with hRap 1. An initial screen was carried out using an N-terminal LexA fused to 
a full-length hRapl as bait to screen a human fetal liver cDNA library. The full-length 
hRapl-LexA fusion bait was slightly toxic to cells as indicated by slow cell growth in 
liquid culture and a delay in colony formation. This bait behaved as expected in terms of 
yeast two-hybrid interaction, interacting with TRF2 but not TRFI (Li et al. 2000). 
Analysis of several hundred colonies that grew on histidine-deficient plates out of the 
initial 4 million transformants resulted in no true positive results for this initial screen. 
Several criteria were used in order to verify that a colony growing on histidine dropout 
plates is a true positive in the screen. First, colonies were restreaked on histidine dropout 
plates to verify phenotype. Secondly, a filter lift assay was used to verify that the bait-
prey combination could turn on the P-galactosidase gene as well. Finally, the prey 
plasmid DNA was then isolated, re-transformed into yeast and both nutritional and |3-
galactosidase phenotypes are tested to verify that the phenotype is plasmid-linked. 
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A second screen was undertaken using the C-terminus of hRapl as a bait. The C-
terminal bait consisted of LexA fused to amino aids 128-399 of hRapl. This bait 
contains the myb domains, coiled-coil domain and RCT of hRapl and interacts with 
hTRF2 in a yeast two-hybrid setting (Li et al. 2000). The C-terminus of scRapl was 
chosen because it is the portion of the protein that interacts with Riflp, Rif2p, Sir3p, and 
Sir4p. The background of this screen was high due to the ability of the C-terminal Rapl 
bait to activate transcription. An inhibitor of His, 3-AT, was used in the third screen. 
A third screen was executed using 3-AT and approximately 300 colonies grew on 
selective plates out of approximately four million transformants. Further analysis 
revealed approximately 120 positives in the screen that fell into 5 groups. These groups 
were based on similar restriction digestion patterns after the prey plasmid DNA was 
isolated. These clones met the re-screening criteria mentioned above. A quantitative P-
galactosidase assay was performed after verification that growth on histidine-deficient 
plates and P-galactosidase activation were plasmid-linked (Figure 3-1). 
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Quantities given in standardized units. 
Figure 3-1. Quantitative p-galactosidase results for yeast two-hybrid screen. 
A quantitative P-galactosidase liquid culture assay was performed on the indicated strains 
of yeast. Results are given in standardize units. The formula for b-galactosidase units = 
(1000 x OD420) / (t x V x OD600) where t = elapsed time in minutes of incubation and V 
= 0.1 ml x concentration factor. 
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The positive clones in the screen were sequenced and the resulting sequences 
were entered as queries against the Genbank database using a standard BLAST 
algorithm. The sequences corresponded to two genes. The first is a human gene with no 
homology to known genes in the human genome. This gene, designated C144 because it 
corresponds to clone 144 of the 300 initial colonies picked in the screen, is a novel 
human gene containing a CCHC-type zinc finger domain. The second clone identified 
was the previously identified human gene FLASH (Flice - Associated Huge) (Imai et al. 
1999). This gene has no known role in human telomere biology. A number of proteins 
that might be expected to appear in the screen did not appear amongst the clones. Neither 
TRF2 nor hRapl (Rapl is capable of forming homodimers) were identified. This 
suggested that the screen was not performed under saturating conditions or that TRF2 or 
Rapl were somehow under-represented in the cDNA library used. Also, no obvious 
homologs of Rifl, Rif2, Sir3, or Sir4 proteins were identified. 
The yeast two-hybrid prey contained only a portion of the full-length C144. The 
1.2 kb fragment of C144 in the prey plasmid was excised and used as a probe to screen a 
human kidney cDNA library in order to determine the full-length sequence of C144. A 
full-length clone containing a 1.6 kb predicted open reading frame (ORF) was isolated 
and sequenced using standard cloning methods. The C144 ORF contains a 543 amino 
acid protein with a predicted molecular weight of 65 kilodaltons (Figure 3-2). The 
predicted starting ATG has an upstream sequence of CAAATCTTG which represents a 
weak Kozak sequence. However, there is also an in-frame stop codon located 60 base 
















Figure 3-2. C144, a novel CCHC-type zinc finger protein. 
A. A schematic diagram of C144. The CCHC zinc finger domain is shown in green. 
B. The protein sequence of the full-length C144 gene. 
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the correct one. The 1.2 kb yeast two-hybrid fragment contains the N-terminal portion of 
C144 extending from amino acid 1 through amino acid 370. 
The predicted C144 protein contains four CCHC-type zinc finger domains in the 
central portion of the open reading frame (Figure 3-1 and 3-2). CCHC-type zinc finger 
domains are a family of widely conserved domains that are able to bind a variety of 
nucleic acid structures, including both ssDNA and dsDNA (Summers 1991). CCHC-type 
zinc finger domains are also found in retroviral gag proteins and are thought to play a role 
in the binding of retroviral RNA genomes to the viral particle (Ramboarina et al. 1999). 
Figure 3-2 depicts the alignment of the C144 CCHC-type zinc finger domains with 
CCHC-type zinc finger domains in a variety of other organisms (Figure 3-3). 
In order to study the possible role of C144 at telomeres and determine whether or 
not C144 is a bona fide hRapl-interacting factor, the full-length cDNA was subcloned 
into pcDNA3-Nmyc and pLPC-Nmyc. In both cases, an amino-terminal myc epitope tag 
was present in the vector and the fusion site began at amino acid number three of the 
predicted protein. 
The presence of a T7 promoter in the pcDNA-Nmyc-C144 construct allowed for 
the expression of C144 in vitro using a rabbit reticulocyte lysate system to perform in 
vitro transcription and translation (IVTT) of C144 (Promega TNT coupled reticulocyte 
system). This construct was also transiently transfected into 293T cells to express myc-
tagged C144 in mammalian cells. Western analysis of both the IVTT and ectopically 
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Figure 3-3. T h e conservation of the C C H C zinc fingers of C144. 
The CCHC zinc finger of C144 is aligned with a number of other CCHC domain 
containing proteins from a variety of organisms. Similar amino acids as determined by 
Kyte-Doolittle criteria are shaded in blue and identical amino acids are boxed. Red stars 
indicated the conserved canonical CCHC residues that define the CCHC domain. 
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protein with an apparent molecular weight of 85 kilodaltons (Figure 3-4). It is interesting 
to note that the IVTT C144 product runs as a single band, whereas ectopically expressed 
C144 in mammalian cells runs as a doublet. This protein runs as a doublet in both 293T 
and HT1080 cells, suggesting that it is not a cell-type specific event. The C144 doublet 
suggests that a post-translational modification occurs under physiologic conditions. The 
nature of this modification is currently unclear. 
Co-immunprecipitation was used to determine if C144 interacts with hRapl and 
other known telomere-bound factors. Tagged versions of C144 and other telomere 
proteins were transfected into 293T cells and co-IP was performed. These experiments 
failed to reveal an interaction between C144 and TRFI, TRF2, or Rapl (Figure 3-5). The 
interaction between TRF2 and hRapl serves as a positive control and ability of these 
proteins to interact confirmed that the technique worked. Co-immunoprecipitation 
experiments using endogenous levels of telomeric proteins rather than this over-
expression system were not carried out because attempts to generate antibodies against 
C144 were unsuccessful. The two peptides used to generate antibodies were 
KYGKGEPKYESKSSKFKSNSDSDYKC and 
PHKKQRKETDLTNKEKTKKPTQDSC. Co-immunoprecipitation using endogenous 
protein would be more reflective of physiologic conditions and complex formation of 
C144 may require more than one binding partner, which would not be detected in an 
experiment in which only pairs of proteins are over-expressed. 
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Figure 3-4. Protein expression of C144. 
A. Calcium phosphate transfection of 293T cells was performed using empty vector and 
pcDNA3 with myc-tagged C144 or TRFI. Whole cells lysates were prepared 48 hr post-
transfection and used for immunoblots using an anti-myc antibody. 
B. In vitro transcription / translation (IVTT) was performed using the Promega T N T 
reticulocyte lysate system with the same plasmids used in A. S35-methionine was added 
to the IVTT reaction. The reactions were subjected to SDS-PAGE. 
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Figure 3-5. Co-immunoprecipitation of C144 and telomere proteins. 
293T cells were trasfected with myc-tagged C144, T R F I and T R F 2 as well as F L A G -
tagged Rapl as indicated. Buffer C lysates were prepared and immunoprecipitations 
were performed using either anti-myc or anti-FLAG antibodies. Immunoblots of either 
the 1 % of the input or the IP pellet were blotted with either anti-myc or anti-FLAG 
antibodies as indicated. 
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Figure 3-6. Alignment of C144 and yeast orthologs. 
Alignment of C144 in human and its ortholog in S. cerevisiae and S. pombe. Similar 
amino acids as determined by Kyte-Doolittle criteria are shaded in blue and identical 
amino acids are boxed. The 5. cerevisiae C144 ortholog is Genbank NP_010106; 
gi:6320026 and the S. pombe C144 ortholog is Genbank NP_595383; gi: 19112175. 
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An ortholog of C144 was identified in S. cerevisiae in order to test the role of this 
gene at yeast telomeres (Figure 3-6). A yeast strain that lacked the 5. cerevisiae C144 
was obtained (gift of Harry Scherthan). In order to determine telomere length, genomic 
DNA was isolated from wild-type and yeast strains without the C144 ortholog. This 
DNA was cut with Xhol and a Southern blot of this genomic DNA was probed with 
radiolabeled telomeric probe. The resulting blot indicates that yeast deleted in the 
ortholog of C144 did not undergo observable telomere length change over the course of 
100 generations (Figure 3-7). In additon, extensive screens for telomere mutants 
performed in the Lundblad laboratory failed to implicate this gene (personal 
communication). 
The second gene identified in the yeast two-hybrid screen is the previously 
identified Flice-associated huge protein (FLASH). The yeast two-hybrid fragment in the 
prey plasmid contained sequence corresponding to amino acids 1253 through 1455 of the 
published FLASH sequence. FLASH (as its name indicates) is a large, 220 kilodalton 
protein which was initially pulled out of a two-hybrid screen using procaspase-8/FLICE 
as a bait (Imai et al. 1999). FLASH functions as an adapter molecule in the process of 
Fas-mediated apoptosis. FasL binds Fas on the cell surface and results in receptor 
trimerization, which, in turn, recruits a complex of other factor known as the DISC 
(death-induced signaling complex). The formation of the DISC ultimately results in the 
processing of procaspase-8 into caspase-8. Caspase-8 is a master caspase that activates 
downstream effector caspases and results in apoptosis. The Yonehara group 
demonstrated that FLASH co-immunoprecipitates with the DISC, with FADD and with 
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Figure 3-7. Telomere blot of 5. cerevisiae C144 delete strain. 
S. cerevisiae wild-type and YDL175c delete strains were streaked out for 4 successive 
rounds of colony formation (representing approximately 25, 50, 75 and 100 generations). 
Genomic D N A was isolated from these yeastand digested with Xhol. Southern blots 
were probed with a telomere-specfic radiolabeled probe. 
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procaspase-8 (Imai et al. 1999). Full-length F L A S H potentiates Fas-mediated apoptosis 
and certain truncated alleles antagonize Fas-mediated apoptosis. 
What, then, could be the role of FLASH at telomeres? It is known that 
overexpression of dominant-negative TRF2 alleles result in apoptosis and that 
deprotected telomeres recruit DNA damage proteins (Karlseder et al. 1999; Takai et al. 
2003). One possibility is that FLASH acts as a sensor for telomere dysfunction and 
triggers apoptosis when a cell can not properly maintain its telomeres. A full-length 
expression construct containing the FLASH open-reading frame was obtained from 
Zhengcheng Zheng (Shanghai Institute of Biochemistry). It was difficult to detect over-
expressed FLASH in 293T cells and the reason for this is unclear. It could be related to 
the relatively large size of FLASH or some aspect of FLASH biology. Anti-peptide 
antibodies were generated using the peptides YGKGEPKTESKSSKFKSNSDSDYKGC 
and HPHKKQRKETDLTNKEKTKKPTQDSC, but these were unable to recognize a 
large molecular weight band consistent with FLASH. IF performed using over-expressed 
myc-tagged FLASH demonstrates that FLASH is a nuclear protein and several 
(approximately 5 to 10) nuclear foci appear in FLASH-transfected cells. However, these 
foci do not colocalize with TRFI, a known telomere protein, in HeLal.2.11 cells (Figure 
3-8). The localization of FLASH to telomeres may well be stimulus-dependent or require 
the over-expression of Rapl as well. Unfortunately, efforts to raise antibodies against 
endogenous FLASH were not successful. Further experiments need to be conducted in 
order to determine conclusively whether or not FLASH is at telomeres. 
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Figure 3-8. IF of F L A S H and telomere proteins 
HeLal.2.11 cells were transfected by electroporation with myc-FLASH and cells were 
fixed 48 hr post-transfection. IF was performed with anti-myc (green) and anti-TRFl 
(red) antibodies along with DAPI stain (blue). Top and bottom are two separate images 
using this staining. 
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C o n c l u s i o n s 
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This thesis focuses primarily on the identification of human Rifl, an ortholog of 
yeast Rifl, and its role as a novel component of the ATM-dependent DNA damage 
response pathway. Rifl localizes to sites of inferred DSBs shortly after the induction of 
DNA damage and this redistribution requires the function of both 53BP1 and ATM, but 
not ATR. RNAi-mediated depletion of Rifl resulted in reduced cell survival after 
irradiation. The thesis also focuses on the identification of several putative Rapl-
interacting factors. Neither C144, a novel zinc finger protein, nor FLASH, the two 
candidates obtained from the yeast two-hybrid screen using Rapl as a bait, were 
confirmed to be bona fide telomere proteins. Finally, this thesis discusses attempts to 
analyze the interaction between the Mrell complex and the TRF2 complex. The 
concluding remarks presented here will focus upon human Rifl since it represents the 
most promising avenue of future research. 
Rifl as an ATM- and 53BP1- dependent DNA damage response factor 
The experimental evidence from chapters 1 and 2 strongly support the role of 
Rifl in the DNA damage response. Most importantly, human Rifl localizes to inferred 
DSBs following ionizing radiation. Rifl is able to form foci in response to several DNA 
damage stimuli, including IR, UV, MMS, HU and etoposide. The response to IR takes 
place within minutes of exposure. Rifl displays similar kinetics to other known DNA 
damage response factors, such as BRCA1, 53BP1 and NBSL Furthermore, Rifl co-
localizes with these factors following DNA damage. 
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A full description of the exact function(s) of human Rifl in the D N A damage 
response was a goal of experiments carried out in this thesis as well as current and future 
experimental work. A systematic approach was taken to address which steps of the DNA 
damage response cascade require Rifl function. The possible roles of human Rifl at the 
outset included Rifl as a primary sensor of DNA damage, Rifl acting at the level of the 
PI3K-like transducers ATM and ATR, Rifl as a direct target of ATM, and Rifl as a 
player in one of the effector arms of the DNA damage response. The effector pathways 
of the DNA damage response include the establishment and maintenance of Gl/S, intra-S 
phase, and G2/M cell cycle arrest, the HR and NHEJ repair pathways, damage-dependent 
apoptosis pathways, and recovery of cells from damage. 
After identifying human Rifl as a bona fide member of the DNA damage 
response, it became important to establish where in the DNA damage response pathway 
human Rifl lies. The observation that 53BP1 and other DNA damage factors localize to 
sites of damage in cells treated with Rifl siRNA indicates that it is unlikely that human 
Rifl acts as the sole or dominant sensor of DNA damage. It is possible that Rifl acts as a 
redundant sensor in certain situations, but there is no evidence to presently support this 
hypothesis. The use of the PI-3 kinase inhibitors caffeine and wortmannin as well as 
studies in A-T cells, which lack ATM, indicated that human Rifl is completely 
dependent on ATM for its localization to sites of DNA damage. The inability of ATRIP 
siRNA to affect human Rifl response to UV or IR supports the hypothesis that Rifl is 
dependent on ATM, but not ATR. Further confirmation of this was accomplished by 
looking at Seckel cells, which have a splice defect in ATR (H. Takai, unpublished result). 
Rifl doe not appear to act at the level of ATM because ATM targets are still 
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phosphorylated in Rifl siRNA treated cells. Rifl siRNA treatment also does not 
influence the level of ATM auto-phosphorylation in response to DNA damage. Together, 
these observations suggest that Rifl acts strictly downstream of ATM. 
The dependence of Rifl function on ATM suggests that Rifl might be directly 
phosphorylated by ATM. The primary sequence of Rifl contains 14 SQ/TQ sites, the 
consensus site of the PI3K-like family members. Rifl contains one site that represents a 
more specific consensus sequence (Kim, et al. 1999). Two experimental approaches 
were used to address whether ATM phosphorylated Rifl. First, co-immunoprecipitation 
experiments in extracts from untreated cells and irradiated cells failed to reveal an 
interaction between ATM and Rifl. It was also unclear whether Rifl shifts in 
immunoblots in an IR- and ATM- dependent manner. Ongoing experiments using ATM 
kinase assays have yielded inconclusive results (S. Buonomo, unpublished observations). 
Experiments in which the putative ATM kinase site(s) are mutated have yet to be 
executed. 
Rifl also requires 53BP1 for its localization to sites of damage following DNA 
damage. Rifl requires at least two independent molecular events in order to form DNA 
damage foci, since 53BP1 still forms foci, albeit to a lesser extent and with delayed 
kinetics, in A-T cells. It has not been formally demonstrated whether ATM-dependent 
phosphorylation of 53BP1 is required for Rifl foci formation. The dependence of Rifl 
on ATM and 53BP1 is specific. Rifl still forms foci in cells deficient in Mrell, Nbsl, 
BRCAl,andChk2. 
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The role of Rifl in the D N A damage response effector pathways 
The demonstration that cells deficient in Rifl are radiosensitive indicates that 
Rifl is necessary for cell survival in response to IR. Further experiments demonstrate 
that Rifl siRNA treatment in other cell lines renders these cells radiosensitive, whereas 
Rifl siRNA treated cells are not hypersensitive to MMS (H. Takai, unpublished results). 
Although these experiments demonstrate the importance of Rifl in the DNA damage 
response, the specific mechanism of Rifl in the DNA damage response was sought. 
An analysis of the DNA damage response effector pathways was conducted. 
Cells are able to halt their progression through the cell cycle in response to DNA damage. 
These checkpoints occur at the Gl/S, intra-S phase, and G2/M phases of the cell cycle 
and prevent the cell from both replicating damaged DNA and attempting to segregate 
damaged chromosomes. The Gl/S transition is examined by assaying BrdU incorporation 
following IR, whereas the G2/M transition is observed by looking at the phosphorylation 
of hsitone H3 after damage. Experiments conducted by Hiro Takai in the de Lange lab 
have demonstrated that Rifl plays a role in the intra-S phase checkpoint. In response to 
irradiation, cells halt replication presumably to prevent inappropriate copying of damaged 
DNA. Radioresistant DNA synthesis (RDS) occurs if the DNA damage response is not 
properly functioning. Two pathways have been described including one pathway in 
which Chk2 phosphorylates Cdc25A and results in Cdk2 inactivation and one pathway in 
which Nbsl and Mrel 1 play a role (Falck et al. 2001; Falck et al. 2002). Cells treated 
with Rifl siRNA display an RDS phenotype. Using cells deficient in Nbsl, a gene 
known to be involved in RDS, and complementation with wild type and mutant Nbsl 
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alleles, Hiro Takai demonstrated that the Rifl R D S effect is distinct and in a separate 
pathway from Nbsl. It is still unclear as to whether Rifl is in the Chk2 RDS pathway. 
Thus, Rifl plays a role in S phase progression following IR that is a separate pathway 
from the previously described ATM-Chk2-Cdc25A checkpoint pathway. 
The ability of Rifl either to participate in or regulate the homologous 
recombination (HR) or non-homologous end-joining (NHEJ) pathways that repair the IR-
induced DSBs was addressed. A number of repair assays were initiated in an attempt to 
determine whether cells deficient in Rifl were competent in terms of DNA repair. These 
experiments were technically challenging because it is difficult to separate the damage-
dependent cell cycle arrest from repair events. Initial experiments did not reveal any 
difference in repair events. These experiments involved observations of metaphase 
chromosomes after cells were exposed to radiation. Experiments were carried out in 
HeLal.2.11 cells treated with caffeine and Rifl siRNA. The interpretation of these 
experiments was difficult because it is technically difficult to have cells enter metaphase 
after irradiation-induced cell cycle arrest. The effects of cell cycle arrest, caffeine and 
repair events must all be considered. The ability of Rifl to act as a direct participant in 
either HR or NHEJ is currently unresolved and should be addressed in the future. 
Rifl in yeast and human: a unifying view? 
The difference between the role of Rifl in yeast and human cells raises questions 
about the physiologic function and the evolutionary history of Rifl. Rifl plays a role in 
telomere biology in yeast cells, whereas Rifl plays a role in the DNA damage response in 
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human cells. There are several speculative possibilities that could explain this apparent 
discrepancy. 
Rifl could function in both the DNA damage response in both yeast and human 
cells. There is evidence to suggest that Rifl plays a role in DNA damage in yeast. Rifl 
deficiency results in a 10 fold increase in chromosome loss rates per generation; Rif2 
deficiency results in a 4 fold increase in chromosome loss rate and loss of both Rifl and 
Rif2 leads to a 40 fold increase in chromosome loss (Wotton and Shore 1997). It is not 
known whether this chromosome instability is associated with a DNA damage response 
role for Rifl in yeast. However, rifl-A yeast do not have a GCR phenotype (Myung et al. 
2001). As mentioned previously, Rifl is in the Tell and Mecl pathways in terms of 
telomere length. There is currently no evidence that Rifl is involved in telomere biology 
in human cells. However, it is tempting to speculate that the telomere and DNA damage 
functions of Rifl are related. S. cerevisiae could have co-opted the DNA damage factor 
Rifl to protect its telomeres and Rifl may actually not function in telomere biology in 
mammalian cells. 
Human Rifl and telomere biology 
Although the experiments described in chapter 1 have failed to detect Rifl at 
functional human telomeres, further studies need to be carried out in order to establish a 
possible role for Rifl in human telomere biology. It is critical to determine whether nor 
not human Rifl plays a role at functional telomeres. One avenue of research involves the 
use of an RNAi hairpin (shRNA) expressed from retroviruses in order to assess the role 
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of Rifl in telomere length regulation. Since the RNAi strategy described in chapter 2 can 
not be used in long term experiments, shRNA might prove ideal for the study of telomere 
length, which requires successive passaging of cells. Additionally, the examination of 
the effects of over-expressed alleles of Rifl may elucidate possible roles of this protein at 
telomeres. 
So far, we have not been able to detect Rifl at human telomeres. However, the 
fact that Rifl has a telomeric function in S. pombe argues in favor of a role for Rifl at 
human telomeres. The structure of fission yeast telomeres more closely resembles that of 
human telomeres than the budding yeast telomeric complex. As discussed above, further 
experiments will be required to determine whether Rifl also plays a role at human 
telomeres. Although there have been several possibilities presented, it is still unclear 
why exactly Rifl has apparently disparate roles in telomere biology in yeast and in the 
DNA damage response in human cells. 
Rifl in human disease and clinical therapy 
Human Rifl, encoded by a gene on chromosome 2 (2q23.3), is a candidate tumor 
suppressor. This view is based on its involvement in the ATM pathway which contains 
other tumor suppressors, including ATM itself, Mrell, Nbsl, BRCA1, and Chk2. Similar 
to mutations in these genes, changes in human Rifl may play a role in certain sporadic or 
familial human cancers. Treatment of cells with Rifl siRNA did not reveal an acute cell 
lethal phenotype upon Rifl inhibition. Mutations in Rifl may therefore be tolerated in the 
germline. Such heterozygous individuals could be at risk for development of cancer if 
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loss of heterozygosity (LOH) at the Rifl locus leads to cells with impaired ability to 
respond to DNA damage. 
Recent data regarding the mouse ortholog of Rifl suggests that Rifl may have an 
entirely different role in development because mouse Rifl was highly expressed in germ 
cells and embryo-derived pluripotent stem cells (Adams and McLaren 2004). It is 
possible that Rifl still functions in the S-phase RDS pathway and that this pathway plays 
an important physiologic function in early cell division and development. Thus, it is 
possible that loss of function mutations may not be tolerated in human cells. The 
generation of mouse that lacks Rifl is on-going (S. Buonomo, personal communication) 
and could address the issue of whether lack of Rifl contributes to heritable, spontaneous, 
or induced tumorigenesis in vivo. 
The strict dependence of Rifl on ATM is unusual among the substrates of this 
kinase, which generally also respond to regulatory inputs from ATR. Because of this 
unique regulation, IR-induced Rifl foci are an excellent indicator for ATM kinase 
activity. A cell-based assay for ATM activity based on Rifl foci could rapidly identify 
individuals with alterations in this pathway and could reveal the ATM status of tumor 
samples, potentially improving cancer diagnosis and treatment. Furthermore, the Rifl 
assay could be helpful in the identification of ATM inhibitors, which have potential 
application as radiosensitizing agents. Additionally, drugs targeting Rifl directly may 
serve as radiosensitizing agents with applications in the clinic. 
A final application of Rifl in the clinic could be the use of genetic testing. If 
Rifl turns out to be involved in human tumorigenesis (particularly intriguing given the 
role of several other DNA damage response factors in human cancer predisposition 
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syndromes), mutations of Rifl could be characterized and screening paradigms can be 
designed to aid in patient care. Importantly, Rifl status may serve as a prognostic marker 
for the responsiveness of individual tumors to radiotherapy. Since cells deficient in Rifl 
are radiosensitive, one might reasonably predict that tumors lacking Rifl and other DNA 
damage response factors would undergo a more dramatic response to radiation therapy. 
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A p p e n d i x - Investigating h o w t h e M r e l l 
c o m p l e x interacts w i t h t h e T R F 2 c o m p l e x 
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Introduction 
The previous chapter discussed the use of a genetic method, the yeast two-hybrid 
screen, to search for novel Rapl-interacting factors. Work in the de Lange lab has led to 
the discovery of several Rapl-interacting factors in mammalian cells. In addition to 
TRF2, which interacts tightly with Rapl and brings it to human telomeres, the Mrell 
complex, including Mrell, Rad50 and Nbsl, has been shown to be present in a complex 
with TRF2 and hRapl (Zhu et al. 2000). Most of the Mrell complex is nucleoplasmic 
and only a small percentage of Mrell complex components is localized to the telomere 
(Zhu et al. 2000). This is demonstrated by the observation that Triton X-100 pre-
extraction of a large quantity of nucleoplasmic Mrell complex is required in order to 
visualize the co-localization between the Mrell complex and the telomeric protein TRFI 
by IF (Zhu et al. 2000). Although the Mrell complex is a component of IRIFs, the 
telomeric proteins TRFI and TRF2 do not re-localize to IRIFs (Zhu et al. 2000). 
Furthermore, Nbsl is phosphorylated in S phase and its localization at telomeres only 
occurs during S phase (Zhu et al. 2000). It is unclear what the role of the Mrel 1 complex 
is at human telomeres. As discussed in the introduction, the Mrell complex contains 
several enzymatic activities that may have a role in t-loop processesing and the Mrell 
complex is known to play a role in telomere length regulation in S. cerevisiae. 
In order to further extend these observations, the specific binding interactions 
between the TRF2-hRapl-Mrell complex must be defined and characterized. Although 
it is known that the Mrell complex is found in a complex with TRF2, it is unclear 
whether this interaction is dependent upon hRapl. It is also unclear which component of 
the Mrell complex binds to TRF2, hRapl, or a third protein that interacts with either 
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TRF2 or Rapl. T w o approaches were taken to further study the protein-protein 
interactions between TRF2, Rapl and the Mrell complex. The first approach involves 
using a GST-hRapl fusion to attempt to pull down baculovirus-derived Mrell complex. 
The second approach involves using baculovirus-derived Mre 11 complex to attempt to 
supershift TRF2-DNA or Rap 1-TRF2-DNA complexes in electromobility shift assays 
(EMSAs). 
Results and discussion 
In order to study the interactions between the TRF2 complex and the Mrell 
complex, the components of these complexes were produced in vitro through various 
methods. A baculovirus system was used to product TRF2, hRapl, and the Mrell 
complex (Figure 4-1A). The TRF2 and hRAPl baculoviruses were previously 
constructed in the de Lange lab (Broccoli et al. 1997a; Li et al. 2000), while the Mrell 
complex baculoviruses were a generous gift of Tanya Paull and Martin Gellert (Paull and 
Gellert 1998; Paull and Gellert 1999). The baculoviruses for Mrell, Nbsl, and Rad50 
must be used together to infect insect cells in order to obtain a stable Mrel 1 complex in 
vitro. Mrell can be produced alone, but Nbsl and Rad50 each require Mrell for their 
stability. It is unclear whether the mechanism underlying the requirement of Mrell for 
the stability of Nbsl and Rad50 is co-translational or post-translational. The purity of the 
baculovirus-derived proteins was assessed through Coomassie-staining (Figure 4-1 A). 
Mrell protein itself could be isolated at high yield and purity (Figure 4-1 A). The 
Mrell/Nbs 1/Rad50 complex yielded less protein and relatively more contaminants 
(Figure 4-1 A). Additionally, antibodies that recognize Mrell, Nbsl, and Rad50 reacted 
with bands of the appropriate size (Figure 4-IB). 
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Figure 4-1. Baculovirus-derived Mrell and Mrell complex. 
A. Mrel 1 alone or Mrel 1, Nbsl and Rad50 baculoviruses (gifts of Tanya Paull and 
Martin Gellert) were used to infect SF21 insect cells. Each Mrel 1 complex component 
was His-eptiope tagged. Cell lysates were prepared 40 hr post-infection. Lysates were 
purified using nickel beads. Samples were run out using SDS-PAGE and stained with 
Coomassie Brillant Blue G. 
B. Baculovirus-derived Mrel 1 complex is immunoblotted with antibodies recognizing 
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The complex presented here looks the same as the purified Mrel 1/Nbsl/Rad50 complex 
(Carney etal. 1998). 
In order to perform G S T pulldown experiments, hRapl was cloned into the 
pGEX-2TK plasmid by PCR to give a GST-hRapl expression construct. E. coli (B21 
strain) were transformed with this plasmid to produce GST-Rap 1 protein (Figure 4-2A). 
Protein concentration was determined through the Bradford assay and comparing the 
GST-hRapl fusion to known quantities of B S A on Coomassie-stained gels following 
SDS-PAGE (Figure 4-2A). Protein purity was determined by examining these gels and 
observing a prominent band at the correctly predicted molecular weight of 73 kD (Figure 
4-2A). There are a number of other bands in this preparation (Figure 4-2A). An 
immunoblot of the GST-hRapl fusion with an antibody that recognizes hRapl reveals 
both that the 73 kD band indeed contains hRapl and that the bands seen in Figure 4-2A 
also contain hRapl (Figure 4-2B). Degradation is the most likely explanation for these 
smaller molecular weight bands (Figure 4-2B). 
The first approach used involved attempts to pulldown baculovirus-derived 
Mre 11 complex with a GST-Rap 1 fusion protein. Early experiments gave an impression 
that GST-Rapl could indeed pulldown the Mrell complex (Figure 4-3). When the 
experiment was reproduced, there was some degree of binding of the Mrel 1 complex to 
G S T alone. A number of different conditions were attempted, including the addition of 
baculovirus-derived TRF2 and the use of SDS / TritonX-100. TRF2 was added to 
possibly stabilize the complex and SDS / Triton X-100 was used to decrease the 
background binding of the Mrel 1 complex. Further attempts reveal that, while 
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Figure 4-2 Preparation of G S T and GST-Rapl proteins. 
A. GST and GST-hRapl was produced in BL21 strain E. coli. Cell lysates were made 
and proteins were purified using glutathione sepharose beads. Samples were run out 
using SDS-PAGE and stained with Coomassie Brilliant Blue G. The top and bottom gels 
shown are 7 % and 9% SDS-PAGE, respectively. 












































































































































































Figure 4-3. GST-hRapl pulldown of the Mrell complex, TRFI and TRF2. 
G S T and GST-hRapl were used to pulldown baculovirus-derived Mrel 1 complex, TRFI 
and TRF2. Mrel 1 complex was added in the top three blots, TRFI in the lower left blot 
and TRF2 in the lower right blot. Immunoblots were performed on the samples using 
antibodies recognizing Mrel 1, Rad50, Nbsl, TRFI and TRF2 as indicated. 1% input 
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promising, the background binding of the Mrel 1 complex continued to be a problem. 
There is a strong enrichment of baculovirus-derived TRF2 in a pulldown with GST-
hRapl relative to a pulldown with GST alone (Figure 4-3). Although there is a bit of 
background binding with baculovirus-derived TRFI, there is a small enrichment in GST-
hRapl in comparison to GST alone pulldown (Figure 4-3). These controls demonstrate 
that GST-hRapl behaves as expected in terms of its ability to bind to Rapl and its 
inability to interact with TRFI. However, the amount of enrichment of TRFI is not 
completely insignificant. 
Another approach to understanding the binding interactions between the TRF2-
hRapl complex and the Mrel 1 complex is the use of electrophoretic mobility shift assay 
(EMSA), also known as gel-shift analysis. A labeled probe containing twelve TTAGGG 
double-stranded repeats corresponding to human telomeric DNA was used to assay the 
ability of the Mre 11 complex to supershift or affect the mobility of TRF2-telomeric DNA 
or Rapl-TRF2-telomeric DNA complexes. This system was originally developed to 
assay the ability of TRFI to bind telomeric DNA (Bianchi et al. 1997). is capable of 
binding telomeric DNA directly and producing an EMSA shift. Human Rapl, while 
unable to bind DNA directly, can supershift a TRF2-DNA complex (Broccoli et al. 
1997a; Li et al. 2000). Initial attempts were performed to determine if baculovirus-
derived Mrell or Mrell complex could supershift TRF2-DNA (Figure 4-4). The initial 
data was promising in that Mrell complex appeared to shift the TRF2-DNA complex 
(Figure 4-A lanes 5 and 9). Although some of this data appeared promising, a technical 
problem involved the fact that the Mrel 1 complex was fairly dilute and a large amount of 
salt was added to the EMSA reactions along with Mrel 1 complex protein. The salt 
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A . 
TRF2(ng): n 100 50 0 10° 50 
high-salt Mre11 complex <uL): 0 0 0 12 12 6 3 0 12 6 3 0 
* * 
B. 
TRF2(ng): 0 100 50 0 100 50 
low-salt Mre11 complex (pL): 0 0 0 8 8 
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Figure 4-4. Gel shift analysis to determine if Mrell complex can supershift a TRF2-
D N A complex. 
A. E M S A performed using the indicated quantities of baculovirus-derived TRF2 and/or 
Mrell complex prepared with 450 m M KCI and a radiolabeled probe containing twelve 
T T A G G G telomeric duplex repeats. 
B. Same as in A., except that Mrel 1 complex dialyzed against 150 m M KCI is used. 
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carried along with the Mrell complex may affect the TRF2-DNA complex and give the 
appearance that Mrell complex is able to supershift the TRF2-DNA complex. In order 
to solve this problem, Mrell complex was prepared as previously, but was dialyzed 
against 150 mM KCI to lower the amount of salt. The EMSA experiments were then 
repeated (Figure 4-4B). Although these experiments were repeated numerous times 
under varying protein concentrations, no evidence exists that conclusively and 
reproducibly indicates that Mrel 1 complex is able to supershift the TRF2-DNA complex. 
Mrel 1 complex may also be recruited to the telomere through Rapl. As a result, 
EMSA was performed to determine whether or not the Mrel 1 complex could supershift 
the Rapl-TRF2-DNA complex. Rapl is able to supershift the TRF2-DNA complex ((Li 
et al. 2000), Figure 4-5). Baculovirus-derived Mrell or Mrell complex were added to 
the Rapl-TRF2-DNA complex (Figure 4-5A and 4-5B, respectively). Although there 
may be small effects on the shift, these are not reproducible. It is unclear whether this is 
due to the gel shift conditions used, the quality of the protein preparations, or reflects the 
biology of the Mrel 1 complex. 
165 
Figure 4-5. Gel shift analysis to determine if Mrell complex can supershift a Rapl-
TRF2-DNA complex. 
A. E M S A performed using the indicated quantities of baculovirus-derived TRF2, Rapl, 
and/or Mrel 1 and a radiolabeled probe containing 11 T T A G G G telomeric duplex repeats. 





TRF2(ng): 0 100 50 25 0 0 0 0 0 
Rapl (ng): 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 250 100 50 0 
Mre11 (ng): 0 0 0 0 1K 500 250 100 50 0 1K 500 250 100 50 0 0 0 0 
. _ 
B. 
TRF2(ng):0 50 100 0 100 
Rapl (ng): 0 100 50 25 0 100 50 25 0 100 
0 
50 
Mre11 complex (|iL): 8 4 2 0 8 4 2 0 8 
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Yeast Two-Hybrid library-scale transformation 
The library transformation of L40 yeast cells was performed as follows. A full-
length human Rapl fused to LexA or a carboxy-terminal human Rapl fused to LexA 
were used to screen transformants from of a human fetal liver two-hybrid library 
(Clontech) created in pGADlO. An overnight culture of the yeast bait strain was grown 
at 30 °C in appropriate dropout media. A 50 ml culture was then inoculated with 0.25 ml 
of the overnight culture and grown overnight at 30 °C. 200 ml of Y P D (prewarmed to 30 
°C) was inoculated with enough culture to give OD600 of 0.3 and cells were grown for 3 
hours at 30 °C (at least one doubling). Cells were pelleted at 2.5 K for 5 min at room 
temperature, resuspended in 100 ml TE (10 m M Tris-HCl pH 8.0 / I m M EDTA), pelleted 
agan and resuspended in 4 ml 100 m M LiOAc / 0.5 X TE (10 m M Tris-HCl pH 8.0 / 
I m M EDTA). 0.2 uL denatured carrier D N A (10 mg / ml) and 50 micrograms of library 
D N A was then added. Then, 28 ml 100 m M LiOAc / 4 0 % polyethylene glycol / lx TE 
(10 m M Tris-HCl pH 8.0 / I m M EDTA) was added, mixed, and incubated 30 min at 30 
°C with gentle shaking. 3.5 ml dimethyl sulfoxide was added with swirling to mix and 
cells were heat shocked at 42 °C for 6 min with occasional swirling. After heat shock, 
cells were immediately diluted with 80 ml Y P D and cooled to room temperature in a 
water bath. The cells were pelleted at 2.5 K for 5 min at room temperature, washed with 
100 ml Y P D resuspended in 200 ml Y P D (prewarmed to 30 °C) and incubated at 30 °C 
for 1 hr with gentle shaking. Cells were pelleted again at 2.5 K for 5 min at room 
temperature and resuspended in 100 ml SD -Trp, - Leu. 10 uL and 1 iiL of this were 
plated on SD -Trp, -Leu to allow a determination of the number of transformants plated 
during the screen. The remaining cells were pelleted and resuspended in 200 ml SD 
-Trp, -Leu (prewarmed to 30 °C) and incubated at 30 °C with shaking between 4 hr and 
16 hr. Cells are pelleted, washed twice with SD -Trp, -Leu, -His and resuspended in 10 
ml S D -Trp, -Leu, -His. Plate 0.1 uL and 0.01 uL on SD -Trp, -Leu to assess number of 




Yeast transformation was performed as follows. The yeast strain to be 
transformed is grown to mid-log phase (OD600 = 0.6 - 0.8). Cells are harvested in a 
clinical centrifuge for 15 min at 10 K at 4 °C and resuspended in 1/2 total volume of 1 x 
YTB. Cells are centrifuged for 15 min at 10 K at 4 °C again and resuspended in 1ml of 
IX Y T B per 50 ml starting culture. For each transformation, 50 uL of cells are placed in 
an eppendorf tube. Add 5 uL of boiled carrier D N A at 5 mg/ml (eg herring sperm D N A ) 
and the plasmid or library D N A (usually 1 to 5 u,L). Shake gently to mix, add 0.5 ml of 
polyethylene glycol 40%/ LiAc / TE (10 m M Tris-HCl pH 8.0 / I m M EDTA) solution, 
vortex and incubate at 30 °C for 30 min without shaking. Heat shock the cells at 42 °C 
for 20 min, spin tubes in microfuge for 2 min at setting 3, wash cells once with 0.5 ml of 
H20, resuspend cells in 0.3 ml of H20 and plate on appropriate nutritional selection 
plates. 
A "quick" method of yeast transformation was also used. In this method, a 2 x 2 
cm patch of the yeast strain to be transformed was grown at 30 °C. The patch is collected 
with a sterile toothpick and placed in an eppendorf tube with H20. The cells are spun 
down, the H20 is aspirated, and cells are resuspended in 0.7 ml 4 0 % polyethylene glycol 
/ 0.1 M LiOAc / TE (10 m M Tris-HCl pH 7.5 / I m M EDTA). 5 liL of herring sperm 
D N A (5 mg/ml) and 3 liL of D N A are added and the tube is incubated at room 
temperature overnight. The following day, the tubes are heat shocked at 42 °C for 20 
min, spun 2 min at speed 3, and the pellets are washed once with 0.5 ml H20. The cells 
are then resuspended in 300 uL H20 and plated on appropriate nutritional selection 
plates. 
Yeast protein extracts 
Yeast protein extracts were prepared from 50 ml of yeast culture grown to mid-
log phase (OD600 approximately 0.5) at 30 °C. The culture is then centrifuged at 2.5 K 
for 5 min at 4 °C and washed once with sterile, ice-cold H20. The pellet is resuspended 
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in 0.5 ml 2 X Laemelli buffer (125 m M Tris-HCl, 4 % SDS, 2 0 % glycerol, 10% 
mercaptoefhanol, 0.004% bromophenol blue). The samples are then transfered to an 
Eppendorf tube containing 100 ul glass beads, vortexed 1 min, boiled 5 min, and placed 
on ice for 3 min. The vortex and ice steps are repeated three times and samples are 
centrifuged at 14 K for 1 min at 4 °C. Finally, transfer supernatant to new tube and store 
at-80°C. 
Yeast plasmid isolation 
In order to isolate plasmid DNA from yeast, a 3 cm x 3 cm patch of the 
appropriate yeast strain was grown and collected with a toothpick into 0.5 ml H20 in an 
Eppendorf tube. The cells are spun down at 3 K for 2 min at room temperature and the 
supernatant is aspirated. The cells are then resuspended in 100 uL STET (50 m M Tris-
HCl pH 8.0, 50 m M EDTA, 8 % sucrose, 5 % Triton X-100) and then 0.2 g of glass beads 
area added. The tubes are vortexed at room temperature for 15 min, another 100 uL 
STET (50 m M Tris-HCl pH 8.0, 50 m M EDTA, 8 % sucrose, 5 % Triton X-100) are added 
and the tubes are vortexed for 10 min after which they are centrifuged at 14 K for 10 min 
at 4 °C. 100 uL of the supernatant is removed, combined with 100 uL 4 M ammonium 
acetate, and then stored at -20C for at least 1 hr. Tubes are spun at 14 K for 10 min at 4 
°C and 150 uL of supernatant is transferred to new tube with 200 uL ice-cold EtOH and 
incubated for at least 15 min at -20 C. Tubes are spun again 14 K for 15 minutes at 4 °C. 
Aspirate the supernatant, speedvac to dry the D N A pellet and reuspend in 20 u.L 0.1 x TE 
(10 m M Tris-HCl pH 8.0 / I m M EDTA). 
P-galactosidase filter lift assay 
To perform the |3-galactosidase filter lift assay, yeast strains are first grown on 
plates. A filter ( V W R qualitative diameter 7.5 cm grade 410, cat. # 28321-055) is placed 
on top of the cells, removed and placed in liquid N2 for 20-30 sec, allowed to warm to 
room temperature and then placed in liquid N2 for another 20-30 sec and allowed to warm 
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to room temperature again. Another filter is placed in an empty Petri dish and covered 
with 1 ml of Z X solution (10 ml Z buffer, 27 ul beta-mercaptoethanol, and 500 ul X-gal 
stock (20 mg/ml in D M F ) for final concentration of 1 mg/ml; Z buffer is 16.1 g/L 
Na2HPO4-7H20, 5.5 g/L NaH2P04-7H20,0.75 g/L KCI and 0.246 g/L MgS04-7H20. 
The original filter is placed, cell side up, on top of the wetted filter in the Petri dish and 
another 100-300 ul of Z X buffer is added. Eliminate bubbles and place in 37 °C 
incubator. The filters are observed and the time required for a given colony to turn blue 
is recorded. 
Quantitative P-galactosidase assay 
To perform the quantitative beta-galactosidase liquid culture assay, the 
appropriate yeast strains are grown to an ODgoo between 0.5 and 0.8. The exact O D is 
recorded. Then, place 1.5 ml of culture in an Eppendorf tube, centrifuge 14 K for 30 sec 
at room temperature and aspirate the supernatant. Wash and resuspend pellet in 1.5 ml Z 
buffer, spin down cells, and resuspend in 300 lambda Z buffer. After pipetting 100 
lambda into a new Eppendorf tube, place tubes in liquid N 2 and then thaw cells at 37 C in 
water bath for 1 min. After also setting up blank tube with 100 lambda Z buffer, add 0.7 
ml of Z buffer (16.1 g/L Na2HPO4-7H20,5.5 g/L NaH2P04-7H20,0.75 g/L KCI and 0.246 
g/L MgS04-7H20) and P-mercaptoethanol to the reaction and blank tubes. Start a timer 
as one adds 0.16 ml O N P G to reaction and blank tubes and places in 30 C incubator. To 
stop the reactions add 0.4 ml 1 M Na2C03 to reaction and blank and record time. After 
spinning tubes at 14K at room temperature, the OD420. Calculate the standard units by the 
following formula: beta-galactosidase units = (1000 x OD420) / (t x V x OD600) where t 
= elapsed time in minutes of incubation and V = 0.1 ml x concentration factor. 
Yeast telomere blot 
The isolation of genomic DNA from yeast is the first step in the yeast telomere 
blot. To perform this, 8-10 ml culures of appropriate yeast strains are grown on a roller. 
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The cultures are then centrifuged at 14 K for 10 minutes at 4 °C, the supernatants are 
aspirated and the pellets are resuspended in 1 ml H20 and transferred to Eppendorf tubes. 
The samples are centrifuged 14 K for 5-10 sec and the supernatant is aspirated. The 
pellets are then resuspended in 0.6 ml of a sorbitol/EDTA/zymolase solution (For 10 ml 
of 0.9 M sorbitol / 0.1 M E D T A solution, add 3 mg of powdered zymolase 20,000 and 20 
ul of beta-mercaptoethanol; 1 L of sorbitol / E D T A solution made by adding 550 ml H20 
to flask, then 163.98 g sorbitol, 200 ml 0.5 M EDTA, mix and bring up to 1 L) made 
fresh and incubated at 37 °C for 1 hr. The samples are centifrigued 14 K for 5 sec, the 
supernatants are aspirated and the pellets are resuspended in 0.6 ml TE (10 m M Tris-HCl 
pH 8.0 / I m M EDTA). 120 ul EDTA/Tris/SDS solution (2 ml 0.5 M EDTA, 1 ml 2 M 
Tris base, 0.5 ml H20, and 0.5 ml 2 0 % SDS) is added to each sample. The samples are 
mixed gently by inverting the tubes and then they are incubated at 65 °C for 30 min. 
Following this, 200 ul 5 M K O A c is added to each sample and the samples are mixed 
completely by inverting and incubated on ice for 1 hr. The samples are then spun down 
in a centrifuge 14 K for 15 min at 4 °C, the supernatants are poured off carefully into into 
fresh tubes containing 550 ul of isopropanol and the tubes are mixed immediately by 
inverting the tubes. The samples are centrifuged 14 K for 10 minutes at 4 °C, the 
supernatants are decanted and the pellets are washed with 1 ml 7 0 % ethanol, centrifuged 
at 14 K for 2-5 minutes at 4 °C and the supernatants are carefully aspirated. The pellets 
are then dried for 5-10 min on a SpeedVac. After drying, the pellets are resuspended in 
500 ul TE + 3 ul RNase and incubated at 37 °C for 1 hr (vortexing the tubes briefly at 30 
min). The samples are then centrifuged 14 K for 15 min at 4 °C and the supernatant is 
transferred to a new tube. 20 ul of 5 M NaCl and 300 ul isopropanol is added to each 
sample and then the tubes are inverted to precipitate the DNA. The samples are 
centrifuged 14 K for 10 min at 4 °C, the supernatants are decanted, the pellets are washed 
with 7 0 % ethanol. After the samples are again centrifuged 14 K for 10 min at 4 °C, the 
ethanol is aspirated and the pellets are dried in a speed-vac. Finally, the samples are 
resuspend in 20 nl T E (10 m M Tris-HCl pH 8.0 / I m M EDTA) and vortexed well to 
resuspend the pellets. 
173 
The radiolabeled telomere probe is made according to the following protocol. To 
prepare poly(dA-dC)-poly(dG-dT) D N A (Pharmacia Biotech), resuspend at 1 U/ml TE 
(50 ng/ul) and then further dilute to a concentration of 10 ng/ul. The telomere probe is 
made via random priming using the Megaprime D N A labeling system kit (Amersham). 
First, 5 ul poly(dA-dC)-poly(dG-dT) D N A is aliquoted into an Eppendorf tube and then 
15 ul H20 is added to a final volume of 20 ul. The D N A is then dantured 95°C for 10 
min, snap cooled on ice for 5 min. and briefly spun to collect contents. The following are 
then added in order: 5 ul primer solution, 5 >ul reaction buffer, 4 ul cold dATP, 4 ul cold 
dTTP (from Amersham kit thus far), 5 ul radioactive dGTP, 5 ul radioactive dCTP, and 2 
ul Klenow. The reaction mix is then incubated at 37°C for 30 min and the D N A is then 
precipitated by adding 50 ul TE (10 m M Tris-HCl pH 8.0 / I m M EDTA), 1 ul glycogen, 
50 ul 7.5 M ammonium acetate, and 300 ul 9 5 % ethanol. The mixture is then left to 
stand at room temperature for 15 min. The supernatant is removed carefully with a 
pasteur pipet and dispensed into a clean eppendorf (save this). The pellet should be 
visible as a small white pellet (due to the glycogen). The pellet is washed with 300 ul 
7 0 % ethanol and mixed by inverting. The samples are then centrifuged 14 K for 2 min at 
4°C and the supernatant if removed. The amount of radioactivity incorporated into the 
probe is then estimated by comparing the amount of signal from the tube of radioactive 
supernatant with the tube of the actual probe. The probe should have at least 3 0 % of the 
radioactivity incorporated into the probe. The probe is then dried using a Speedvac for 5-
10 min, and resuspend in 200 fil TE (10 m M Tris-HCl pH 8.0 / I m M EDTA). 
The telomere blot for S. cerevisiae samples is performed as follows. First, 
yeast genomic D N A samples are digested with Xhol. Approximatedly 5 to 8 pil of a 
standard yeast D N A prep (i.e. 8 to 10 ml of yeast prepped into 20 ]A of D N A ) is used and 
1 to 2 fi\ of Xhol enzyme and appropriate buffer is added in a 20 p\ total reaction volume. 
The D N A is digested at 37°C for a minimum of 4 hr. The samples and molecular weight 
markers are subjected to electrophoresis on a large agarose gel at 55 volts (for about 16-
18 hr). Prior to transfer, a picture of the gel is taken with a ruler aligned with the 
molecular weight markers and the top marking the top of the well. The gel is then soaked 
in denaturation solution for 30 min (the solution is changed after 15 min). A Hybond N 
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membrane is cut and the gel is blotted overnight in 10 X SSC. The D N A is then 
crosslinked to the membrane using UV, the membrane is pre-hybridized in telomere 
hybridization solution (6 X SSC, 4 X Denhardt's reagent, 0.5 % SDS, 25 micrograms / 
ml E. coli D N A ) at 60°C for 6 hr, and the blot is hybridized in telomere hyrbidization 
solution with telomeric probe prepared as above (and denatured 95°C for 5 min and 
quickly cooled on ice just prior to use) at 60°C for at least 16 hr. The blot is then washed 
four times in 4 X SSC, 0.1% SDS for 15 min each and three times in 0.1 X SSC, 0.1% 
SDS for 10 min each while monitoring with a Geiger counter. The blot was then exposed 
overnight on a phosphorimager. 
Cell culture 
Cells were passaged by treatment with trypsin and seeding at appropriate 
densities per cell line. Cell numbers were determined by using a Coulter Counter to 
assay a 1:20 dilution of cell suspension in diluent fluid. For cell freezing, cells were 
harvested, washed with media and resuspended in approximately 0.5 ml 2 x A freezing 
solution (40 ml FBS (Hyclone), 0.4 ml gentamycin stock solution [stock is 50 mg/ml 
gentamycin from Sigma], 4 ml HEPES stock solution [stock is 1 M HEPES pH 7.6], and 
156 ml L15 media (Sigma) and is sterilized through a 0.2 micron filter] per 10 cm2 plate. 
0.5 ml of 2 x D freezing media (40 ml PVP stock solution [stock is 100 mg PVP (Sigma) 
per ml of HEPES-buffered saline, 30 ml D M S O (Sigma), 4 ml HEPES stock solution 
[stock is 1 M HEPES pH 7.6], and 126 ml L15 media (Sigma) and is sterilized through a 
0.2 micron filter) is then added and 1 ml of each mixture is added per cryovial. The vials 
were placed in a room temperature Styrofoam box at -80°C overnight before being 
transferred to a liquid N2 storage container several days later. 
IMR90 primary human fibroblasts (ATCC), AG02496 and AG04405 primary A-
T fibroblasts (Coriell Cell Repository), SV40-transformed NBS-1 LB1 cells ((Zdzienicka 
1999); a gift from Margaret Zdziencka), and ATLD-3 and ATLD-4 cells (Stewart et al. 
1999), a gift from John Petrini) were grown in D M E M , 15% fetal bovine serum. HeLa 
and 293T cells were grown in D M E M , 10% bovine calf serum. U20S cells (ATCC) were 
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grown in McCoy's modified medium with 10% fetal bovine serum. HCC1937 cells 
(ATCC) and HCT-15 cells (ATCC) were grown in RPMI media with 10% fetal bovine 
serum and 1 m M sodium pyruvate. All media were supplemented with 2 m M L-
glutamine, 0.1 m M non-essential amino acids, 100 units of penicillin per ml and 0.1 mg 
of streptomycin per ml. 
For IR treatment, cells were exposed to y-irradiation using a Cs137 source at a rate 
of 770 rad/min in 6 cm2 dishes. For U V radiation, cells were washed with PBS and 
exposed to 25 J/m2 U V radiation (265 nm) in a Stratalinker (Stratagene). The lid was 
removed from the dishes just prior to U V radiation and replaced immediately after this 
treatment. After U V radiation, cells were incubated in media until harvest. M M S and 
etoposide (0.01% w/v and 50 mg/ml, respectively) were added to the media and cells 
were incubated for 1 hr before harvesting. Caffeine and wortmannin (20 m M and 100 
m M , respectively) were added to the media 2 hrs and 1 hr, respectively, before 
irradiation. 
Antibodies 
Antibodies 1025 and 1060 were affinity purified from rabbit serum immunized 
with keyhole limpet haemocyanin-conjugated Rifl peptides (NSESDSSEAKEEG 
S R K K R S G K W K N K and EEGIIDANKTETNTEYSKSEEKLDN; both with an added C-
terminal Cys residue). Peptides were obtained from Bio-synthesis Incorporated and rabbit 
serum obtained from Covance Research Products. K L H was obtained from Pierce. 
Serum obtained from mice immunized with the KLH-conjugated 1060 peptide was also 
used but without affinity purification. Antibodies 1066 and 1067 are crude serum from 
rabbits immunized with a GST fusion protein consisting of G ST fused to a portion of 
Rifl extending from amino acid 907 to amino acid 1327. 
For other proteins, following antibodies were used: TRFI, 371 ((van Steensel and 
de Lange 1997)); TRF2, 647 ((Smogorzewska et al. 2000)); A T M 2C1 (GeneTex); 
phospho-ATM Ser 1981 ((Bakkenist and Kastan 2003); a gift from Mike Kastan); 
ATRIP-N ((Cortez et al. 2001); a gift from Steve Elledge); BRCA1 Ab-1 (Oncogene 
176 
Research Products); phospho-BRCAl Serl524 (Oncogene Research Products); phospho-
Chkl Ser317 (Cell Signaling); phospho-Chkl Ser345 (Cell Signalling); F A N C D 2 (a gift 
from Arlene Auerbach); g-H2AX Ser 139 (Upstate); phospho-Histone H3 Ser 10 
(Upstate); Nbsl ((Maser et al. 2001); a gift from John Petrini); phospho-p53 Serl5 (Cell 
Signalling); p53, DOl (Santa Cruz); phospho-Radl7 Ser 645 (Cell Signalling); 53BP1 
((Schultz et al. 2000); a gift from Thanos Halazonetis); a-tubulin clone B-5-1-2 (Sigma); 
and g-tubulin clone GTU-88 (Sigma). 
To prepare whole cell lysates, cell were trypsinized, washed once with media, 
washed once with cold PBS, counted and resuspended at 1 x IO4 cells/ml 4X Laemmli 
buffer (0.24 m M Tris-HCl, 4 % SDS, 2 0 % glycerol, 10% beta-mercaptoethanol, 0.004% 
bromophenol blue), boiled for 10 min and then sheared through a 28 gauge insulin 
syringe. To prepare buffer C extract, cells were trypsinized, washed once with media, 
twice with ice-cold PBS, and incubated in buffer C (van Steensel et al. 1998) on ice for 
30 min. After centrifugation at 4°C for 10 min at 14 K, the supernatant was collected and 
the Bradford assay was used to determine protein concentration. The extract was then 
combined with Laemmli buffer and boiled for 10 min. Protein samples were separated by 
SDS-PAGE and blotted to either nitrocellulose or P V D F (for A T M ) membranes. 
Membranes were blocked in 10% non-fat powdered milk/0.5% Tween-20 in PBS for 30 
min at room temperature and incubated with primary antibodies in 0.1% non-fat 
powdered milk/0.1% Tween-20 in PBS (IB) at 4°C overnight. Membranes were washed 
three times in IB, incubated with secondary antibody in IB for 40 min at room 
temperature, washed three times with IB, twice with PBS, and once with H20. E C L 
(Amersham) was applied and membranes were exposed to film. 
GST pulldowns 
This protocol was obtained from the Amersham Pharmacia biotech manual and 
Edward Yang. Large scale bacterial sonicates were obtained by growing BL21 bacteria 
in 2 x Y T A at 20-30°C with shaking until mid-log phase. 100 m M stock of IPTG was 
added to give a final concentration of 1 m M and cells were grown from 2-6 hr at 30°C. 
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Cells were spun down at 8 K for 10 min at 4°C, the supernatant was discarded, and the 
pellet was drained and placed on ice. The pellet was then resuspended in 1/20111 volume 
of 1 x PBS with 1 m M P M S F and protease inhibitor cocktail, sonicated, and 2 0 % Triton 
X-100 was added to give a final concentration of 1% Triton X-100. The samples were 
mixed gently for 30 min, centrifuged for 10 min at 10K in 4°C, and the supernatant 
containing the protein was transferred to a new tube. To purify the GST-fusion protein, 2 
ml 5 0 % glutathione bead slurry (prepared by spinning down beads, washing with PBS 
three times and resuspending beads in an equal volume of PBS) was added to each 100 
ml of bacterial sonicate and incubated on nutator for 30 min at room temperature. The 
beads were then sedimented and washed with PBS three times. 
G S T pulldowns were performed at 4°C with 10 ug of GST fusion protein which 
was added to 1 ml of B C x buffer (20 m M Tris-HCl pH 8.0, 2 0 % glycerol, x m M KCI 
where x depends on require salt (i.e. BC150 implies 150 m M KCI), 0.1 m M E D T A pH 
8.0, 0.1% NP-40, 1 m M PMSF, 1 m M D T T and protease inhibitors and given quantities 
of baculovirus-derived proteins. After 6 hr nutation in cold room, cells were spun down 
and pellets where washed with B C buffer (usually BC300 or BC400) three times. Pellets 
were resuspended in 2 x Laemelli buffer, boiled for 10 min, and then stored at -20°C until 
used for immunoblotting. 
Electromobility shift assays 
Electromobility shift assays (EMSA) were performed using a radiolabeled 
pTH12 probe containing human telomeric T T A G G G repeats. The 142 bp Hindlll / 
Asp718 fragment was isolated from pTH12 [TTAGGG],2 and gel purified using the 
QIAEXII gel purification kit. The isolated fragment was then diluted to a concentration 
of 75 ng/iul. In order to label this fragment, the following mix was made: 2 ul lOx O L B 
(0.5M Tris-HCl pH 6.8, 0.1 M MgOAc, 1 m M DTT, 0.5 mg/ml BSA; aliquots stored at 
-80°C) with fresh dG, dA, and dT (for 100 ul working buffer, add 0.6 ul each dGTP, 
dATP, and dTTP (Pharmacia)), 2 ul 75 ng/ul 142 bp pTH12 fragment, 5 ul 32P-a-dCTP 
(3000 Ci/mmol), 10 ul H20, and 1 ul Klenow (2 U/ul). This mix is then incubated for 1 
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hr at RT, add 80 ul TENS (Tris-HCl pH 7.5, 10 m M E D T A pH 8.0, 100 m M NaCl, 0.1% 
SDS) and mix, add 5 ul sheared E. coli D N A and mix. This was purified over a Sepadex 
G50 column as follows: G50 column equilibrated in a 3 ml syringe with TENS, probe is 
added and allowed to settle, 1 ml TENS is added and collected, 0.8 ml TENS is added 
and collected to be used as probe. The 0.8 ml is divided into two eppendorf tubes, 
extracted once with phenol/CIAA and once with chloroform. 40 phenol/CIAA 2 M 
NaOAc pH 5.5 and 2 X volumes ethanol are then added to precipitate probe. The probe 
is then mixed and incubated at -20 C for at least one hour, centrifuged 14K for 15 min at 
4°C, washed once with 7 0 % ethanol, spun again and resuspended in 10 m M Tris-HCl pH 
7.5. 
For E M S A under TRF2 conditions, samples are run on a 0.8% agarose gel made 
with 0.1 x TBE. The following mix is then made: 1 ul 8 0 % glycerol, 0.5 ul 1 ug/ul 
sheared E. coli D N A , 2 ul 150 m M TRIS-HC1 pH 7.5, 0.5 ul 100 ng/ul beta-casein, and 
0.5 ul labeled pTH12 probe. This mix is combined with the appropriate amounts of H20 
and quantities of protein in a total reaction volume of 20 ul. The samples are mixed 
gently and incubated at room temperature for 20 minutes and then subjected to gel 
electrophoresis at 200V for 30 minutes. The gel is then dried onto DE81/Whatmann 
paper at 80°C on a gel dryer and exposed to phosphorimager cassette overnight. 
Calcium phosphate transfection of 293T cells 
Twenty-four hours before transfection, plate 4-5x106 cells per 10 cm2 plate so 
that cells are 30-40% confluent at the time of transfection. 15-20 micrograms of D N A is 
transfected per plate. First, the following mix for two plates if prepared (in this order): 
856 ul H20, 124 ul 2 M CaCl2, 20 1 ug/ul D N A and vortex this mix. Then, 1 ml of 2 x 
HBSS (50 m M HEPES pH 7.05, 10 m M KCI, 12 m M dextrose, 280 m M NaCl, 1.5 m M 
Na2P04) is added dropwise while bubbling the mix with a 1 ml pipette. 1 ml of the final 
mix is added slowly and evenly onto a plate of the appropriate cells. 12-16 hr later, the 
media is aspirated and 10 ml fresh media is added to the plates. Cells are typically 
harvested 24 hr later. 
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Co-immunoprecipitation in 293T cells 
To perform co-immunoprecipitation from 293T cells, transfected 293T cells are 
harvested by flushing the cells off with ice-cold PBS and the cells are transferred to a 
Falcon tube. The cells are collected and the PBS is aspirated. The cells are then lysed by 
resuspending them in 0.5 ml lysis buffer (50 m M Tris-HCl pH 7.4, 1% Triton X-100, 
0.1% SDS, 150 m M NaCl, 1 m M EDTA, 1 m M DTT, 1 m M PMSF, 1 ug/ul aprotinin, 10 
ug/ul pepstatin, 1 ug/ul leupeptin) and gently resuspending the cells with a pippet. The 
lysate is then transferred to an Eppendorf tube, vortexed 3-5 sec and kept on ice. 25 ul 5 
M NaCl (raising the sodium concentration to 400 m M ) is added to each tube. The 
samples are then vortexed, incubated on ice for 5 minutes, 0.5 ml ice-old H20 (sodium 
concentration is now 200 m M ) is added. The samples are then mixed well after adding 
H20 and samples are centrifuged 14K for 10 min at 4°C. The resulting supernatant is 
then transferred to a new tube and a aliquot is saved fot the input sample. 
To begin the immunoprecipitation from these prepare lysates, antibody is added 
to the remaining supernatant and the samples are nutated in cold room for 5 hr. Then, 60 
ul 5 0 % slurry pre-blocked protein A or protein G beads is added to each tube and the 
samples are nutated in the cold room for another hour. In order to block protein A/G 
beads, 3-4 ml of beads are placed into a Falcon tube, spun down down 1 K for 1 min at 
4°C, and washed with PBS twice. The beads are resuspended in 10 ml of 5 % B S A in 
PBS and keep on ice for 30 minutes, washed three times with PBS and stored with an 
equal volume of PBS containing 0.02% sodium azide at 4°C. Then, the tubes are 
centrifuged 4 K for 5 sec at 4°C to collect the beads which are then washed three or four 
times with 1 ml cold lysis buffer. The final centrifugation is performed at 14K for 10 sec 
at 4°C. The buffer is removed and 45-60 ul pre-boiled 2 x Laemelli buffer is added to 
each pellet. The pellets are resuspend, boiled for 10 min and stored at -20°C. 
Multiple Tissue Northern Blots 
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Multiple tissue northern blots (Clontech) were pre-hybridized in Church's buffer 
(0.5M NaP04 pH 7.2, 1 m M E D T A pH 8.0, 7 % (w/v) SDS, 1% (w/v) BSA) at 55°C for 1 
hr. A radiolabeled probe was then denatured at 95°C for 5 min. The blots were 
hybridized in Church's buffer at overnight at 55°C and washed with Church's wash (40 
m M NaP04 pH 7.2, 1 m M E D T A pH 8.0, 1% (w/v) SDS) and exposed to a 
phosphorimager overnight. 
In vitro transcription / translation 
The in vitro transciption / translation system (Promega TNT coupled reticulocyte 
system) is performed using RNase-free reagents. The following reagents are combined: 
12.5 ul reticulocyte lysate, 1 ul T N T buffer, 0.5 ul polymerase (T7 or T3), 0.5 ul amino 
acids - methionine, 2 ul S35-labeled methionine, 0.5 ul RNasin, 5.5 ul HzO, 2.5 ul of 0.2 
ug /ul DNA. The mix is then incubated for 1 hr. Samples are immediately processed by 
laoding 3 \i\ undiluted sample with 2 x Laemelli buffer on SDS-PAGE. One must make 
sure that the dye front is off of the gel to prevent background. The gel is then incubated 
with Amplify (Amersham) for 15 min, transferred to Whatmann paper, dried on a gel 
dryer at 80°C for 30 min, and exposed to film. 
Transient transfection by electroporation 
Exponentially growing cells are harvested by trypsinization, washed once with 
media, washed once with PBS and resuspended at a density of 1 xlO6 cells per ul of 
transfection buffer (21 m M HEPES pH 7.05, 137 m M NaCl, 0.7 m M Na2HP04, 5 m M 
KCI, 6 m M glucose). 800 ul of suspension is then combined with 15 ug of plasmid D N A 
in an electroporation cuvette and electroporated at 300 m V with a capacitance setting of 
960 uF. The cell debris at the top of the cuvette was removed with a pipette tip and cells 
are then plated. One-third of the volume is plated onto a 10 cm2 dish with additional 
media and coverslips for immunofluorescence and two-thirds of the volume was plated 
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on a 10 cm2 dish with media for protein extracts. Cells were processed 24 hr after 
electroporation. 
Immunofluorescence 
To stain cells for immunofluorescence, tissue culture cells plated on dished with 
coverslips are washed twice with PBS, fixed with 2 % paraformaldehyde in PBS (stored at 
-20°C) for 10 min at room temperature, washed twice with PBS and permeabilized with 
0.5% NP-40 in PBS for 10 min at room temperature and washed three times with PBS. 
Cells can be stored at 4°C wrapped in PBS with sodium azide. Coverslips are placed on 
parafilm in a humidified tray and blocked with PBG (0.2% (w/v) cold water fish gelatin 
(Sigma), 0.5% (w/v) BSA (Sigma) in PBS; stored at -20°C) for 30 minutes at room 
temperature. Cells are then incubated with primary antibody diluted in PBG for 3 hr at 
room temperature, washed three times with PBG for 5 minutes at room temperature, 
incubated with secondary antibody diluted 1:100 in PBG for 40 min at room temperature, 
washed three times with PBG for 5 minutes at room temperature (with the last wash 
containing 4,6-diamidino-2-phenylindole (DAPI)). Coverslips are then washed twice 
with PBS and mounted on glass slides. This is done by draining the excess PBS and 
placing coverslip with cells down onto a drop of embedding media (dissolve 20 mg p-
phenylene diamine (Sigma) in 2 ml lOx PBS by vortexing and immediately add 10 ml 
glycerol, mixing carefully to avoid air bubbles and store in 1 ml aliquots at -70°C; should 
be colorless and not used if yellow or brown). The excess is removed with a tissue and 
the coverslip is sealed with clear nail polish. 
Alternatively, cells can be pre-extracted with Triton X-100 or treated with a 
cytoskeleton pre-extraction protocol. For Triton X-100 extraction, cells grown on 
coverslips are rinsed twice with PBS and extracted with Triton X-100 extraction buffer 
(0.5% Triton X-100, 20 m M HEPES-KOH pH 7.9, 50 m M NaCl, 3 m M MgCl2, and 300 
m M sucrose) at either room temperature or 4°C for 1-5 min. Cells are then rinsed twice 
with PBS and fixed in 3 % paraformaldehyde/ 2 % sucrose for 10 min at room 
temperature, washed twice with PBS, permeabilized in Triton X-100 buffer for 10 
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minutes at room temperature, rinsed twice with PBS and stored in PBS with sodium 
azide. 
Images were captured using an Axioplan2 Zeis microscope with a Hamamatsu 
digital camera using OpenLab software and images were processed using Adobe 
Photoshop and Adobe Illustrator. 
RNAi 
The following sequences were used as Rifl siRNAs: 








53BP1 siRNAs 1 and 2 (Wang et al. 2002); ATRIP siRNAs 1 and 2 (Cortez et al. 
2001); BRCA1 (Ganesan et al. 2002); GFP (Novina et al. 2002); lamin A/C and 
luciferase GL2 (Elbashir et al. 2001); and scrambled (Dharmacon, Scramble I duplex) 
were used. All siRNAs were obtained from Dharmacon. HeLa2 or U20S cells were 
transfected using OligofectamineTM (Invitrogen) according to the manufacturer's 
instructions. Briefly, 2.0 x IO5 of HeLa2 or 1.0 x 105 of U20S cells per well of a 6-well 
plate were plated 18-24 hr prior to transfection. Transfections were done twice with a 24 
hr interval. Cells were processed 48-72 hr after the first transfection as indicated. As a 
control, cells were mock treated or treated with lamin, GFP, scrambled, or luciferase 
siRNAs. 
Clonogenic survival assay 
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Cells transfected with Rifl and control siRNAs were harvested and counted in 
parallel 72 hr after transfection. The cells diluted to the same cell density (5 x IO4 
cells/ml), irradiated, and subsequently plated in triplicate at a range of cell densities. 
After 10 to 14 days, plates were gently washed with P B S and stained with 5 0 % 
M e O H / 7 % glacial acetic acid/43% H2O/0.1% Coomassie Brilliant Blue G for 10 min, 
rinsed with water and air-dried. Colonies were counted for the various treatments on 
plates with similar numbers of colonies. 
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